{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'plotly'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[90], line 6\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mnumpy\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m \u001b[38;5;21;01mnp\u001b[39;00m\n\u001b[1;32m      5\u001b[0m \u001b[38;5;66;03m#import holoviews as hv\u001b[39;00m\n\u001b[0;32m----> 6\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mplotly\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mgraph_objects\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m \u001b[38;5;21;01mgo\u001b[39;00m\n",
      "\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'plotly'"
     ]
    }
   ],
   "source": [
    "import shlex\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "#import holoviews as hv\n",
    "import plotly.graph_objects as go"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "OfficialTitle                  53\n",
       "StudyType                       0\n",
       "StartDate                      42\n",
       "Condition                       0\n",
       "ConditionAncestorTerm         571\n",
       "ArmGroupInterventionName     1128\n",
       "InterventionArmGroupLabel    1124\n",
       "InterventionDescription      1158\n",
       "dtype: int64"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_data = pd.read_csv('clinical_trials_dataset.csv')\n",
    "#text_data = text_data.dropna(axis=0,how='any').reset_index(drop=True)\n",
    "text_data = text_data[['OfficialTitle','StudyType','StartDate',\n",
    "           'Condition','ConditionAncestorTerm',\n",
    "           'ArmGroupInterventionName','InterventionArmGroupLabel','InterventionDescription']].copy()\n",
    "#text_data[text_data['ArmGroupInterventionName'].str.contains('Genetic')]\n",
    "text_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#deal with nan values column by column\n",
    "test = text_data.copy()\n",
    "test = test.fillna({'StartDate':'unknown'}).copy()\n",
    "test = test.fillna({'OfficialTitle':'unknown'}).copy()\n",
    "test['ConditionAncestorTerm'] = test['ConditionAncestorTerm'].fillna(test['Condition'])\n",
    "test = test.fillna({'ArmGroupInterventionName':'other or NA'}).copy()\n",
    "test = test.fillna({'InterventionArmGroupLabel':'other or NA'}).copy()\n",
    "test = test.fillna({'InterventionDescription':'other or NA'}).copy()\n",
    "text_data = test.copy()\n",
    "\n",
    "del test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "OfficialTitle                0\n",
       "StudyType                    0\n",
       "StartDate                    0\n",
       "Condition                    0\n",
       "ConditionAncestorTerm        0\n",
       "ArmGroupInterventionName     0\n",
       "InterventionArmGroupLabel    0\n",
       "InterventionDescription      0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#replace nan values with other appropriate values\n",
    "text_data.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>OfficialTitle</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>Condition</th>\n",
       "      <th>ConditionAncestorTerm</th>\n",
       "      <th>ArmGroupInterventionName</th>\n",
       "      <th>InterventionArmGroupLabel</th>\n",
       "      <th>InterventionDescription</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Phase I/IIa, First-in-human, Open-label, Singl...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>September 2024</td>\n",
       "      <td>Drug Resistant Epilepsy</td>\n",
       "      <td>Brain Diseases|Central Nervous System Diseases...</td>\n",
       "      <td>Genetic: lentiviral gene therapy</td>\n",
       "      <td>lentiviral gene therapy treatment (Interventio...</td>\n",
       "      <td>lentiviral gene therapy to treat drug resistan...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>A Phase I Study to Assess the Safety, Tolerabi...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 7, 2022</td>\n",
       "      <td>Alzheimer's Disease|Mild Cognitive Impairment</td>\n",
       "      <td>Dementia|Brain Diseases|Central Nervous System...</td>\n",
       "      <td>Genetic: AAV2-BDNF Gene Therapy|Biological: AA...</td>\n",
       "      <td>Gene transfer of AAV2-BDNF|Gene transfer of AA...</td>\n",
       "      <td>AAV2-BDNF is a genetically engineered adeno-as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>A Phase I/II Clinical Trial of Hematopoietic S...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>April 9, 2010</td>\n",
       "      <td>Lysosomal Storage Disease|Metachromatic Leukod...</td>\n",
       "      <td>Metabolism, Inborn Errors|Genetic Diseases, In...</td>\n",
       "      <td>Genetic: OTL-200 Gene Therapy</td>\n",
       "      <td>OTL-200 Gene Therapy</td>\n",
       "      <td>Autologous hematopoietic stem/progenitor cells...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Phase I/II Clinical Trial of Autologous Hemato...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 23, 2021</td>\n",
       "      <td>Severe Combined Immunodeficiency Due to RAG1 D...</td>\n",
       "      <td>Immune System Diseases|Primary Immunodeficienc...</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "      <td>Gene therapy</td>\n",
       "      <td>Patients will be infused with autologous CD34+...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>A Phase I/II Gene Therapy Trial for X-CGD With...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 2013</td>\n",
       "      <td>X-linked Chronic Granulomatous Disease</td>\n",
       "      <td>Pathologic Processes|Phagocyte Bactericidal Dy...</td>\n",
       "      <td>Genetic: ex-vivo gene-therapy</td>\n",
       "      <td>ex-vivo gene-therapy</td>\n",
       "      <td>transplantation autologous CD34+ cells, transd...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5804</th>\n",
       "      <td>An Open-label, Dose-escalation Study to Evalua...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 5, 2023</td>\n",
       "      <td>Neovascular Age-related Macular Degeneration</td>\n",
       "      <td>Retinal Degeneration|Retinal Diseases|Eye Dise...</td>\n",
       "      <td>Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG...</td>\n",
       "      <td>Dose Level 1|Dose Level 2|Dose Level 3</td>\n",
       "      <td>SKG0106 is a recombinant adeno-associated viru...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5858</th>\n",
       "      <td>WEST-KOaST Study: WES (Whole Exome Sequencing)...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>December 1, 2023</td>\n",
       "      <td>Testicular Cancer</td>\n",
       "      <td>Endocrine Gland Neoplasms|Neoplasms by Site|Ne...</td>\n",
       "      <td>Genetic: Analysis of biological samples of sal...</td>\n",
       "      <td>First-degree family members of patients with t...</td>\n",
       "      <td>The project aims to collect biological samples...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5864</th>\n",
       "      <td>Phase II Study of Capecitabine in Combination ...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2006</td>\n",
       "      <td>Esophageal Cancer</td>\n",
       "      <td>Gastrointestinal Neoplasms|Digestive System Ne...</td>\n",
       "      <td>Drug: capecitabine|Drug: oxaliplatin|Genetic: ...</td>\n",
       "      <td>Chemo|Chemo|Chemo|Chemo|Chemo|Chemo|Chemo|Chem...</td>\n",
       "      <td>Oral|IV|Correlative Study|Correlative Study|Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5887</th>\n",
       "      <td>Neoadjuvant Intratumoral Injection of Dendriti...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 1, 2006</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Neoplasms by Site|Neoplasms|Breast Diseases|Sk...</td>\n",
       "      <td>Biological: therapeutic autologous dendritic c...</td>\n",
       "      <td>Vaccine|Vaccine|Vaccine|Vaccine|Vaccine|Vaccin...</td>\n",
       "      <td>injected into the primary breast mass or palpa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6076</th>\n",
       "      <td>A Phase I/II Trial of Temozolomide and ABT-888...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 13, 2009</td>\n",
       "      <td>Brain and Central Nervous System Tumors</td>\n",
       "      <td>Astrocytoma|Glioma|Neoplasms, Neuroepithelial|...</td>\n",
       "      <td>Drug: temozolomide|Drug: veliparib|Genetic: DN...</td>\n",
       "      <td>Dose Escalation|Dose Escalation|Dose Escalatio...</td>\n",
       "      <td>other or NA</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>425 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          OfficialTitle       StudyType  \\\n",
       "0     Phase I/IIa, First-in-human, Open-label, Singl...  Interventional   \n",
       "5     A Phase I Study to Assess the Safety, Tolerabi...  Interventional   \n",
       "7     A Phase I/II Clinical Trial of Hematopoietic S...  Interventional   \n",
       "8     Phase I/II Clinical Trial of Autologous Hemato...  Interventional   \n",
       "12    A Phase I/II Gene Therapy Trial for X-CGD With...  Interventional   \n",
       "...                                                 ...             ...   \n",
       "5804  An Open-label, Dose-escalation Study to Evalua...  Interventional   \n",
       "5858  WEST-KOaST Study: WES (Whole Exome Sequencing)...  Interventional   \n",
       "5864  Phase II Study of Capecitabine in Combination ...  Interventional   \n",
       "5887  Neoadjuvant Intratumoral Injection of Dendriti...  Interventional   \n",
       "6076  A Phase I/II Trial of Temozolomide and ABT-888...  Interventional   \n",
       "\n",
       "             StartDate                                          Condition  \\\n",
       "0       September 2024                            Drug Resistant Epilepsy   \n",
       "5     February 7, 2022      Alzheimer's Disease|Mild Cognitive Impairment   \n",
       "7        April 9, 2010  Lysosomal Storage Disease|Metachromatic Leukod...   \n",
       "8        July 23, 2021  Severe Combined Immunodeficiency Due to RAG1 D...   \n",
       "12           July 2013             X-linked Chronic Granulomatous Disease   \n",
       "...                ...                                                ...   \n",
       "5804       May 5, 2023       Neovascular Age-related Macular Degeneration   \n",
       "5858  December 1, 2023                                  Testicular Cancer   \n",
       "5864     November 2006                                  Esophageal Cancer   \n",
       "5887       May 1, 2006                                      Breast Cancer   \n",
       "6076     July 13, 2009            Brain and Central Nervous System Tumors   \n",
       "\n",
       "                                  ConditionAncestorTerm  \\\n",
       "0     Brain Diseases|Central Nervous System Diseases...   \n",
       "5     Dementia|Brain Diseases|Central Nervous System...   \n",
       "7     Metabolism, Inborn Errors|Genetic Diseases, In...   \n",
       "8     Immune System Diseases|Primary Immunodeficienc...   \n",
       "12    Pathologic Processes|Phagocyte Bactericidal Dy...   \n",
       "...                                                 ...   \n",
       "5804  Retinal Degeneration|Retinal Diseases|Eye Dise...   \n",
       "5858  Endocrine Gland Neoplasms|Neoplasms by Site|Ne...   \n",
       "5864  Gastrointestinal Neoplasms|Digestive System Ne...   \n",
       "5887  Neoplasms by Site|Neoplasms|Breast Diseases|Sk...   \n",
       "6076  Astrocytoma|Glioma|Neoplasms, Neuroepithelial|...   \n",
       "\n",
       "                               ArmGroupInterventionName  \\\n",
       "0                      Genetic: lentiviral gene therapy   \n",
       "5     Genetic: AAV2-BDNF Gene Therapy|Biological: AA...   \n",
       "7                         Genetic: OTL-200 Gene Therapy   \n",
       "8                                 Genetic: Gene therapy   \n",
       "12                        Genetic: ex-vivo gene-therapy   \n",
       "...                                                 ...   \n",
       "5804  Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG...   \n",
       "5858  Genetic: Analysis of biological samples of sal...   \n",
       "5864  Drug: capecitabine|Drug: oxaliplatin|Genetic: ...   \n",
       "5887  Biological: therapeutic autologous dendritic c...   \n",
       "6076  Drug: temozolomide|Drug: veliparib|Genetic: DN...   \n",
       "\n",
       "                              InterventionArmGroupLabel  \\\n",
       "0     lentiviral gene therapy treatment (Interventio...   \n",
       "5     Gene transfer of AAV2-BDNF|Gene transfer of AA...   \n",
       "7                                  OTL-200 Gene Therapy   \n",
       "8                                          Gene therapy   \n",
       "12                                 ex-vivo gene-therapy   \n",
       "...                                                 ...   \n",
       "5804             Dose Level 1|Dose Level 2|Dose Level 3   \n",
       "5858  First-degree family members of patients with t...   \n",
       "5864  Chemo|Chemo|Chemo|Chemo|Chemo|Chemo|Chemo|Chem...   \n",
       "5887  Vaccine|Vaccine|Vaccine|Vaccine|Vaccine|Vaccin...   \n",
       "6076  Dose Escalation|Dose Escalation|Dose Escalatio...   \n",
       "\n",
       "                                InterventionDescription  \n",
       "0     lentiviral gene therapy to treat drug resistan...  \n",
       "5     AAV2-BDNF is a genetically engineered adeno-as...  \n",
       "7     Autologous hematopoietic stem/progenitor cells...  \n",
       "8     Patients will be infused with autologous CD34+...  \n",
       "12    transplantation autologous CD34+ cells, transd...  \n",
       "...                                                 ...  \n",
       "5804  SKG0106 is a recombinant adeno-associated viru...  \n",
       "5858  The project aims to collect biological samples...  \n",
       "5864  Oral|IV|Correlative Study|Correlative Study|Co...  \n",
       "5887  injected into the primary breast mass or palpa...  \n",
       "6076                                        other or NA  \n",
       "\n",
       "[425 rows x 8 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_data[(text_data['ArmGroupInterventionName'].str.contains('Genetic:')) & (text_data['StudyType']=='Interventional')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#this is for condition names\n",
    "#the split('|') must be already applied to cond_list, function does not do that\n",
    "def minimum_cond_name(cond_list):\n",
    "    con_size=[]\n",
    "    for elem in text_data['ConditionAncestorTerm'][0].split('|'):\n",
    "        con_size.append(elem.count(' '))\n",
    "    return cond_list[con_size.index(min(con_size))]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "#add column with modified conditions\n",
    "text_data['mod_ConditionAncestorTerm'] = [minimum_cond_name(con_term.split('|')) for con_term in text_data['ConditionAncestorTerm']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "condword_list = [' '.join(word.split(',')) if ',' in word else word for word in text_data['mod_ConditionAncestorTerm'].values]\n",
    "cond_word_count = []\n",
    "for word in condword_list:\n",
    "    for each_word in word.split(' '):\n",
    "        cond_word_count.append(each_word)\n",
    "\n",
    "frequency_map = {}\n",
    "for item in cond_word_count:\n",
    "    if item in frequency_map:\n",
    "        frequency_map[item] += 1\n",
    "    else:\n",
    "        frequency_map[item] = 1\n",
    "\n",
    "frequency_map_df = pd.DataFrame(frequency_map.items(),columns=['word','frequency']).sort_values(by='frequency',ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>word</th>\n",
       "      <th>frequency</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>2204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td></td>\n",
       "      <td>1330</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Diseases</td>\n",
       "      <td>942</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>by</td>\n",
       "      <td>914</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Type</td>\n",
       "      <td>521</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>Metastasis</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>515</th>\n",
       "      <td>Frontline</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514</th>\n",
       "      <td>From</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>Complete</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>928</th>\n",
       "      <td>Infertility</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>929 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            word  frequency\n",
       "8      Neoplasms       2204\n",
       "3                      1330\n",
       "1       Diseases        942\n",
       "27            by        914\n",
       "76          Type        521\n",
       "..           ...        ...\n",
       "518   Metastasis          1\n",
       "515    Frontline          1\n",
       "514         From          1\n",
       "512     Complete          1\n",
       "928  Infertility          1\n",
       "\n",
       "[929 rows x 2 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pick_words= ['Diseases']\n",
    "frequency_map_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# even filter out conditions based on popular words\n",
    "selected_cond_words = []\n",
    "for elem in text_data['mod_ConditionAncestorTerm'].values:\n",
    "    if len(list(set(elem.split(' ')) & set(pick_words)))!=0:\n",
    "        selected_cond_words.append(elem)\n",
    "    else:\n",
    "        selected_cond_words.append('others')\n",
    "\n",
    "text_data['selected_conditionterms'] = selected_cond_words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "mod_ConditionAncestorTerm\n",
       "Neoplasms by Histologic Type             517\n",
       "Neoplasms by Site                        394\n",
       "Neoplasms, Glandular and Epithelial      269\n",
       "Respiratory Tract Neoplasms              243\n",
       "Pathologic Processes                     191\n",
       "                                        ... \n",
       "Asthma in Children                         1\n",
       "Vasculitis                                 1\n",
       "Advanced Nonhaematologic Malignancies      1\n",
       "Acute Leukaemia                            1\n",
       "Infertility, Male                          1\n",
       "Name: count, Length: 720, dtype: int64"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_data['mod_ConditionAncestorTerm'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Genetic: gene transduced PBL and/or gene transduced HSC\n",
      "Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort|Genetic: Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort\n",
      "Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort|Genetic: Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort\n",
      "Genetic: OTL-103\n",
      "Genetic: Strimvelis\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: Ad5-yCD/mutTKSR39rep-ADP\n",
      "Genetic: Intervention on primary cultured cells\n",
      "Genetic: OTL-103\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314|Genetic: RGX-314\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Dose 1 of BMN 331|Genetic: Dose 2 of BMN 331|Genetic: Dose 3 of BMN 331|Genetic: Dose 4 of BMN 331|Genetic: Dose 5 of BMN 331|Genetic: Dose 6 of BMN 331|Genetic: Dose 7 of BMN 331\n",
      "Genetic: Injection of GS001\n",
      "Genetic: One 20cm2/10cm2 autologous skin sheet graft\n",
      "Genetic: WT1 TCR-transduced T cells\n",
      "Genetic: Infusion of lentiviral TYF-CGD-modified autologous stem cells\n",
      "Genetic: Ad.hIL-12\n",
      "Genetic: GX-12|Drug: HAART\n",
      "Genetic: RGX-202|Genetic: RGX-202\n",
      "Genetic: RGX-202|Genetic: RGX-202\n",
      "Genetic: Low dose LX2006|Genetic: Mid Dose LX2006|Genetic: High Dose LX2006\n",
      "Genetic: Low dose LX2006|Genetic: Mid Dose LX2006|Genetic: High Dose LX2006\n",
      "Genetic: Low dose LX2006|Genetic: Mid Dose LX2006|Genetic: High Dose LX2006\n",
      "Genetic: Single dose intravenous injection of BBM 002\n",
      "Genetic: Single dose intravenous injection of BBM-H901\n",
      "Genetic: TSHA-102|Genetic: TSHA-102\n",
      "Genetic: TSHA-102|Genetic: TSHA-102\n",
      "Genetic: Gene-modified autologous stem cells\n",
      "Genetic: TSHA-102|Genetic: TSHA-102\n",
      "Genetic: TSHA-102|Genetic: TSHA-102\n",
      "Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Biological: Aflibercept (EYLEA®)\n",
      "Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Biological: Aflibercept (EYLEA®)\n",
      "Genetic: RGX-314|Genetic: RGX-314|Biological: Ranibizumab (LUCENTIS®)\n",
      "Genetic: RGX-314|Genetic: RGX-314|Biological: Ranibizumab (LUCENTIS®)\n",
      "Genetic: Retrovirus Construct\n",
      "Genetic: SGT-94\n",
      "Genetic: HG004\n",
      "Genetic: transduced CD34+ hematopoietic stem cell\n",
      "Genetic: GC304|Genetic: GC304|Genetic: GC304\n",
      "Genetic: GC304|Genetic: GC304|Genetic: GC304\n",
      "Genetic: GC304|Genetic: GC304|Genetic: GC304\n",
      "Genetic: GC101|Genetic: GC101\n",
      "Genetic: GC101|Genetic: GC101\n",
      "Genetic: GC101|Genetic: GC101|Genetic: GC101\n",
      "Genetic: GC101|Genetic: GC101|Genetic: GC101\n",
      "Genetic: GC101|Genetic: GC101|Genetic: GC101\n",
      "Genetic: AT132|Genetic: AT132\n",
      "Genetic: AT132|Genetic: AT132\n",
      "Genetic: FLT190\n",
      "Biological: Ad5-CMV-NIS|Drug: liothyronine sodium|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Radiation: iodine I 131\n",
      "Genetic: JWK006|Genetic: JWK006|Genetic: JWK006\n",
      "Genetic: JWK006|Genetic: JWK006|Genetic: JWK006\n",
      "Genetic: JWK006|Genetic: JWK006|Genetic: JWK006\n",
      "Genetic: rAAV2.REP1\n",
      "Genetic: MYDICAR-single intracoronary infusion|Genetic: Placebo; single intracoronary infusion\n",
      "Genetic: MYDICAR-single intracoronary infusion|Genetic: Placebo; single intracoronary infusion\n",
      "Genetic: RP-A501\n",
      "Genetic: OZ1 transduced cells\n",
      "Genetic: DREPAGLOBE drug product\n",
      "Biological: Ranibizumab|Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Genetic: RGX-314 Dose 3|Drug: Local steroid|Genetic: RGX-314 Dose 3|Drug: Topical steroid\n",
      "Biological: Ranibizumab|Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Genetic: RGX-314 Dose 3|Drug: Local steroid|Genetic: RGX-314 Dose 3|Drug: Topical steroid\n",
      "Biological: Ranibizumab|Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Genetic: RGX-314 Dose 3|Drug: Local steroid|Genetic: RGX-314 Dose 3|Drug: Topical steroid\n",
      "Biological: Ranibizumab|Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Genetic: RGX-314 Dose 3|Drug: Local steroid|Genetic: RGX-314 Dose 3|Drug: Topical steroid\n",
      "Biological: Ranibizumab|Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Genetic: RGX-314 Dose 3|Drug: Local steroid|Genetic: RGX-314 Dose 3|Drug: Topical steroid\n",
      "Genetic: BD311\n",
      "Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Drug: Topical Steroid\n",
      "Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Drug: Topical Steroid\n",
      "Genetic: RGX-314 Dose 1|Genetic: RGX-314 Dose 2|Genetic: RGX-314 Dose 3|Drug: Topical Steroid\n",
      "Genetic: intracerebral administration of AAVrh.10cuARSA\n",
      "Genetic: RGX-111|Genetic: RGX-111\n",
      "Genetic: RGX-111|Genetic: RGX-111\n",
      "Genetic: Gene Transfer|Drug: scAAV2/8-LP1-hFIXco\n",
      "Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN\n",
      "Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN\n",
      "Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN\n",
      "Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN|Genetic: scAAv9/JeT-GAN\n",
      "Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043\n",
      "Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043\n",
      "Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043\n",
      "Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043\n",
      "Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043|Genetic: ADVM-043\n",
      "Genetic: SPK-8016\n",
      "Genetic: LX2020\n",
      "Biological: Genetic: GC301\n",
      "Genetic: KL003 cell injection Drug Product\n",
      "Genetic: CL20-i4-EF1α-hγc-OPT|Drug: Busulfan|Device: CliniMacs\n",
      "Genetic: ARU-1801\n",
      "Genetic: SBT101|Procedure: Imitation Procedure\n",
      "Genetic: Strimvelis\n",
      "Genetic: Gene-modified autologous stem cells\n",
      "Genetic: Ad5.SSTR/TK.RGD|Drug: Ganciclovir (GCV)\n",
      "Genetic: pHIV7-shI-TAR-CCR5RZ treated CD4 cells\n",
      "Genetic: SPK-8011\n",
      "Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level -1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 2|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 3\n",
      "Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level -1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 2|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 3\n",
      "Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level -1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 2|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 3\n",
      "Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level -1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 1|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 2|Drug: Cyclophosphamide or Bendamustine|Genetic: Dose Level 3\n",
      "Genetic: RGX-121\n",
      "Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection\n",
      "Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection\n",
      "Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection\n",
      "Genetic: AT-GTX-501\n",
      "Genetic: Low dose AT-GTX-502|Genetic: High dose AT-GTX-502\n",
      "Genetic: Low dose AT-GTX-502|Genetic: High dose AT-GTX-502\n",
      "Genetic: AAV2/5-RPGR|Genetic: AAV2/5-RPGR\n",
      "Genetic: AAV2/5-RPGR|Genetic: AAV2/5-RPGR\n",
      "Genetic: bb1111\n",
      "Genetic: SRP-9004|Genetic: SRP-9004|Genetic: SRP-9004\n",
      "Genetic: SRP-9004|Genetic: SRP-9004|Genetic: SRP-9004\n",
      "Genetic: SRP-9004|Genetic: SRP-9004|Genetic: SRP-9004\n",
      "Genetic: Strimvelis\n",
      "Genetic: CD40 Gene Transfer\n",
      "Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection|Biological: Aflibercept intravitreal injection\n",
      "Genetic: LX102 subretinal injection|Genetic: LX102 subretinal injection|Biological: Aflibercept intravitreal injection\n",
      "Genetic: AAV2-hAQP1 Concentration 1|Genetic: AAV2-hAQP1 Concentration 2|Other: Placebo\n",
      "Genetic: AAV2-hAQP1 Concentration 1|Genetic: AAV2-hAQP1 Concentration 2|Other: Placebo\n",
      "Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381\n",
      "Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381\n",
      "Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381\n",
      "Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381\n",
      "Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381|Genetic: RGX-381\n",
      "Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec\n",
      "Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec\n",
      "Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec|Genetic: zocaglusagene nuzaparvovec\n",
      "Genetic: Infusion of autologous EFS-ADA LV CD34+ cells|Drug: Busulfan|Drug: Peg-Ada|Other: Haematopoietic Stem Cell Transplantation (HSCT)\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121|Genetic: RGX-121\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100|Genetic: GS-100\n",
      "Genetic: CSL222 (AAV5-hFIXco-Padua)\n",
      "Genetic: AT-GTX-501\n",
      "Genetic: TYF-ADA gene-modified autologous stem cells\n",
      "Genetic: NGN-101|Genetic: NGN-101|Genetic: NGN-101\n",
      "Genetic: NGN-101|Genetic: NGN-101|Genetic: NGN-101\n",
      "Genetic: NGN-101|Genetic: NGN-101|Genetic: NGN-101\n",
      "Genetic: FLT190\n",
      "Genetic: AAV5-hFIX|Genetic: AAV5-hFIX\n",
      "Genetic: AAV5-hFIX|Genetic: AAV5-hFIX\n",
      "Genetic: AAV1/SERCA2a|Drug: Placebo\n",
      "Genetic: ARTEGENE drug product\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: AAV-GAD Dose 1|Genetic: AAV-GAD Dose 2|Procedure: Sham Surgery\n",
      "Genetic: AAV-GAD Dose 1|Genetic: AAV-GAD Dose 2|Procedure: Sham Surgery\n",
      "Genetic: ADVM-043\n",
      "Genetic: Single dose intravenous injection of BBM-H901\n",
      "Genetic: CTNS-RD-04 or CTNS-RD-04-LB (where the suffix \"-LB\" stands for LentiBOOST)\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: FT-002|Genetic: FT-002|Genetic: FT-002\n",
      "Genetic: FT-002|Genetic: FT-002|Genetic: FT-002\n",
      "Genetic: FT-002|Genetic: FT-002|Genetic: FT-002\n",
      "Genetic: OTL-200\n",
      "Procedure: Intrathalamic AAV.PGRN administration|Genetic: Intrathalamic AVB-101|Procedure: Intrathalamic AAV.PGRN administration|Genetic: Intrathalamic AVB-101\n",
      "Procedure: Intrathalamic AAV.PGRN administration|Genetic: Intrathalamic AVB-101|Procedure: Intrathalamic AAV.PGRN administration|Genetic: Intrathalamic AVB-101\n",
      "Genetic: UX701|Genetic: UX701|Genetic: UX701|Genetic: UX701|Other: Placebo|Genetic: UX701|Other: Placebo\n",
      "Genetic: UX701|Genetic: UX701|Genetic: UX701|Genetic: UX701|Other: Placebo|Genetic: UX701|Other: Placebo\n",
      "Genetic: UX701|Genetic: UX701|Genetic: UX701|Genetic: UX701|Other: Placebo|Genetic: UX701|Other: Placebo\n",
      "Genetic: UX701|Genetic: UX701|Genetic: UX701|Genetic: UX701|Other: Placebo|Genetic: UX701|Other: Placebo\n",
      "Genetic: UX701|Genetic: UX701|Genetic: UX701|Genetic: UX701|Other: Placebo|Genetic: UX701|Other: Placebo\n",
      "Genetic: GS010|Other: Sham Intravitreal Injection\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: FT-003|Genetic: FT-003|Genetic: FT-003\n",
      "Genetic: OTL-200\n",
      "Genetic: rAAV2-hRPE65\n",
      "Genetic: SGT-003|Genetic: SGT-003\n",
      "Genetic: SGT-003|Genetic: SGT-003\n",
      "Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Drug: transient immune-modulation|Drug: Placebo\n",
      "Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Drug: transient immune-modulation|Drug: Placebo\n",
      "Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Drug: transient immune-modulation|Drug: Placebo\n",
      "Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Drug: transient immune-modulation|Drug: Placebo\n",
      "Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Genetic: GNSC-001|Drug: transient immune-modulation|Genetic: GNSC-001|Drug: transient immune-modulation|Drug: Placebo\n",
      "Genetic: NGN-401|Genetic: NGN-401\n",
      "Genetic: NGN-401|Genetic: NGN-401\n",
      "Genetic: AdCD40L\n",
      "Genetic: GNT0003\n",
      "Genetic: LYS-GM101\n",
      "Genetic: AT342|Genetic: AT342|Genetic: AT342\n",
      "Genetic: AT342|Genetic: AT342|Genetic: AT342\n",
      "Genetic: AT342|Genetic: AT342|Genetic: AT342\n",
      "Genetic: GC301|Genetic: GC301|Genetic: GC301\n",
      "Genetic: GC301|Genetic: GC301|Genetic: GC301\n",
      "Genetic: GC301|Genetic: GC301|Genetic: GC301\n",
      "Genetic: CRG003 injection\n",
      "Genetic: BBM-F101 injection\n",
      "Genetic: NGGT006\n",
      "Genetic: Cohort1|Genetic: Cohort2\n",
      "Genetic: Cohort1|Genetic: Cohort2\n",
      "Genetic: AAV9-hSyn1-miGRIK2|Genetic: AAV9-hSyn1-miGRIK2\n",
      "Genetic: AAV9-hSyn1-miGRIK2|Genetic: AAV9-hSyn1-miGRIK2\n",
      "Genetic: Single dose intravenous injection of BBM-H803\n",
      "Genetic: Rexin-G Dose 1|Genetic: Rexin-G Dose 2|Genetic: Rexin-G Dose 3|Genetic: Rexin-G Dose 4\n",
      "Genetic: Rexin-G Dose 1|Genetic: Rexin-G Dose 2|Genetic: Rexin-G Dose 3|Genetic: Rexin-G Dose 4\n",
      "Genetic: Rexin-G Dose 1|Genetic: Rexin-G Dose 2|Genetic: Rexin-G Dose 3|Genetic: Rexin-G Dose 4\n",
      "Genetic: Rexin-G Dose 1|Genetic: Rexin-G Dose 2|Genetic: Rexin-G Dose 3|Genetic: Rexin-G Dose 4\n",
      "Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Drug: Oral corticosteroids\n",
      "Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Drug: Oral corticosteroids\n",
      "Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Other: Placebo|Drug: Oral corticosteroids|Drug: Placebo for oral corticosteroids|Genetic: DTX401|Drug: Oral corticosteroids\n",
      "Genetic: Autologous CD34+ cells genetically modified\n",
      "Genetic: AAV9/CLN7\n",
      "Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101)|Drug: busulfan|Drug: PEG-ADA ERT\n",
      "Genetic: AAV-GAD\n",
      "Genetic: SRP-6004\n",
      "Genetic: SRP-9003\n",
      "Genetic: PF-06939926\n",
      "Genetic: DTX301|Other: Placebo|Drug: Oral Corticosteroids|Drug: Placebo for oral corticosteroids|Drug: Sodium Acetate|Genetic: DTX301|Other: Placebo|Drug: Oral Corticosteroids|Drug: Placebo for oral corticosteroids|Drug: Sodium Acetate\n",
      "Genetic: DTX301|Other: Placebo|Drug: Oral Corticosteroids|Drug: Placebo for oral corticosteroids|Drug: Sodium Acetate|Genetic: DTX301|Other: Placebo|Drug: Oral Corticosteroids|Drug: Placebo for oral corticosteroids|Drug: Sodium Acetate\n",
      "Genetic: Lenti-D\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: delandistrogene moxeparvovec\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: delandistrogene moxeparvovec\n",
      "Genetic: DTX101|Genetic: DTX101\n",
      "Genetic: DTX101|Genetic: DTX101\n",
      "Genetic: SHP648|Genetic: SHP648|Genetic: SHP648\n",
      "Genetic: SHP648|Genetic: SHP648|Genetic: SHP648\n",
      "Genetic: SHP648|Genetic: SHP648|Genetic: SHP648\n",
      "Genetic: SAF-301\n",
      "Procedure: Skin Biopsy|Genetic: Gene Modified Neuroblastoma Cells\n",
      "Genetic: rAAV2-CBSB-hRPE65\n",
      "Genetic: SPK-8011|Genetic: SPK-8011|Genetic: SPK-8011\n",
      "Genetic: SPK-8011|Genetic: SPK-8011|Genetic: SPK-8011\n",
      "Genetic: SPK-8011|Genetic: SPK-8011|Genetic: SPK-8011\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: GMCN-508A Drug Product\n",
      "Genetic: OTOV101N+OTOV101C Injections\n",
      "Genetic: TN-401|Genetic: TN-401\n",
      "Genetic: TN-401|Genetic: TN-401\n",
      "Genetic: SAF-301\n",
      "Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells\n",
      "Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells\n",
      "Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells|Genetic: CMV-TCR transduced donor-derived T cells\n",
      "Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)|Drug: busulfan|Drug: PEG-ADA ERT\n",
      "Genetic: delandistrogene moxeparvovec\n",
      "Genetic: delandistrogene moxeparvovec|Biological: imlifidase\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102|Genetic: HMI-102\n",
      "Genetic: LentiGlobin BB305 Drug Product\n",
      "Genetic: GMCN-508B (LentiRed)\n",
      "Genetic: VRX496-Modified Autologous T cells\n",
      "Genetic: FLT201\n",
      "Genetic: NGGT002\n",
      "Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR\n",
      "Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR\n",
      "Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR|Biological: Genetic: AAV5-hRKp.RPGR\n",
      "Genetic: BIIB111|Genetic: BIIB111\n",
      "Genetic: BIIB111|Genetic: BIIB111\n",
      "Genetic: ZS801\n",
      "Genetic: FT-001 Low Dose|Genetic: FT-001 Mid Dose|Genetic: FT-001 High Dose\n",
      "Genetic: FT-001 Low Dose|Genetic: FT-001 Mid Dose|Genetic: FT-001 High Dose\n",
      "Genetic: FT-001 Low Dose|Genetic: FT-001 Mid Dose|Genetic: FT-001 High Dose\n",
      "Genetic: Experimental: OTL-203|Genetic: Active Comparator: Allo-HSCT\n",
      "Genetic: Experimental: OTL-203|Genetic: Active Comparator: Allo-HSCT\n",
      "Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose\n",
      "Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose\n",
      "Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose\n",
      "Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose|Biological: Genetic: AAV5-hRKp.RPGR Low Dose\n",
      "Genetic: Engensis (VM202)|Drug: Placebo\n",
      "Genetic: verbrinacogene setparvovec\n",
      "Genetic: Long-Term Follow-Up of Patients who Received Engensis (VM202)|Drug: Long-Term Follow-Up of Patients who Received Placebo\n",
      "Genetic: NL003|Genetic: NL003|Genetic: NL003|Other: Normal Saline\n",
      "Genetic: NL003|Genetic: NL003|Genetic: NL003|Other: Normal Saline\n",
      "Genetic: NL003|Genetic: NL003|Genetic: NL003|Other: Normal Saline\n",
      "Genetic: GS010\n",
      "Genetic: NL003|Other: Normal Saline\n",
      "Genetic: NL003|Other: Normal Saline\n",
      "Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)|Drug: Busulfan|Drug: Peg-Ada\n",
      "Genetic: BIIB111|Genetic: BIIB112\n",
      "Genetic: BIIB111|Genetic: BIIB112\n",
      "Genetic: Autologous WT1 TCR transduced T cells\n",
      "Genetic: delandistrogene moxeparvovec|Drug: Standard of Care\n",
      "Genetic: SRD-001|Genetic: SRD-001\n",
      "Genetic: SRD-001|Genetic: SRD-001\n",
      "Genetic: BD211 Drug Product\n",
      "Genetic: No Intervention\n",
      "Genetic: AAV-mediated REP1 gene replacement\n",
      "Genetic: PF-06939926|Other: Placebo|Other: Placebo|Genetic: PF-06939926\n",
      "Genetic: PF-06939926|Other: Placebo|Other: Placebo|Genetic: PF-06939926\n",
      "Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Prophylactic Corticosteroid Taper Regimen\n",
      "Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Prophylactic Corticosteroid Taper Regimen\n",
      "Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Prophylactic Corticosteroid Taper Regimen\n",
      "Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Reactive Corticosteroid Taper Regimen|Genetic: scAAV8OTC|Drug: Prophylactic Corticosteroid Taper Regimen\n",
      "Genetic: SGT-53|Drug: Temozolomide\n",
      "Genetic: SGT-53|Drug: nab-paclitaxel|Drug: Gemcitabine\n",
      "Genetic: Autologous HER2-specific T cells|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous CAR Positive T cells\n",
      "Genetic: Autologous HER2-specific T cells|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous CAR Positive T cells\n",
      "Genetic: Autologous HER2-specific T cells|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous CAR Positive T cells\n",
      "Genetic: Autologous HER2-specific T cells|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous CAR Positive T cells\n",
      "Genetic: Autologous HER2-specific T cells|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous HER2-specific T cells|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Autologous CAR Positive T cells\n",
      "Genetic: bb1111|Genetic: bb1111|Genetic: bb1111\n",
      "Genetic: bb1111|Genetic: bb1111|Genetic: bb1111\n",
      "Genetic: bb1111|Genetic: bb1111|Genetic: bb1111\n",
      "Genetic: LX101|Genetic: LX101\n",
      "Genetic: LX101|Genetic: LX101\n",
      "Genetic: ZS802\n",
      "Genetic: GT005\n",
      "Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\n",
      "Genetic: LentiGlobin BB305 Drug Product\n",
      "Genetic: LentiGlobin BB305 Drug Product\n",
      "Genetic: PF-06939926\n",
      "Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen\n",
      "Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen\n",
      "Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen\n",
      "Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen|Genetic: DTX401|Drug: steroid regimen\n",
      "Genetic: VCN-01\n",
      "Genetic: VGB-R04\n",
      "Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\n",
      "Genetic: CD19.CAR-aNKT cells|Genetic: CD19.CAR-aNKT cells\n",
      "Genetic: CD19.CAR-aNKT cells|Genetic: CD19.CAR-aNKT cells\n",
      "Genetic: SPK-3006\n",
      "Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: mycophenolate mofetil|Drug: cyclosporine|Drug: methylprednisolone\n",
      "Genetic: SGT-001|Genetic: SGT-001\n",
      "Genetic: SGT-001|Genetic: SGT-001\n",
      "Genetic: Convection enhanced delivery/AAV2-GDNF\n",
      "Genetic: Eladocagene Exuparvovec\n",
      "Genetic: GS010|Genetic: GS010|Drug: Placebo\n",
      "Genetic: GS010|Genetic: GS010|Drug: Placebo\n",
      "Genetic: OZ1|Genetic: CD34+ cells|Other: Placebo|Genetic: CD34+ cells\n",
      "Genetic: OZ1|Genetic: CD34+ cells|Other: Placebo|Genetic: CD34+ cells\n",
      "Genetic: OZ1|Genetic: CD34+ cells|Other: Placebo|Genetic: CD34+ cells\n",
      "Genetic: OAV101\n",
      "Genetic: OAV101\n",
      "Genetic: Blood tests\n",
      "Genetic: Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII\n",
      "Genetic: C7R-GD2.CART cells|Genetic: C7R-GD2.CART cells\n",
      "Genetic: C7R-GD2.CART cells|Genetic: C7R-GD2.CART cells\n",
      "Genetic: ADVM-022|Genetic: ADVM-022\n",
      "Genetic: ADVM-022|Genetic: ADVM-022\n",
      "Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid|Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid\n",
      "Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid|Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid\n",
      "Genetic: INGN 201\n",
      "Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: Mycophenolate mofetil|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: cyclosporine|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]\n",
      "Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: Mycophenolate mofetil|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: cyclosporine|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]\n",
      "Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: Mycophenolate mofetil|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: cyclosporine|Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]\n",
      "Genetic: SKG0201 Injection\n",
      "Genetic: OAV101|Procedure: Sham control\n",
      "Genetic: VTX-801\n",
      "Genetic: C7R-GD2.CART cells (ICV infusion)|Genetic: C7R-GD2.CART cells (IV infusion)\n",
      "Genetic: C7R-GD2.CART cells (ICV infusion)|Genetic: C7R-GD2.CART cells (IV infusion)\n",
      "Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol\n",
      "Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol\n",
      "Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol\n",
      "Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol|Genetic: CD19CAR/virus specific T cells|Drug: Benadryl and Tylenol\n",
      "Genetic: NGGT002|Genetic: NGGT002|Genetic: NGGT002\n",
      "Genetic: NGGT002|Genetic: NGGT002|Genetic: NGGT002\n",
      "Genetic: NGGT002|Genetic: NGGT002|Genetic: NGGT002\n",
      "Genetic: Previously treated CAR-T patients\n",
      "Genetic: HTR2 T Cells|Genetic: HTR2 T Cells\n",
      "Genetic: HTR2 T Cells|Genetic: HTR2 T Cells\n",
      "Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1\n",
      "Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1\n",
      "Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1\n",
      "Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 2|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1|Genetic: CD19.CAR-CD28Z T Cells - dose escalation 1\n",
      "Genetic: CD19CAR-28-zeta T cells|Drug: Ipilimumab\n",
      "Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT\n",
      "Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT\n",
      "Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT\n",
      "Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT|Genetic: Intraparenchymal rAAV1 - (mi)RNA HTT\n",
      "Genetic: iC9-GD2 T Cells - fresh|Genetic: iC9-GD2 T Cells - frozen|Drug: Cytoxan|Drug: Fludara|Drug: Keytruda|Genetic: iC9-GD2 T cells\n",
      "Genetic: iC9-GD2 T Cells - fresh|Genetic: iC9-GD2 T Cells - frozen|Drug: Cytoxan|Drug: Fludara|Drug: Keytruda|Genetic: iC9-GD2 T cells\n",
      "Genetic: iC9-GD2 T Cells - fresh|Genetic: iC9-GD2 T Cells - frozen|Drug: Cytoxan|Drug: Fludara|Drug: Keytruda|Genetic: iC9-GD2 T cells\n",
      "Drug: cyclophosphamide|Drug: Fludarabine|Genetic: GINAKIT Cells\n",
      "Genetic: AB-1003 dose level 1|Genetic: AB-1003 dose level 2|Other: Placebo\n",
      "Genetic: AB-1003 dose level 1|Genetic: AB-1003 dose level 2|Other: Placebo\n",
      "Drug: Carboplatin|Biological: Pembrolizumab|Genetic: Transferrin Receptor-Targeted Liposomal p53 cDNA\n",
      "Genetic: ZS801\n",
      "Genetic: VGB-R04\n",
      "Genetic: GD2 T cells|Biological: VZV vaccine|Drug: Fludarabine|Drug: Cyclophosphamide\n",
      "Genetic: voretigene neparvovec\n",
      "Genetic: PTG-CARCIK-CD19\n",
      "Genetic: Autologous CD34+ cells transduced with TNS9.3.55\n",
      "Genetic: GCSF, Central venous line placement, Stem cell Collection (leukapheresis)\n",
      "Genetic: Next generation sequencing|Diagnostic Test: Imaging and fluid biomarkers\n",
      "Genetic: RGX-314\n",
      "Genetic: DOTAP:Chol-fus1\n",
      "Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G\n",
      "Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G\n",
      "Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G\n",
      "Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G\n",
      "Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G|Genetic: Rexin-G\n",
      "Genetic: Rexin-G\n",
      "Genetic: HPV Specific T Cells|Genetic: HPV Specific T Cells|Drug: Cytoxan|Drug: Fludarabine|Biological: Nivolumab\n",
      "Genetic: HPV Specific T Cells|Genetic: HPV Specific T Cells|Drug: Cytoxan|Drug: Fludarabine|Biological: Nivolumab\n",
      "Genetic: Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase|Drug: Rapamycin|Drug: Rituxan|Drug: Diphenhydramine|Drug: Acetaminophen|Drug: Lidocaine|Drug: LMX 4 Topical Cream|Drug: Rapamycin|Other: saline|Drug: Rituxan|Drug: Diphenhydramine|Drug: Acetaminophen|Drug: Lidocaine|Drug: LMX 4 Topical Cream\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)|Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)|Procedure: Placebo Infusion\n",
      "Genetic: HEMGENIX|Biological: Factor IX (FIX)\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: delandistrogene moxeparvovec|Genetic: placebo|Genetic: delandistrogene moxeparvovec|Genetic: placebo\n",
      "Genetic: EGEN-001 (phIL-12-005/PPC)\n",
      "Genetic: prophylactic 4SCAR19 cells\n",
      "Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI\n",
      "Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI\n",
      "Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI\n",
      "Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI|Procedure: HSCT|Genetic: DLI\n",
      "Genetic: EGEN-001 (phIL-12-005/PPC)\n",
      "Genetic: Ad/PNP and fludarabine monophosphate\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo\n",
      "Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo\n",
      "Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo|Genetic: ICM-203|Drug: Placebo\n",
      "Genetic: ICM-203|Genetic: ICM-203|Genetic: ICM-203\n",
      "Genetic: ICM-203|Genetic: ICM-203|Genetic: ICM-203\n",
      "Genetic: ICM-203|Genetic: ICM-203|Genetic: ICM-203\n",
      "Genetic: Lenti-D Drug Product (eli-cel)\n",
      "Genetic: ICM-203|Drug: Placebo\n",
      "Genetic: IVB102 Injection|Genetic: IVB102 Injection|Genetic: IVB102 Injection\n",
      "Genetic: IVB102 Injection|Genetic: IVB102 Injection|Genetic: IVB102 Injection\n",
      "Genetic: IVB102 Injection|Genetic: IVB102 Injection|Genetic: IVB102 Injection\n",
      "Genetic: Autologous Genetically modified T cells\n",
      "Genetic: Ad5FGF-4|Genetic: Ad5FGF-4|Genetic: Placebo\n",
      "Genetic: Ad5FGF-4|Genetic: Ad5FGF-4|Genetic: Placebo\n",
      "Genetic: Ad5FGF-4|Genetic: Ad5FGF-4|Genetic: Placebo\n",
      "Genetic: Alferminogene tadenovec\n",
      "Genetic: AGAR T cells\n",
      "Genetic: CARE T cells|Drug: Cytoxan|Drug: Fludara\n",
      "Genetic: GINAKIT Cells\n",
      "Genetic: 21.15.GPC3-CAR T cells\n",
      "Genetic: nula-cel Drug Product\n",
      "Genetic: RM-004\n",
      "Genetic: CATCH T cells\n",
      "Genetic: Autologous CD5.CAR/28zeta CAR T cells|Genetic: Allogeneic CD5.CAR/28zeta CAR T cells\n",
      "Genetic: Autologous CD5.CAR/28zeta CAR T cells|Genetic: Allogeneic CD5.CAR/28zeta CAR T cells\n",
      "Genetic: CD7.CAR/28zeta CAR T cells\n",
      "Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells\n",
      "Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells\n",
      "Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells\n",
      "Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells|Genetic: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells\n",
      "Genetic: genetically modified CTLs in combo with CD45 antibodies\n",
      "Genetic: MYDICAR Phase 1|Genetic: MYDICAR Phase 2|Genetic: Placebo Phase 2 only\n",
      "Genetic: MYDICAR Phase 1|Genetic: MYDICAR Phase 2|Genetic: Placebo Phase 2 only\n",
      "Genetic: MYDICAR Phase 1|Genetic: MYDICAR Phase 2|Genetic: Placebo Phase 2 only\n",
      "Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)\n",
      "Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)\n",
      "Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)|Genetic: VRC-HIVAAV070-00-GT (AAV8-VRC07)\n",
      "Genetic: SRP-9003|Genetic: SRP-9003\n",
      "Genetic: SRP-9003|Genetic: SRP-9003\n",
      "Genetic: GLYCAR T cells|Drug: Cytoxan|Drug: Fludarabine\n",
      "Genetic: intra-striatal rAAV5-miHTT|Genetic: intra-striatal rAAV5-miHTT\n",
      "Genetic: intra-striatal rAAV5-miHTT|Genetic: intra-striatal rAAV5-miHTT\n",
      "Genetic: AAV5-hFIXco-Padua|Biological: Factor IX (FIX)\n",
      "Genetic: intra-striatal rAAV5-miHTT|Genetic: intra-striatal rAAV5-miHTT|Other: Imitation (sham) surgery|Genetic: intra-striatal rAAV5-miHTT\n",
      "Genetic: intra-striatal rAAV5-miHTT|Genetic: intra-striatal rAAV5-miHTT|Other: Imitation (sham) surgery|Genetic: intra-striatal rAAV5-miHTT\n",
      "Genetic: intra-striatal rAAV5-miHTT|Genetic: intra-striatal rAAV5-miHTT|Other: Imitation (sham) surgery|Genetic: intra-striatal rAAV5-miHTT\n",
      "Genetic: AAV5-hFIXco-Padua (AMT-061)\n",
      "Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning|Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning\n",
      "Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning|Genetic: SB-728mR-HSPC Infusion 3 days following busulfan conditioning\n",
      "Genetic: OAV101\n",
      "Genetic: LY3884961|Drug: Methylprednisolone|Drug: Sirolimus|Drug: Prednisone|Genetic: LY3884961|Drug: Methylprednisolone|Drug: Sirolimus|Drug: Prednisone\n",
      "Genetic: LY3884961|Drug: Methylprednisolone|Drug: Sirolimus|Drug: Prednisone|Genetic: LY3884961|Drug: Methylprednisolone|Drug: Sirolimus|Drug: Prednisone\n",
      "Genetic: TN-201|Genetic: TN-201\n",
      "Genetic: TN-201|Genetic: TN-201\n",
      "Genetic: RP-A601\n",
      "Genetic: ADVM-022\n",
      "Genetic: Gene Modified T Cells\n",
      "Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy\n",
      "Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy\n",
      "Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy\n",
      "Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Tamoxifen Citrate|Drug: Aromatase Inhibition Therapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy|Procedure: Neoadjuvant Therapy|Procedure: Therapeutic Conventional Surgery|Other: Laboratory Biomarker Analysis|Genetic: Gene Expression Analysis|Drug: Systemic Chemotherapy\n",
      "Genetic: GAP T cells|Drug: Cytoxan|Drug: Fludara\n",
      "Genetic: Blood\n",
      "Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.\n",
      "Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.\n",
      "Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.\n",
      "Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.|Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.\n",
      "Drug: Cyclosporine|Genetic: Gene expression analysis|Genetic: Microarray analysis|Other: Laboratory biomarker analysis\n",
      "Drug: Cyclosporine|Genetic: Gene expression analysis|Genetic: Microarray analysis|Other: Laboratory biomarker analysis\n",
      "Other: MTM|Genetic: Pharmacogenetic testing|Other: Software-based drug & gene interaction risk analysis|Other: MTM|Other: Software-based drug & gene interaction risk analysis|Other: MTM\n",
      "Genetic: Point-of-care genetic screening with subsequent prasugrel administration to CYP2C19*2 carriers\n",
      "Genetic: Gene Profile explore\n",
      "Genetic: T cells or CAR T cells|Drug: Pembrolizumab Injectable Product|Genetic: T cells or CAR T cells|Drug: Nivolumab Injectable Product\n",
      "Genetic: T cells or CAR T cells|Drug: Pembrolizumab Injectable Product|Genetic: T cells or CAR T cells|Drug: Nivolumab Injectable Product\n",
      "Genetic: XIST gene deletion|Genetic: XIST gene deletion\n",
      "Genetic: XIST gene deletion|Genetic: XIST gene deletion\n",
      "Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T\n",
      "Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T\n",
      "Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T\n",
      "Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T\n",
      "Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T|Genetic: SB-728-T\n",
      "Genetic: Oxidized-LDL gene polymorphism|Genetic: Oxidized-LDL gene polymorphism\n",
      "Genetic: Oxidized-LDL gene polymorphism|Genetic: Oxidized-LDL gene polymorphism\n",
      "Biological: Antibiotic selection based on the antibiotic susceptibility testing|Genetic: PPI selection based on the CYP2C19 gene polymorphism|Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing|Biological: Antibiotic selection based on the antibiotic susceptibility testing|Genetic: PPI selection based on the CYP2C19 gene polymorphism|Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing\n",
      "Biological: Antibiotic selection based on the antibiotic susceptibility testing|Genetic: PPI selection based on the CYP2C19 gene polymorphism|Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing|Biological: Antibiotic selection based on the antibiotic susceptibility testing|Genetic: PPI selection based on the CYP2C19 gene polymorphism|Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing\n",
      "Genetic: different effection|Genetic: different effection|Genetic: different effection\n",
      "Genetic: different effection|Genetic: different effection|Genetic: different effection\n",
      "Genetic: different effection|Genetic: different effection|Genetic: different effection\n",
      "Genetic: Gene analysis|Other: Historical data of lipid-lowering drug administration|Other: Historical data of plasma lipids, xanthoma changes\n",
      "Genetic: detection of vacuolating cytotoxin A (Vac A) and cytotoxin-associated gene A (Cag A) virulent H.Pylori genotypes by polymerase chain reaction amplification(PCR) in gastric biopsies :|Diagnostic Test: Culture and sensitivity of endoscopic gastric biopsies:|Other: Histopathological examination endoscopic gastric biopsies:|Procedure: Upper endoscopy|Drug: empirical H.pylori regimens|Diagnostic Test: H.Pylori Ag in stool\n",
      "Genetic: Genetic analysis\n",
      "Other: Chemosensitivity Assay|Other: Cytology Specimen Collection Procedure|Genetic: Gene Expression Analysis|Genetic: Genetic Variation Analysis|Drug: In Vitro Sensitivity-Directed Chemotherapy\n",
      "Other: Chemosensitivity Assay|Other: Cytology Specimen Collection Procedure|Genetic: Gene Expression Analysis|Genetic: Genetic Variation Analysis|Drug: In Vitro Sensitivity-Directed Chemotherapy\n",
      "Genetic: gene expression levels|Genetic: gene expression levels\n",
      "Genetic: gene expression levels|Genetic: gene expression levels\n",
      "Genetic: genotyping for three genes (TPMT, NUDT15 and FTO)|Other: non-genotyping\n",
      "Diagnostic Test: Glucocerebrosidase|Genetic: GBA gene|Diagnostic Test: Glucocerebrosidase|Genetic: GBA gene\n",
      "Diagnostic Test: Glucocerebrosidase|Genetic: GBA gene|Diagnostic Test: Glucocerebrosidase|Genetic: GBA gene\n",
      "Genetic: VEGF genotyping\n",
      "Genetic: PCR-RFLP|Genetic: PCR-RFLP\n",
      "Genetic: PCR-RFLP|Genetic: PCR-RFLP\n",
      "Genetic: DNA and tissue microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: mass spectrometry\n",
      "Genetic: DNA and tissue microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: mass spectrometry\n",
      "Genetic: Molecular Profiling\n",
      "Genetic: HG202\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis|Drug: sorafenib tosylate|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Procedure: needle biopsy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Genetic: western blotting|Genetic: RNA analysis\n",
      "Genetic: gene expression analysis|Genetic: molecular genetic technique|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Genetic: molecular genetic technique|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Genetic: molecular genetic technique|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Genetic: molecular genetic technique|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: Pre-treatment biopsy|Genetic: Post treatment biopsy|Genetic: Pre treatment blood sampling|Genetic: Post treatment blood sampling\n",
      "Genetic: Pre-treatment biopsy|Genetic: Post treatment biopsy|Genetic: Pre treatment blood sampling|Genetic: Post treatment blood sampling\n",
      "Genetic: Pre-treatment biopsy|Genetic: Post treatment biopsy|Genetic: Pre treatment blood sampling|Genetic: Post treatment blood sampling\n",
      "Genetic: Pre-treatment biopsy|Genetic: Post treatment biopsy|Genetic: Pre treatment blood sampling|Genetic: Post treatment blood sampling\n",
      "Genetic: Germline BRCA Test (blood)|Genetic: FoundationOne Dx Genomic Profile (archival Tumour Specimen)|Other: Follow-up\n",
      "Genetic: Germline BRCA Test (blood)|Genetic: FoundationOne Dx Genomic Profile (archival Tumour Specimen)|Other: Follow-up\n",
      "Genetic: Blood sample for phenotypic and pharmacogenetic analysis.|Genetic: Blood sample for phenotypic and pharmacogenetic analysis.\n",
      "Genetic: Blood sample for phenotypic and pharmacogenetic analysis.|Genetic: Blood sample for phenotypic and pharmacogenetic analysis.\n",
      "Genetic: Therapeutic 4SCAR19 cells\n",
      "Genetic: microarray analysis|Genetic: polymerase chain reaction\n",
      "Genetic: microarray analysis|Genetic: polymerase chain reaction\n",
      "Genetic: DNA/RNA sequencing and expression levels|Genetic: Protein expression analysis|Procedure: Lung tumor biopsy|Procedure: Blood sample\n",
      "Genetic: DNA/RNA sequencing and expression levels|Genetic: Protein expression analysis|Procedure: Lung tumor biopsy|Procedure: Blood sample\n",
      "Genetic: HLADQA1*05A>G screening|Other: Standard of Care\n",
      "Genetic: ST-400 Investigational product\n",
      "Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit\n",
      "Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit\n",
      "Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit|Genetic: Sano Genetics Testing Kit\n",
      "Biological: Bcr-abl multipeptide vaccine|Genetic: Cytokine gene adjuvant\n",
      "Genetic: Gene mutation analyses and FISH\n",
      "Genetic: Pan-genomic Testing\n",
      "Genetic: MPA SNP\n",
      "Biological: filgrastim|Drug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: fluorouracil|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy|Drug: docetaxel|Drug: epirubicin hydrochloride|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy\n",
      "Biological: filgrastim|Drug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: fluorouracil|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy|Drug: docetaxel|Drug: epirubicin hydrochloride|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy\n",
      "Other: flow cytometry|Other: DNA methylation analysis|Other: cytogenetic analysis|Drug: decitabine|Genetic: microarray analysis|Genetic: gene expression analysis|Other: pharmacological study|Genetic: polymorphism analysis\n",
      "Other: flow cytometry|Other: DNA methylation analysis|Other: cytogenetic analysis|Drug: decitabine|Genetic: microarray analysis|Genetic: gene expression analysis|Other: pharmacological study|Genetic: polymorphism analysis\n",
      "Other: flow cytometry|Other: DNA methylation analysis|Other: cytogenetic analysis|Drug: decitabine|Genetic: microarray analysis|Genetic: gene expression analysis|Other: pharmacological study|Genetic: polymorphism analysis\n",
      "Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1|Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1\n",
      "Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1|Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1\n",
      "Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1|Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1\n",
      "Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1|Genetic: CYP2D6|Behavioral: Brief Pain Inventory-Short Form (BPI-SF)|Behavioral: M.D. Anderson Symptom Inventory (MDASI)|Genetic: OPRM1\n",
      "Genetic: BRCA 1|Drug: Chemotherapy|Genetic: BRCA 1|Drug: Chemotherapy\n",
      "Genetic: BRCA 1|Drug: Chemotherapy|Genetic: BRCA 1|Drug: Chemotherapy\n",
      "Genetic: delandistrogene moxeparvovec\n",
      "Genetic: IDH mutation test performed at diagnosis\n",
      "Genetic: Genotyping assays\n",
      "Genetic: Enterovirus vaccination\n",
      "Genetic: GeneSight Psychotropic (GEN)|Genetic: Enhanced-GeneSight Psychotropic (E-GEN)|Other: Treatment as Usual (TAU)\n",
      "Genetic: GeneSight Psychotropic (GEN)|Genetic: Enhanced-GeneSight Psychotropic (E-GEN)|Other: Treatment as Usual (TAU)\n",
      "Genetic: SNP|Genetic: SNP|Genetic: SNP|Drug: Palbociclib|Genetic: SNP|Drug: Rivaroxaban|Genetic: SNP\n",
      "Genetic: SNP|Genetic: SNP|Genetic: SNP|Drug: Palbociclib|Genetic: SNP|Drug: Rivaroxaban|Genetic: SNP\n",
      "Genetic: SNP|Genetic: SNP|Genetic: SNP|Drug: Palbociclib|Genetic: SNP|Drug: Rivaroxaban|Genetic: SNP\n",
      "Genetic: SNP|Genetic: SNP|Genetic: SNP|Drug: Palbociclib|Genetic: SNP|Drug: Rivaroxaban|Genetic: SNP\n",
      "Genetic: SNP|Genetic: SNP|Genetic: SNP|Drug: Palbociclib|Genetic: SNP|Drug: Rivaroxaban|Genetic: SNP\n",
      "Genetic: GeneSight Psychotropic (GEN)|Genetic: Enhanced-GeneSight Psychotropic (E-GEN)|Other: Treatment as Usual (TAU)\n",
      "Genetic: GeneSight Psychotropic (GEN)|Genetic: Enhanced-GeneSight Psychotropic (E-GEN)|Other: Treatment as Usual (TAU)\n",
      "Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing\n",
      "Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing\n",
      "Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing\n",
      "Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing|Genetic: Genomic sequencing\n",
      "Drug: Exemestane Tablets|Other: ovarian function suppression/ablation|Genetic: CYP2D6*10 gene test|Other: ovarian function suppression/ablation|Genetic: CYP2D6*10 gene test|Drug: Tamoxifen\n",
      "Drug: Exemestane Tablets|Other: ovarian function suppression/ablation|Genetic: CYP2D6*10 gene test|Other: ovarian function suppression/ablation|Genetic: CYP2D6*10 gene test|Drug: Tamoxifen\n",
      "Genetic: HG205\n",
      "Genetic: obtain tissue specimens\n",
      "Genetic: DNA methylation analysis|Genetic: microarray analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: DNA methylation analysis|Genetic: microarray analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: DNA methylation analysis|Genetic: microarray analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: Polymerase Chain Reaction and Whole Genome Amplification\n",
      "Genetic: Molecular monitoring by quantification of cell-free DNA\n",
      "Genetic: Blood and tumor samples\n",
      "Genetic: DNA sequencing, RNA gene expression analysis, molecular profiling\n",
      "Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis|Other: immunohistochemistry staining method\n",
      "Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis|Other: immunohistochemistry staining method\n",
      "Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis|Other: immunohistochemistry staining method\n",
      "Genetic: DNA methylation|Genetic: DNA methylation|Genetic: DNA methylation\n",
      "Genetic: DNA methylation|Genetic: DNA methylation|Genetic: DNA methylation\n",
      "Genetic: DNA methylation|Genetic: DNA methylation|Genetic: DNA methylation\n",
      "Drug: Standard therapy of septic shock|Genetic: Mesenchymal stromal cells|Drug: Standard therapy of septic shock\n",
      "Genetic: KL003 cell injection Drug Product\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Drug: prednisone|Drug: cyclophosphamide|Drug: etoposide|Drug: Vincristine|Drug: pralatrexate|Other: laboratory biomarker analysis|Genetic: comparative genomic hybridization|Genetic: gene expression analysis|Genetic: nucleic acid sequencing|Genetic: mutation analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: RNA analysis\n",
      "Genetic: Pharmacogenomic index|Diagnostic Test: Therapeutic drug monitoring\n",
      "Genetic: tissue-of-origin (ORIGIN-PanCA○R) profiling|Genetic: tissue-of-origin (ORIGIN-PanCA○R) profiling\n",
      "Genetic: tissue-of-origin (ORIGIN-PanCA○R) profiling|Genetic: tissue-of-origin (ORIGIN-PanCA○R) profiling\n",
      "Genetic: Genetic analysis\n",
      "Genetic: 2ml peripheral venous blood was collected to detect genetic genes|Genetic: 2ml peripheral venous blood was collected to detect genetic genes\n",
      "Genetic: 2ml peripheral venous blood was collected to detect genetic genes|Genetic: 2ml peripheral venous blood was collected to detect genetic genes\n",
      "Genetic: NGS test\n",
      "Genetic: gene expression|Genetic: gene expression\n",
      "Genetic: gene expression|Genetic: gene expression\n",
      "Genetic: tumor genetic predisposition to develop sarcoma assessment|Genetic: tumor genetic predisposition to develop sarcoma assessment\n",
      "Genetic: tumor genetic predisposition to develop sarcoma assessment|Genetic: tumor genetic predisposition to develop sarcoma assessment\n",
      "Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab\n",
      "Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab\n",
      "Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab\n",
      "Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab|Genetic: SNP|Drug: Palbociclib 125mg|Drug: Bevacizumab\n",
      "Genetic: ADRB2-genotype guided treatment|Other: Randomisation\n",
      "Behavioral: Start with the Heart Students|Behavioral: Start with the Heart Teachers|Behavioral: Cue Centered Therapy Counselors|Behavioral: Cue Centered Therapy Students|Behavioral: Start with the Heart Students|Behavioral: Cue Centered Therapy Students|Genetic: iSWAB-DNA\n",
      "Genetic: comparative genomic hybridization|Genetic: cytogenetic analysis|Genetic: fluorescence in situ hybridization|Genetic: gene rearrangement analysis\n",
      "Genetic: comparative genomic hybridization|Genetic: cytogenetic analysis|Genetic: fluorescence in situ hybridization|Genetic: gene rearrangement analysis\n",
      "Genetic: comparative genomic hybridization|Genetic: cytogenetic analysis|Genetic: fluorescence in situ hybridization|Genetic: gene rearrangement analysis\n",
      "Genetic: comparative genomic hybridization|Genetic: cytogenetic analysis|Genetic: fluorescence in situ hybridization|Genetic: gene rearrangement analysis\n",
      "Genetic: ctDNA screening\n",
      "Genetic: CCR5 gene modification\n",
      "Genetic: blood samples collected from all patients|Genetic: blood samples collected from all patients\n",
      "Genetic: blood samples collected from all patients|Genetic: blood samples collected from all patients\n",
      "Device: Laser Treatment|Diagnostic Test: Blood analysis|Diagnostic Test: Сlinical urine test|Diagnostic Test: Electrocardiography|Diagnostic Test: Vaginal smear|Diagnostic Test: Colposcopy|Diagnostic Test: Pelvic ultrasound|Diagnostic Test: Doppler ultrasonography|Diagnostic Test: Vaginal Health Index|Diagnostic Test: Biopsy of the vaginal wall|Diagnostic Test: The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire|Diagnostic Test: Pelvic Floor Distress Inventory Questionnaire|Diagnostic Test: International Consultation on Incontinence Questionnaire - Short Form|Diagnostic Test: Pelvic Floor Impact Questionnaire|Procedure: Anterior and/or posterior colporrhaphy|Other: Physical examination|Other: Сonsultation|Genetic: Buccal smear|Diagnostic Test: Blood analysis|Diagnostic Test: Сlinical urine test|Diagnostic Test: Electrocardiography|Diagnostic Test: Vaginal smear|Diagnostic Test: Colposcopy|Diagnostic Test: Pelvic ultrasound|Diagnostic Test: Doppler ultrasonography|Diagnostic Test: Vaginal Health Index|Diagnostic Test: Biopsy of the vaginal wall|Diagnostic Test: The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire|Diagnostic Test: Pelvic Floor Distress Inventory Questionnaire|Diagnostic Test: International Consultation on Incontinence Questionnaire - Short Form|Diagnostic Test: Pelvic Floor Impact Questionnaire|Procedure: Anterior and/or posterior colporrhaphy|Other: Physical examination|Other: Сonsultation|Diagnostic Test: Blood analysis|Diagnostic Test: Сlinical urine test|Diagnostic Test: Electrocardiography|Diagnostic Test: Vaginal smear|Diagnostic Test: Colposcopy|Diagnostic Test: Pelvic ultrasound|Diagnostic Test: Doppler ultrasonography|Diagnostic Test: Vaginal Health Index|Diagnostic Test: Biopsy of the vaginal wall|Diagnostic Test: The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire|Diagnostic Test: Pelvic Floor Distress Inventory Questionnaire|Diagnostic Test: International Consultation on Incontinence Questionnaire - Short Form|Diagnostic Test: Pelvic Floor Impact Questionnaire|Procedure: Pelvic surgical procedure|Other: Physical examination|Other: Сonsultation\n",
      "Drug: Standard of Care|Genetic: Voriconazole genotype-specific dosing\n",
      "Drug: imatinib mesylate|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Other: flow cytometry|Procedure: biopsy\n",
      "Drug: imatinib mesylate|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Other: flow cytometry|Procedure: biopsy\n",
      "Drug: imatinib mesylate|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Other: flow cytometry|Procedure: biopsy\n",
      "Drug: Warfarin|Genetic: warfarin pharmacogenetic dosing\n",
      "Drug: Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial|Diagnostic Test: Spirometry|Genetic: RNA Sequencing|Diagnostic Test: Laboratory testing|Drug: Corticosteroid|Drug: Tofacitinib 5mg [Xeljanz] 1 year open-label extension\n",
      "Diagnostic Test: flow cytometric immunophenotyping|Genetic: Xist gene by fluorescence insitu hybridization\n",
      "Genetic: ERCC1 pathways analysis\n",
      "Drug: Propranolol|Genetic: DNA and RNA Analysis|Genetic: DNA and RNA Analysis\n",
      "Drug: Propranolol|Genetic: DNA and RNA Analysis|Genetic: DNA and RNA Analysis\n",
      "Genetic: mutation|Genetic: mutation\n",
      "Genetic: mutation|Genetic: mutation\n",
      "Genetic: Gene mutations analysis and FISH\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: ART-I02|Genetic: ART-I02|Genetic: ART-I02\n",
      "Genetic: SB-728mR-T|Drug: Cyclophosphamide|Genetic: SB-728mR-T|Drug: Cyclophosphamide\n",
      "Genetic: SB-728mR-T|Drug: Cyclophosphamide|Genetic: SB-728mR-T|Drug: Cyclophosphamide\n",
      "Drug: lapatinib ditosylate|Genetic: gene expression analysis|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: delolimogene mupadenorepvec|Drug: gemcitabine|Drug: nab-paclitaxel|Genetic: delolimogene mupadenorepvec|Drug: gemcitabine|Drug: nab-paclitaxel|Biological: atezolizumab\n",
      "Genetic: delolimogene mupadenorepvec|Drug: gemcitabine|Drug: nab-paclitaxel|Genetic: delolimogene mupadenorepvec|Drug: gemcitabine|Drug: nab-paclitaxel|Biological: atezolizumab\n",
      "Genetic: gene expression analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Genetic: polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: Circulating tumour DNA dynamics\n",
      "Genetic: Genetic testing and GAIN report\n",
      "Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis\n",
      "Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis\n",
      "Drug: everolimus|Drug: erlotinib hydrochloride|Procedure: biopsy|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: polyacrylamide gel electrophoresis|Other: pharmacological study|Radiation: external beam radiation therapy|Genetic: microarray analysis\n",
      "Drug: everolimus|Drug: erlotinib hydrochloride|Procedure: biopsy|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: polyacrylamide gel electrophoresis|Other: pharmacological study|Radiation: external beam radiation therapy|Genetic: microarray analysis\n",
      "Genetic: Genotyping results\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis|Genetic: Exome analysis\n",
      "Genetic: identify genetic polymorphism in Thai HIV infected\n",
      "Genetic: Soluble and genetic biomarkers measurements|Genetic: Soluble and genetic biomarkers measurements\n",
      "Genetic: Soluble and genetic biomarkers measurements|Genetic: Soluble and genetic biomarkers measurements\n",
      "Drug: Montanide ISA 51 VG|Drug: gp100:154-162 Peptide|Procedure: Radiation|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Anti-gp 100:154 TCR PBL|Drug: MART-1: 26-35(27L) Peptide|Drug: Montanide ISA 51 VG|Procedure: Radiation|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Anti-MART-1 F5 TCR PBL\n",
      "Drug: Montanide ISA 51 VG|Drug: gp100:154-162 Peptide|Procedure: Radiation|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Anti-gp 100:154 TCR PBL|Drug: MART-1: 26-35(27L) Peptide|Drug: Montanide ISA 51 VG|Procedure: Radiation|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Anti-MART-1 F5 TCR PBL\n",
      "Diagnostic Test: Dextrometorphan|Genetic: Genotyping by single nulcetoide polymorphism.|Diagnostic Test: Dextrometorphan|Genetic: Genotyping by single nulcetoide polymorphism.\n",
      "Diagnostic Test: Dextrometorphan|Genetic: Genotyping by single nulcetoide polymorphism.|Diagnostic Test: Dextrometorphan|Genetic: Genotyping by single nulcetoide polymorphism.\n",
      "Genetic: DNA analysis|Other: Hormonal analysis\n",
      "Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay\n",
      "Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay\n",
      "Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay\n",
      "Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay|Genetic: CYP2C19 test|Diagnostic Test: P2RY12 assay\n",
      "Genetic: Saliva sample collection for genetic analyses\n",
      "Genetic: Sanger sequencing method|Genetic: Sanger sequencing method|Genetic: Sanger sequencing method\n",
      "Genetic: Sanger sequencing method|Genetic: Sanger sequencing method|Genetic: Sanger sequencing method\n",
      "Genetic: Sanger sequencing method|Genetic: Sanger sequencing method|Genetic: Sanger sequencing method\n",
      "Genetic: Genomind®Professional PGx Express TM|Genetic: Genomind®Professional PGx Express TM\n",
      "Genetic: Genomind®Professional PGx Express TM|Genetic: Genomind®Professional PGx Express TM\n",
      "Biological: therapeutic autologous lymphocytes|Genetic: gene expression analysis|Other: laboratory biomarker analysis\n",
      "Drug: lenalidomide|Biological: rituximab|Genetic: polymerase chain reaction|Genetic: nucleic acid sequencing|Genetic: polymorphism analysis|Other: flow cytometry|Other: laboratory biomarker analysis\n",
      "Drug: lenalidomide|Biological: rituximab|Genetic: polymerase chain reaction|Genetic: nucleic acid sequencing|Genetic: polymorphism analysis|Other: flow cytometry|Other: laboratory biomarker analysis\n",
      "Drug: lenalidomide|Biological: rituximab|Genetic: polymerase chain reaction|Genetic: nucleic acid sequencing|Genetic: polymorphism analysis|Other: flow cytometry|Other: laboratory biomarker analysis\n",
      "Genetic: mutation analysis|Genetic: tumor replication error analysis\n",
      "Genetic: mutation analysis|Genetic: tumor replication error analysis\n",
      "Biological: therapeutic autologous lymphocytes|Drug: cyclophosphamide|Biological: aldesleukin|Genetic: polymerase chain reaction|Genetic: gene rearrangement analysis|Procedure: lymph node biopsy|Biological: genetically engineered lymphocyte therapy|Procedure: bone marrow aspiration|Other: flow cytometry|Other: laboratory biomarker analysis|Other: enzyme-linked immunosorbent assay\n",
      "Biological: therapeutic autologous lymphocytes|Drug: cyclophosphamide|Biological: aldesleukin|Genetic: polymerase chain reaction|Genetic: gene rearrangement analysis|Procedure: lymph node biopsy|Biological: genetically engineered lymphocyte therapy|Procedure: bone marrow aspiration|Other: flow cytometry|Other: laboratory biomarker analysis|Other: enzyme-linked immunosorbent assay\n",
      "Drug: bortezomib|Drug: cisplatin|Drug: cyclophosphamide|Drug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: lenalidomide|Drug: melphalan|Drug: thalidomide|Genetic: gene expression analysis|Genetic: microarray analysis|Other: laboratory biomarker analysis|Procedure: autologous-autologous tandem hematopoietic stem cell transplantation\n",
      "Drug: bortezomib|Drug: cisplatin|Drug: cyclophosphamide|Drug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: lenalidomide|Drug: melphalan|Drug: thalidomide|Genetic: gene expression analysis|Genetic: microarray analysis|Other: laboratory biomarker analysis|Procedure: autologous-autologous tandem hematopoietic stem cell transplantation\n",
      "Drug: lapatinib ditosylate|Genetic: TdT-mediated dUTP nick end labeling assay|Genetic: gene expression analysis|Genetic: microarray analysis|Other: immunohistochemistry staining method|Procedure: biopsy|Radiation: radiation therapy\n",
      "Drug: lapatinib ditosylate|Genetic: TdT-mediated dUTP nick end labeling assay|Genetic: gene expression analysis|Genetic: microarray analysis|Other: immunohistochemistry staining method|Procedure: biopsy|Radiation: radiation therapy\n",
      "Drug: lapatinib ditosylate|Genetic: TdT-mediated dUTP nick end labeling assay|Genetic: gene expression analysis|Genetic: microarray analysis|Other: immunohistochemistry staining method|Procedure: biopsy|Radiation: radiation therapy\n",
      "Genetic: G6PD gene deficiency\n",
      "Genetic: molecular profiling of tumors|Genetic: Clinical Germline Analysis\n",
      "Genetic: molecular profiling of tumors|Genetic: Clinical Germline Analysis\n",
      "Genetic: Blood sampling for microRNA testing\n",
      "Drug: everolimus|Genetic: molecular response by PCR\n",
      "Genetic: kras\n",
      "Drug: paclitaxel|Genetic: microarray analysis|Procedure: biopsy|Procedure: neoadjuvant therapy\n",
      "Genetic: polymorphism analysis|Other: high performance liquid chromatography|Other: laboratory biomarker analysis|Procedure: radiomammography\n",
      "Genetic: ONCOTYPEDX Test\n",
      "Behavioral: Sleep quality and physical activity|Genetic: Nicotine dependence|Diagnostic Test: Nicotine and cotinine serum levels|Behavioral: Smoking|Behavioral: Sleep quality and physical activity|Diagnostic Test: Nicotine and cotinine serum levels\n",
      "Genetic: NY-ESO-1 T cells|Drug: cyclophosphamide|Drug: Fludarabine|Biological: Interleukin 2\n",
      "Genetic: GeneSight Psychotropic|Genetic: GeneSight Psychotropic\n",
      "Genetic: GeneSight Psychotropic|Genetic: GeneSight Psychotropic\n",
      "Procedure: Diagnostic Biopsy and Surgical Procedure|Procedure: Intravoxel incoherent motion MRI (IVIM)|Procedure: Dynamic Contrast Enhanced MRI (DCE-MRI)|Genetic: RNA gene expression analysis\n",
      "Genetic: Tissue specimen\n",
      "Genetic: Genomic sequencing\n",
      "Other: Measurement of Plasma Concentrations of NOACs|Genetic: Identification of ABCB1 polymorphisms coding for P-gp\n",
      "Drug: sunitinib malate|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: western blotting|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery\n",
      "Drug: sunitinib malate|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: western blotting|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery\n",
      "Drug: sunitinib malate|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: western blotting|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery\n",
      "Genetic: Genomic sequencing\n",
      "Genetic: Blood and tumor samples|Genetic: Blood and tumor samples\n",
      "Genetic: Blood and tumor samples|Genetic: Blood and tumor samples\n",
      "Biological: recombinant human chorionic gonadotropin|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: needle biopsy\n",
      "Genetic: blood samples\n",
      "Genetic: Sequencing of DPYD gene\n",
      "Genetic: CYP2C19 genotyping\n",
      "Genetic: oral epithelial cells obtained by rinsing with 3% sucrose\n",
      "Genetic: Informing study subjects about their high CVD polygenic risk score\n",
      "Genetic: AdNRGM\n",
      "Genetic: Blood and tumor samples\n",
      "Genetic: RNA-seq|Genetic: whole exon sequencing|Other: Cytogenetics test\n",
      "Genetic: RNA-seq|Genetic: whole exon sequencing|Other: Cytogenetics test\n",
      "Genetic: DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD|Genetic: DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD\n",
      "Genetic: DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD|Genetic: DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD\n",
      "Genetic: cytokine|Genetic: cytokine polymorphisms|Genetic: cytokine polymorphism\n",
      "Genetic: cytokine|Genetic: cytokine polymorphisms|Genetic: cytokine polymorphism\n",
      "Genetic: cytokine|Genetic: cytokine polymorphisms|Genetic: cytokine polymorphism\n",
      "Drug: tamoxifen citrate|Genetic: gene expression analysis|Other: pharmacogenomic studies|Other: questionnaire administration|Procedure: quality-of-life assessment|Drug: tamoxifen citrate|Genetic: gene expression analysis|Other: pharmacogenomic studies|Other: questionnaire administration|Procedure: quality-of-life assessment\n",
      "Drug: tamoxifen citrate|Genetic: gene expression analysis|Other: pharmacogenomic studies|Other: questionnaire administration|Procedure: quality-of-life assessment|Drug: tamoxifen citrate|Genetic: gene expression analysis|Other: pharmacogenomic studies|Other: questionnaire administration|Procedure: quality-of-life assessment\n",
      "Genetic: Geneticure for RDN Genetic Panel\n",
      "Genetic: Personalised medicine (Salmeterol)|Genetic: Personalised medicine (Montelukast)|Other: Standard care\n",
      "Genetic: Personalised medicine (Salmeterol)|Genetic: Personalised medicine (Montelukast)|Other: Standard care\n",
      "Biological: carcinoembryonic antigen-expressing measles virus|Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Drug: decitabine|Other: laboratory biomarker analysis|Other: pharmacological study|Other: high performance liquid chromatography|Genetic: microarray analysis|Genetic: RNA analysis|Other: mass spectrometry|Genetic: DNA methylation analysis|Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry\n",
      "Drug: decitabine|Other: laboratory biomarker analysis|Other: pharmacological study|Other: high performance liquid chromatography|Genetic: microarray analysis|Genetic: RNA analysis|Other: mass spectrometry|Genetic: DNA methylation analysis|Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry\n",
      "Drug: decitabine|Other: laboratory biomarker analysis|Other: pharmacological study|Other: high performance liquid chromatography|Genetic: microarray analysis|Genetic: RNA analysis|Other: mass spectrometry|Genetic: DNA methylation analysis|Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry\n",
      "Drug: celecoxib|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: mass spectrometry|Procedure: biopsy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery\n",
      "Drug: celecoxib|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: mass spectrometry|Procedure: biopsy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery\n",
      "Genetic: PLIN1 gene sequencing\n",
      "Genetic: EDIT-301\n",
      "Drug: Azacitidine|Drug: Docetaxel|Drug: Prednisone|Genetic: GADD45α methylation and expression analysis|Drug: Pegfilgrastim|Drug: Filgrastim|Drug: Azacitidine|Drug: Docetaxel|Drug: Prednisone|Drug: Pegfilgrastim|Drug: Filgrastim\n",
      "Genetic: ECUR-506|Genetic: ECUR-506|Genetic: ECUR-506\n",
      "Genetic: ECUR-506|Genetic: ECUR-506|Genetic: ECUR-506\n",
      "Genetic: ECUR-506|Genetic: ECUR-506|Genetic: ECUR-506\n",
      "Drug: IV-PCA morphine|Drug: Placebo PO|Procedure: Quantitative Sensory Testing (QST)|Other: Psychometric assessment|Genetic: COMT-haplotypes|Drug: Propranolol PO|Drug: IV-PCA morphine|Procedure: Quantitative Sensory Testing (QST)|Other: Psychometric assessment|Genetic: COMT-haplotypes\n",
      "Drug: IV-PCA morphine|Drug: Placebo PO|Procedure: Quantitative Sensory Testing (QST)|Other: Psychometric assessment|Genetic: COMT-haplotypes|Drug: Propranolol PO|Drug: IV-PCA morphine|Procedure: Quantitative Sensory Testing (QST)|Other: Psychometric assessment|Genetic: COMT-haplotypes\n",
      "Drug: panobinostat|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Drug: panobinostat|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis\n",
      "Genetic: blood sample|Genetic: blood sample\n",
      "Genetic: blood sample|Genetic: blood sample\n",
      "Genetic: mRNA expression and SNP analysis|Diagnostic Test: Blood sampling|Genetic: mRNA expression and SNP analysis|Diagnostic Test: Blood sampling\n",
      "Genetic: mRNA expression and SNP analysis|Diagnostic Test: Blood sampling|Genetic: mRNA expression and SNP analysis|Diagnostic Test: Blood sampling\n",
      "Drug: Panitumumab|Drug: Irinotecan hydrochloride|Genetic: Chromogenic in situ hybridization|Genetic: Fluorescence in situ hybridization|Genetic: Gene expression analysis|Other: Laboratory biomarker analysis\n",
      "Drug: Panitumumab|Drug: Irinotecan hydrochloride|Genetic: Chromogenic in situ hybridization|Genetic: Fluorescence in situ hybridization|Genetic: Gene expression analysis|Other: Laboratory biomarker analysis\n",
      "Drug: Panitumumab|Drug: Irinotecan hydrochloride|Genetic: Chromogenic in situ hybridization|Genetic: Fluorescence in situ hybridization|Genetic: Gene expression analysis|Other: Laboratory biomarker analysis\n",
      "Genetic: EDIT-301\n",
      "Genetic: microsatellite instability analysis|Genetic: mutation analysis|Genetic: clonality analysis|Genetic: microsatellite instability analysis|Genetic: mutation analysis\n",
      "Genetic: microsatellite instability analysis|Genetic: mutation analysis|Genetic: clonality analysis|Genetic: microsatellite instability analysis|Genetic: mutation analysis\n",
      "Genetic: microsatellite instability analysis|Genetic: mutation analysis|Genetic: clonality analysis|Genetic: microsatellite instability analysis|Genetic: mutation analysis\n",
      "Genetic: microsatellite instability analysis|Genetic: mutation analysis|Genetic: clonality analysis|Genetic: microsatellite instability analysis|Genetic: mutation analysis\n",
      "Genetic: microsatellite instability analysis|Genetic: mutation analysis|Genetic: clonality analysis|Genetic: microsatellite instability analysis|Genetic: mutation analysis\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration\n",
      "Genetic: Demonstration of genetic mutations causing Raynaud's phenomenon\n",
      "Genetic: Mutations|Genetic: Mutations\n",
      "Genetic: Mutations|Genetic: Mutations\n",
      "Biological: Biological samples|Genetic: Genetic test\n",
      "Genetic: Blood collection for genetic analysis\n",
      "Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: western blotting|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery|Radiation: intensity-modulated radiation therapy\n",
      "Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: western blotting|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery|Radiation: intensity-modulated radiation therapy\n",
      "Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: western blotting|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery|Radiation: intensity-modulated radiation therapy\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Behavioral: Cognitive remediation therapy|Genetic: COMT Genotyping\n",
      "Dietary Supplement: defined green tea catechin extract|Genetic: gene expression analysis|Genetic: protein analysis|Other: laboratory biomarker analysis\n",
      "Dietary Supplement: defined green tea catechin extract|Genetic: gene expression analysis|Genetic: protein analysis|Other: laboratory biomarker analysis\n",
      "Genetic: Ryanodine Receptor 2 gene expression|Genetic: Ryanodine Receptor 2 gene expression\n",
      "Genetic: Ryanodine Receptor 2 gene expression|Genetic: Ryanodine Receptor 2 gene expression\n",
      "Genetic: sequencing of a panel of 14 genes in leptin melanocortin pathway\n",
      "Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.\n",
      "Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.\n",
      "Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.\n",
      "Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.|Genetic: DNA from subjects will be stored in the biobank of our study.\n",
      "Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement\n",
      "Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement\n",
      "Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement|Genetic: Sorcin gene expression|Other: Annexin A3 serum mesurement\n",
      "Genetic: To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker\n",
      "Drug: vorinostat|Other: laboratory biomarker analysis|Procedure: biopsy|Radiation: F-18 16 alpha-fluoroestradiol|Procedure: positron emission tomography|Drug: anastrozole|Drug: letrozole|Drug: exemestane|Genetic: gene expression analysis\n",
      "Biological: oblimersen sodium|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: vincristine sulfate|Drug: prednisone|Procedure: biopsy|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Genetic: cytogenetic analysis\n",
      "Biological: oblimersen sodium|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: vincristine sulfate|Drug: prednisone|Procedure: biopsy|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Genetic: cytogenetic analysis\n",
      "Biological: oblimersen sodium|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: vincristine sulfate|Drug: prednisone|Procedure: biopsy|Genetic: microarray analysis|Other: immunohistochemistry staining method|Genetic: gene expression analysis|Genetic: cytogenetic analysis\n",
      "Genetic: TPMT genotyping; Drug: azathioprine or 6-mercaptopurine|Drug: azathioprine (AZA) or 6-mercaptopurine (6-MP)\n",
      "Drug: erlotinib hydrochloride|Drug: oxaliplatin|Drug: fluorouracil|Radiation: radiation therapy|Procedure: conventional surgery|Other: immunohistochemistry staining method|Procedure: positron emission tomography|Procedure: computed tomography|Procedure: laboratory biomarker analysis|Genetic: gene expression analysis|Radiation: fludeoxyglucose F 18\n",
      "Genetic: Sampling|Genetic: Sampling\n",
      "Genetic: Sampling|Genetic: Sampling\n",
      "Biological: bevacizumab|Drug: temozolomide|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: DNA methylation analysis\n",
      "Biological: bevacizumab|Drug: temozolomide|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: DNA methylation analysis\n",
      "Genetic: Sanger and/or Next Generation Sequencing (NGS)\n",
      "Genetic: Measurement of VDR genetic polymorphism|Genetic: Measurement of VDR genetic polymorphism\n",
      "Genetic: Measurement of VDR genetic polymorphism|Genetic: Measurement of VDR genetic polymorphism\n",
      "Drug: cidofovir|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Procedure: biopsy|Procedure: histopathologic examination\n",
      "Drug: cidofovir|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Procedure: biopsy|Procedure: histopathologic examination\n",
      "Drug: cidofovir|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Procedure: biopsy|Procedure: histopathologic examination\n",
      "Drug: VEGF inhibitor PTC299|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: biopsy\n",
      "Drug: VEGF inhibitor PTC299|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: biopsy\n",
      "Drug: VEGF inhibitor PTC299|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: biopsy\n",
      "Drug: cisplatin|Drug: docetaxel|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy\n",
      "Drug: cisplatin|Drug: docetaxel|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy\n",
      "Genetic: polymorphism analysis|Other: laboratory biomarker analysis\n",
      "Drug: cisplatin|Drug: gemcitabine hydrochloride|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunohistochemistry staining method|Procedure: adjuvant therapy|Procedure: conventional surgery|Radiation: radiation therapy\n",
      "Drug: cisplatin|Drug: gemcitabine hydrochloride|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunohistochemistry staining method|Procedure: adjuvant therapy|Procedure: conventional surgery|Radiation: radiation therapy\n",
      "Genetic: Exome sequencing in pediatrics cancers\n",
      "Genetic: Pharmacogenomics|Genetic: Pharmacogenomics|Other: Busulfan plasma level measurements|Genetic: Pharmacogenomics\n",
      "Genetic: Pharmacogenomics|Genetic: Pharmacogenomics|Other: Busulfan plasma level measurements|Genetic: Pharmacogenomics\n",
      "Genetic: Pharmacogenomics|Genetic: Pharmacogenomics|Other: Busulfan plasma level measurements|Genetic: Pharmacogenomics\n",
      "Genetic: CYP2C19 genotyping|Genetic: CYP2C19 genotyping\n",
      "Genetic: CYP2C19 genotyping|Genetic: CYP2C19 genotyping\n",
      "Drug: cyclophosphamide|Drug: fludarabine|Drug: IL-2 (Proleukin)|Genetic: Unmodified Tumour Infiltrating Lymphocytes (UTIL-01)|Drug: cyclophosphamide|Drug: fludarabine|Drug: IL-2 (Proleukin)|Genetic: Gene modified Tumour Infiltrating Lymphocytes (CoTIL-01)\n",
      "Drug: cyclophosphamide|Drug: fludarabine|Drug: IL-2 (Proleukin)|Genetic: Unmodified Tumour Infiltrating Lymphocytes (UTIL-01)|Drug: cyclophosphamide|Drug: fludarabine|Drug: IL-2 (Proleukin)|Genetic: Gene modified Tumour Infiltrating Lymphocytes (CoTIL-01)\n",
      "Biological: bevacizumab|Drug: erlotinib hydrochloride|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: biopsy\n",
      "Biological: bevacizumab|Drug: erlotinib hydrochloride|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: biopsy\n",
      "Genetic: Molecular Profiling|Genetic: Molecular Profiling\n",
      "Genetic: Molecular Profiling|Genetic: Molecular Profiling\n",
      "Genetic: Periodontitis Group|Genetic: Periodontitis Group\n",
      "Genetic: Periodontitis Group|Genetic: Periodontitis Group\n",
      "Genetic: blood sample examination|Genetic: blood sample examination\n",
      "Genetic: blood sample examination|Genetic: blood sample examination\n",
      "Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization\n",
      "Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization\n",
      "Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization\n",
      "Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization\n",
      "Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization|Genetic: somatic cytogenetic and genetic characterization\n",
      "Genetic: Laboratory Biomarker Analysis|Other: Medical Chart Review\n",
      "Genetic: Microarray analysis|Other: Laboratory biomarker analysis\n",
      "Genetic: Gene Polymorphisms of MMP-8|Genetic: Gene Polymorphisms of MMP-8\n",
      "Genetic: Gene Polymorphisms of MMP-8|Genetic: Gene Polymorphisms of MMP-8\n",
      "Genetic: HLA-genotyping|Genetic: HLA-genotyping\n",
      "Genetic: HLA-genotyping|Genetic: HLA-genotyping\n",
      "Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping\n",
      "Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping\n",
      "Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping\n",
      "Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping|Drug: Phenotyping|Genetic: Genotyping\n",
      "Genetic: Diagnostic Test\n",
      "Genetic: Tumor molecular profiling\n",
      "Biological: filgrastim|Drug: capecitabine|Drug: celecoxib|Drug: cyclophosphamide|Drug: docetaxel|Drug: doxorubicin hydrochloride|Genetic: gene expression analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: imaging biomarker analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: needle biopsy|Procedure: neoadjuvant therapy|Procedure: radiomammography|Procedure: ultrasound imaging\n",
      "Biological: filgrastim|Drug: capecitabine|Drug: celecoxib|Drug: cyclophosphamide|Drug: docetaxel|Drug: doxorubicin hydrochloride|Genetic: gene expression analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: imaging biomarker analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: needle biopsy|Procedure: neoadjuvant therapy|Procedure: radiomammography|Procedure: ultrasound imaging\n",
      "Biological: filgrastim|Drug: capecitabine|Drug: celecoxib|Drug: cyclophosphamide|Drug: docetaxel|Drug: doxorubicin hydrochloride|Genetic: gene expression analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: imaging biomarker analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: needle biopsy|Procedure: neoadjuvant therapy|Procedure: radiomammography|Procedure: ultrasound imaging\n",
      "Biological: filgrastim|Drug: capecitabine|Drug: celecoxib|Drug: cyclophosphamide|Drug: docetaxel|Drug: doxorubicin hydrochloride|Genetic: gene expression analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: imaging biomarker analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacogenomic studies|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: needle biopsy|Procedure: neoadjuvant therapy|Procedure: radiomammography|Procedure: ultrasound imaging\n",
      "Genetic: Gene mutations analysis|Genetic: Gene methylation analysis|Genetic: Gene expression analysis|Genetic: SNP analysis|Genetic: Protein expression analysis\n",
      "Genetic: Gene mutations analysis|Genetic: Gene methylation analysis|Genetic: Gene expression analysis|Genetic: SNP analysis|Genetic: Protein expression analysis\n",
      "Genetic: Gene mutations analysis|Genetic: Gene methylation analysis|Genetic: Gene expression analysis|Genetic: SNP analysis|Genetic: Protein expression analysis\n",
      "Genetic: Gene mutations analysis|Genetic: Gene methylation analysis|Genetic: Gene expression analysis|Genetic: SNP analysis|Genetic: Protein expression analysis\n",
      "Genetic: Gene mutations analysis|Genetic: Gene methylation analysis|Genetic: Gene expression analysis|Genetic: SNP analysis|Genetic: Protein expression analysis\n",
      "Drug: Hsp90 inhibitor STA-9090|Other: laboratory biomarker analysis|Genetic: polymerase chain reaction|Other: enzyme-linked immunosorbent assay|Genetic: RNA analysis|Other: spectrophotometry|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: gene expression analysis\n",
      "Drug: Hsp90 inhibitor STA-9090|Other: laboratory biomarker analysis|Genetic: polymerase chain reaction|Other: enzyme-linked immunosorbent assay|Genetic: RNA analysis|Other: spectrophotometry|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: gene expression analysis\n",
      "Drug: Hsp90 inhibitor STA-9090|Other: laboratory biomarker analysis|Genetic: polymerase chain reaction|Other: enzyme-linked immunosorbent assay|Genetic: RNA analysis|Other: spectrophotometry|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: gene expression analysis\n",
      "Drug: Hsp90 inhibitor STA-9090|Other: laboratory biomarker analysis|Genetic: polymerase chain reaction|Other: enzyme-linked immunosorbent assay|Genetic: RNA analysis|Other: spectrophotometry|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: gene expression analysis\n",
      "Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Procedure: peripheral blood stem cell transplantation|Procedure: allogeneic bone marrow transplantation|Other: laboratory biomarker analysis|Genetic: gene expression analysis|Other: immunologic technique|Other: flow cytometry|Genetic: polymerase chain reaction|Genetic: cytogenetic analysis|Other: staining method\n",
      "Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Procedure: peripheral blood stem cell transplantation|Procedure: allogeneic bone marrow transplantation|Other: laboratory biomarker analysis|Genetic: gene expression analysis|Other: immunologic technique|Other: flow cytometry|Genetic: polymerase chain reaction|Genetic: cytogenetic analysis|Other: staining method\n",
      "Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Procedure: peripheral blood stem cell transplantation|Procedure: allogeneic bone marrow transplantation|Other: laboratory biomarker analysis|Genetic: gene expression analysis|Other: immunologic technique|Other: flow cytometry|Genetic: polymerase chain reaction|Genetic: cytogenetic analysis|Other: staining method\n",
      "Biological: Blood and urine samples|Genetic: Blood samples|Other: Cardiovascular assessment|Behavioral: Dietary intake|Other: Anthropometric parameters|Other: Hemodynamic parameters|Behavioral: Assessment of compliance with antihypertensive treatments for treated participants|Other: Ambulatory 24 hours measurment of blood pressure|Biological: 24 hours urinary collection|Other: General questionnaires|Other: Women specific questionnaire|Behavioral: Women specific questionnaire|Diagnostic Test: NYHA dyspnea questionnaire|Behavioral: Anxiety questionnaire|Behavioral: Epworth Sleepiness Scale|Other: A questionnaire on the \"perception of the management of cardiovascular risk factors\"|Behavioral: A questionnaire on eating behaviors|Behavioral: A questionnaire on eating habits to determine consumer profiles|Dietary Supplement: A questionnaire on food supplements use|Other: SARS-CoV-2 Infection Questionnaire|Other: Instantaneous expired air analysis|Biological: Capillary sampling\n",
      "Genetic: mutation analysis|Genetic: polymorphism analysis|Other: laboratory biomarker analysis\n",
      "Genetic: mutation analysis|Genetic: polymorphism analysis|Other: laboratory biomarker analysis\n",
      "Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination\n",
      "Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination\n",
      "Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination|Behavioral: Neuropsychological testing|Biological: blood draw|Genetic: genetic testing|Other: Brain imaging examination\n",
      "Genetic: Blood drawn for genotyping|Biological: Blood drawn for pharmacokinetic measures\n",
      "Genetic: VWF gene analysis\n",
      "Genetic: blood samples|Genetic: blood samples\n",
      "Genetic: blood samples|Genetic: blood samples\n",
      "Genetic: Presence of polymorphisms\n",
      "Drug: everolimus|Drug: lenalidomide|Other: laboratory biomarker analysis|Genetic: polymorphism analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: fluorescence in situ hybridization\n",
      "Drug: everolimus|Drug: lenalidomide|Other: laboratory biomarker analysis|Genetic: polymorphism analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: fluorescence in situ hybridization\n",
      "Drug: everolimus|Drug: lenalidomide|Other: laboratory biomarker analysis|Genetic: polymorphism analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: fluorescence in situ hybridization\n",
      "Genetic: Prostate cancer risk gene panel|Genetic: Prostate cancer risk gene panel\n",
      "Genetic: Prostate cancer risk gene panel|Genetic: Prostate cancer risk gene panel\n",
      "Genetic: Stool collection|Genetic: Stool collection|Genetic: Stool collection\n",
      "Genetic: Stool collection|Genetic: Stool collection|Genetic: Stool collection\n",
      "Genetic: Stool collection|Genetic: Stool collection|Genetic: Stool collection\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: DNA analysis|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: reverse transcriptase-polymerase chain reaction|Other: high performance liquid chromatography|Other: laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Other: biologic sample preservation procedure|Other: laboratory biomarker analysis|Procedure: therapeutic conventional surgery|Procedure: timing of surgery|Genetic: gene expression analysis|Other: biologic sample preservation procedure|Other: laboratory biomarker analysis\n",
      "Genetic: gene expression analysis|Other: biologic sample preservation procedure|Other: laboratory biomarker analysis|Procedure: therapeutic conventional surgery|Procedure: timing of surgery|Genetic: gene expression analysis|Other: biologic sample preservation procedure|Other: laboratory biomarker analysis\n",
      "Genetic: RNAseq\n",
      "Genetic: Systematic screening of TTR mutations\n",
      "Drug: bevacizumab|Drug: carboplatin|Drug: erlotinib hydrochloride|Drug: paclitaxel|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: laboratory biomarker analysis\n",
      "Drug: bevacizumab|Drug: carboplatin|Drug: erlotinib hydrochloride|Drug: paclitaxel|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: laboratory biomarker analysis\n",
      "Drug: bevacizumab|Drug: carboplatin|Drug: erlotinib hydrochloride|Drug: paclitaxel|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: laboratory biomarker analysis\n",
      "Genetic: Genotyping|Genetic: Genotyping\n",
      "Genetic: Genotyping|Genetic: Genotyping\n",
      "Genetic: Genetic analysis|Radiation: Body scan (CERVICO THORACO ABDOMINAL) + Cranian IRM|Other: Immunologic analysis|Genetic: Genetic analysis|Radiation: Body scan (CERVICO THORACO ABDOMINAL) + Cranian IRM|Other: Immunologic analysis|Other: QuantiferonTB Gold test\n",
      "Genetic: Genetic analysis|Radiation: Body scan (CERVICO THORACO ABDOMINAL) + Cranian IRM|Other: Immunologic analysis|Genetic: Genetic analysis|Radiation: Body scan (CERVICO THORACO ABDOMINAL) + Cranian IRM|Other: Immunologic analysis|Other: QuantiferonTB Gold test\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Genetic: SKG0106|Genetic: SKG0106|Genetic: SKG0106\n",
      "Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members|Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members\n",
      "Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members|Genetic: Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members\n",
      "Drug: capecitabine|Drug: oxaliplatin|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy\n",
      "Drug: capecitabine|Drug: oxaliplatin|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy\n",
      "Drug: capecitabine|Drug: oxaliplatin|Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy\n",
      "Genetic: WES|Diagnostic Test: Several assays\n",
      "Genetic: BRCA mutation\n",
      "Genetic: specimen samples|Behavioral: questionnaires\n",
      "Biological: therapeutic autologous dendritic cells|Drug: aromatase inhibition therapy|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Drug: tamoxifen citrate|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy\n",
      "Biological: therapeutic autologous dendritic cells|Drug: aromatase inhibition therapy|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Drug: tamoxifen citrate|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy\n",
      "Biological: therapeutic autologous dendritic cells|Drug: aromatase inhibition therapy|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Drug: tamoxifen citrate|Genetic: gene expression analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy\n",
      "Genetic: cytogenetic analysis|Genetic: gene mapping|Genetic: microarray analysis\n",
      "Genetic: cytogenetic analysis|Genetic: gene mapping|Genetic: microarray analysis\n",
      "Genetic: cytogenetic analysis|Genetic: gene mapping|Genetic: microarray analysis\n",
      "Genetic: Whole genome sequencing|Genetic: Whole genome sequencing|Genetic: Whole genome sequencing\n",
      "Genetic: Whole genome sequencing|Genetic: Whole genome sequencing|Genetic: Whole genome sequencing\n",
      "Genetic: Whole genome sequencing|Genetic: Whole genome sequencing|Genetic: Whole genome sequencing\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: DNA methylation analysis|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Procedure: biopsy|Procedure: therapeutic conventional surgery|Radiation: fludeoxyglucose F 18\n",
      "Genetic: BRCA testing and questionnaire assessments\n",
      "Genetic: spliceosome\n",
      "Genetic: Genetic analysis on isolated cells|Genetic: Genetic analysis on isolated cells\n",
      "Genetic: Genetic analysis on isolated cells|Genetic: Genetic analysis on isolated cells\n",
      "Drug: temozolomide|Drug: veliparib|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: proteomic profiling|Other: high performance liquid chromatography|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy\n",
      "Drug: temozolomide|Drug: veliparib|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: proteomic profiling|Other: high performance liquid chromatography|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy\n",
      "Drug: temozolomide|Drug: veliparib|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: proteomic profiling|Other: high performance liquid chromatography|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy\n",
      "Drug: temozolomide|Drug: veliparib|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: proteomic profiling|Other: high performance liquid chromatography|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy\n",
      "Genetic: genetic analysis|Biological: blood and stools samples\n"
     ]
    }
   ],
   "source": [
    "modified_armgroup_interventionName=[]\n",
    "for elem_arm in text_data['ArmGroupInterventionName']:\n",
    "    if 'Genetic:' in elem_arm:\n",
    "        if '|' in elem_arm:\n",
    "            for elem_arm_gene in elem_arm.split('|'):\n",
    "                if 'Genetic:' in elem_arm_gene and ('therapy' in elem_arm_gene.lower() or 'vector' in elem_arm_gene.lower()):\n",
    "                    modified_armgroup_interventionName.append(elem_arm_gene)\n",
    "                    break\n",
    "                elif 'Genetic:' in elem_arm_gene:\n",
    "                    modified_armgroup_interventionName.append('other genetic')\n",
    "                    print(elem_arm)\n",
    "                    break\n",
    "        elif '|' not in elem_arm and ('therapy' in elem_arm.lower() or 'vector' in elem_arm.lower()):\n",
    "            modified_armgroup_interventionName.append(elem_arm)\n",
    "        else:\n",
    "            print(elem_arm)\n",
    "            modified_armgroup_interventionName.append('other genetic')\n",
    "    else:\n",
    "        modified_armgroup_interventionName.append('other') \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "47"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#np.unique(np.array(modified_armgroup_interventionName),return_counts=True)\n",
    "onlygen_modified_armgroup_interventionName = [elem for elem in modified_armgroup_interventionName if 'Genetic:' in elem]\n",
    "len(onlygen_modified_armgroup_interventionName)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Genetic: lentiviral gene therapy',\n",
       " 'Genetic: Gene therapy',\n",
       " 'Genetic: Gene therapy',\n",
       " 'Genetic: AAV2-BDNF Gene Therapy|Biological: AAV2-BDNF Gene Therapy',\n",
       " 'Genetic: OTL-200 Gene Therapy',\n",
       " 'Genetic: Gene therapy',\n",
       " 'Genetic: Gene therapy',\n",
       " 'Genetic: ex-vivo gene-therapy',\n",
       " 'Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes',\n",
       " 'Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes',\n",
       " 'Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy',\n",
       " 'Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy',\n",
       " 'Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy',\n",
       " 'Genetic: Intracerebral LV gene therapy',\n",
       " 'Genetic: Gene Therapy|Drug: Busulfan',\n",
       " 'Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre',\n",
       " 'Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion',\n",
       " 'Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy',\n",
       " 'Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy',\n",
       " 'Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy',\n",
       " 'Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4',\n",
       " 'Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4',\n",
       " 'Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4',\n",
       " 'Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4',\n",
       " 'Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene',\n",
       " 'Genetic: X vivo gene therapy',\n",
       " 'Genetic: X vivo gene therapy',\n",
       " 'Genetic: X vivo gene therapy',\n",
       " 'Genetic: X vivo gene therapy',\n",
       " 'Genetic: rAAV2.REP1 vector',\n",
       " 'Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the α-L-iduronidase cDNA, in their final formulation medium.',\n",
       " 'Genetic: rAAV2-CB-hAAT Gene Vector',\n",
       " 'Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene',\n",
       " 'Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene',\n",
       " 'Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene',\n",
       " 'Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy',\n",
       " 'Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy',\n",
       " 'Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.',\n",
       " 'Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " 'Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo',\n",
       " \"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy\",\n",
       " \"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy\",\n",
       " 'Genetic: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy',\n",
       " 'Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line',\n",
       " 'Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line',\n",
       " 'Genetic: ct-DNA guided therapy',\n",
       " 'Genetic: Gene-modified (GM) T cell therapy',\n",
       " 'Genetic: response to therapy']"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "select_gene_therapy_cases = [elem for elem in text_data['ArmGroupInterventionName'].values for word in onlygen_modified_armgroup_interventionName if elem.find(word)!=-1]\n",
    "select_gene_therapy_cases"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>OfficialTitle</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>Condition</th>\n",
       "      <th>ConditionAncestorTerm</th>\n",
       "      <th>ArmGroupInterventionName</th>\n",
       "      <th>InterventionArmGroupLabel</th>\n",
       "      <th>InterventionDescription</th>\n",
       "      <th>mod_ConditionAncestorTerm</th>\n",
       "      <th>selected_conditionterms</th>\n",
       "      <th>no_of_cases</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Phase I/IIa, First-in-human, Open-label, Singl...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>September 2024</td>\n",
       "      <td>Drug Resistant Epilepsy</td>\n",
       "      <td>Brain Diseases|Central Nervous System Diseases...</td>\n",
       "      <td>Genetic: lentiviral gene therapy</td>\n",
       "      <td>lentiviral gene therapy treatment (Interventio...</td>\n",
       "      <td>lentiviral gene therapy to treat drug resistan...</td>\n",
       "      <td>Brain Diseases</td>\n",
       "      <td>Brain Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Growth and Development, Health-related Quality...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>June 5, 2023</td>\n",
       "      <td>Transfusion-dependent Beta-Thalassemia|Gene Th...</td>\n",
       "      <td>Anemia, Hemolytic, Congenital|Anemia, Hemolyti...</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "      <td>Gene therapy group</td>\n",
       "      <td>Autologous edited hematopoietic stem cell tran...</td>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>A Phase I Study to Assess the Safety, Tolerabi...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 7, 2022</td>\n",
       "      <td>Alzheimer's Disease|Mild Cognitive Impairment</td>\n",
       "      <td>Dementia|Brain Diseases|Central Nervous System...</td>\n",
       "      <td>Genetic: AAV2-BDNF Gene Therapy|Biological: AA...</td>\n",
       "      <td>Gene transfer of AAV2-BDNF|Gene transfer of AA...</td>\n",
       "      <td>AAV2-BDNF is a genetically engineered adeno-as...</td>\n",
       "      <td>Dementia</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>A Phase I/II Clinical Trial of Hematopoietic S...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>April 9, 2010</td>\n",
       "      <td>Lysosomal Storage Disease|Metachromatic Leukod...</td>\n",
       "      <td>Metabolism, Inborn Errors|Genetic Diseases, In...</td>\n",
       "      <td>Genetic: OTL-200 Gene Therapy</td>\n",
       "      <td>OTL-200 Gene Therapy</td>\n",
       "      <td>Autologous hematopoietic stem/progenitor cells...</td>\n",
       "      <td>Metabolism, Inborn Errors</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Phase I/II Clinical Trial of Autologous Hemato...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 23, 2021</td>\n",
       "      <td>Severe Combined Immunodeficiency Due to RAG1 D...</td>\n",
       "      <td>Immune System Diseases|Primary Immunodeficienc...</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "      <td>Gene therapy</td>\n",
       "      <td>Patients will be infused with autologous CD34+...</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>A Phase I/II Gene Therapy Trial for X-CGD With...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 2013</td>\n",
       "      <td>X-linked Chronic Granulomatous Disease</td>\n",
       "      <td>Pathologic Processes|Phagocyte Bactericidal Dy...</td>\n",
       "      <td>Genetic: ex-vivo gene-therapy</td>\n",
       "      <td>ex-vivo gene-therapy</td>\n",
       "      <td>transplantation autologous CD34+ cells, transd...</td>\n",
       "      <td>Pathologic Processes</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>PILOT STUDY OF GENE THERAPY FOR LOCALLY ADVANC...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>December 2010</td>\n",
       "      <td>Pancreatic Adenocarcinoma</td>\n",
       "      <td>Carcinoma|Neoplasms, Glandular and Epithelial|...</td>\n",
       "      <td>Genetic: Gene Therapy product CYL-02 = plasmid...</td>\n",
       "      <td>Therapy</td>\n",
       "      <td>Intratumoral injection of the gene therapy pro...</td>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>A Phase 1/2a Open-label Study to Evaluate Safe...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>September 8, 2023</td>\n",
       "      <td>Age-Related Macular Degeneration</td>\n",
       "      <td>Retinal Degeneration|Retinal Diseases|Eye Dise...</td>\n",
       "      <td>Genetic: NG101 AAV gene therapy|Genetic: NG101...</td>\n",
       "      <td>NG101 Gene Therapy Group 1|NG101 Gene Therapy ...</td>\n",
       "      <td>Sub retinal injection of NG101 (a non-replicat...</td>\n",
       "      <td>Retinal Degeneration</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Lentiviral Gene Therapy for X-linked Adrenoleu...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>October 30, 2018</td>\n",
       "      <td>X-linked Adrenoleukodystrophy</td>\n",
       "      <td>Brain Diseases, Metabolic, Inborn|Brain Diseas...</td>\n",
       "      <td>Genetic: Intracerebral LV gene therapy</td>\n",
       "      <td>Lentivirus-mediated delivery of ABCD1 to the CNS.</td>\n",
       "      <td>Intracerebral LV gene therapy to deliver high ...</td>\n",
       "      <td>Brain Diseases, Metabolic, Inborn</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>ADA Gene Transfer Into Hematopoietic Stem/Prog...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>October 2, 2002</td>\n",
       "      <td>Immunologic Deficiency Syndromes</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>Genetic: Gene Therapy|Drug: Busulfan</td>\n",
       "      <td>Gene Therapy|Gene Therapy</td>\n",
       "      <td>Infusion of autologous CD34+ cells transduced ...</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Gene Therapy for SCID-X1 Using a Self-inactiva...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>April 2011</td>\n",
       "      <td>X-linked Severe Combined Immunodeficiency</td>\n",
       "      <td>Immune System Diseases|Primary Immunodeficienc...</td>\n",
       "      <td>Genetic: Single infusion of autologous CD34+ c...</td>\n",
       "      <td>Single infusion of autologous CD34+ cells</td>\n",
       "      <td>Single infusion of autologous CD34+ cells tran...</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Phase I/II Gene Therapy Protocol for X-Linked ...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>Granulomatous Disease, Chronic, X-linked, Variant</td>\n",
       "      <td>Chronic Disease|Disease Attributes|Pathologic ...</td>\n",
       "      <td>Genetic: pCCLchimGp91s lentiviral vector trans...</td>\n",
       "      <td>pCCLchimGp91s lentiviral vector transduced CD3...</td>\n",
       "      <td>pCCLchimGp91s lentiviral vector transduced CD3...</td>\n",
       "      <td>Chronic Disease</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>AAV8-mediated Low Density Lipoprotein Receptor...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>March 2016</td>\n",
       "      <td>Homozygous Familial Hypercholesterolemia (HoFH)</td>\n",
       "      <td>Hyperlipidemias|Dyslipidemias|Lipid Metabolism...</td>\n",
       "      <td>Genetic: AAV directed hLDLR gene therapy|Genet...</td>\n",
       "      <td>Cohort 1|Cohort 2|Cohort 2 Expansion</td>\n",
       "      <td>AAV directed hLDLR gene therapy is a novel ade...</td>\n",
       "      <td>Hyperlipidemias</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Phase I, Multicentre, Open Label, Single Dose,...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2012</td>\n",
       "      <td>Acute Intermittent Porphyria</td>\n",
       "      <td>Metabolic Diseases|Skin Diseases, Genetic|Gene...</td>\n",
       "      <td>Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...</td>\n",
       "      <td>Cohort A|Cohort B|Cohort C|Cohort D</td>\n",
       "      <td>Intravenous injection of rAAV2/5-PBGD vector, ...</td>\n",
       "      <td>Metabolic Diseases</td>\n",
       "      <td>Metabolic Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Phase I/II Clinical Trial of Haematopoietic St...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>March 2011</td>\n",
       "      <td>Wiskott-Aldrich Syndrome</td>\n",
       "      <td>Disease|Pathologic Processes|Blood Coagulation...</td>\n",
       "      <td>Genetic: Autologous CD34 positive cells transd...</td>\n",
       "      <td>study treatment</td>\n",
       "      <td>transplantation of patient's autologous CD34+ ...</td>\n",
       "      <td>Disease</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>A Phase I/II, Non Randomized, Multicenter, Ope...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>June 24, 2013</td>\n",
       "      <td>X-Linked Chronic Granulomatous Disease</td>\n",
       "      <td>Lymphoproliferative Disorders|Lymphatic Diseas...</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "      <td>Open label</td>\n",
       "      <td>Transplantation of patient's autologous CD34+ ...</td>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>A Phase I/II, Non Randomized, Monocentric Open...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>March 2016</td>\n",
       "      <td>X-Linked Chronic Granulomatous Disease</td>\n",
       "      <td>Lymphoproliferative Disorders|Lymphatic Diseas...</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "      <td>open label</td>\n",
       "      <td>Transplantation of patient's autologous CD34+ ...</td>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>An Open Label Clinical Trial of Retinal Gene T...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>April 2015</td>\n",
       "      <td>Choroideremia</td>\n",
       "      <td>Eye Diseases, Hereditary|Eye Diseases|Choroid ...</td>\n",
       "      <td>Genetic: rAAV2.REP1 vector</td>\n",
       "      <td>Open Label</td>\n",
       "      <td>No additional details needed.</td>\n",
       "      <td>Eye Diseases, Hereditary</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>Phase I/II Study Evaluating Safety and Efficac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 11, 2018</td>\n",
       "      <td>Mucopolysaccharidosis IH</td>\n",
       "      <td>Carbohydrate Metabolism, Inborn Errors|Metabol...</td>\n",
       "      <td>Genetic: Frozen autologous CD34+ hematopoietic...</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>The drug product target dose is more or equal ...</td>\n",
       "      <td>Carbohydrate Metabolism, Inborn Errors</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>Preclinical &amp; Phase I/II Trials of AAV-AAT Vec...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>March 2004</td>\n",
       "      <td>Alpha 1-Antitrypsin Deficiency</td>\n",
       "      <td>Liver Diseases|Digestive System Diseases|Lung ...</td>\n",
       "      <td>Genetic: rAAV2-CB-hAAT Gene Vector</td>\n",
       "      <td>1</td>\n",
       "      <td>Participants will attend a 5-day inpatient vis...</td>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>A Phase I/II Study Evaluating Safety and Effic...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 2015</td>\n",
       "      <td>Beta-Thalassemia</td>\n",
       "      <td>Anemia, Hemolytic, Congenital|Anemia, Hemolyti...</td>\n",
       "      <td>Genetic: Autologous hematopoietic stem cells g...</td>\n",
       "      <td>Adults|Elderly children|Younger children</td>\n",
       "      <td>Autologous CD34+ cell enriched fraction contai...</td>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>An Open-Label Phase I/II Dose Finding Study to...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>October 12, 2022</td>\n",
       "      <td>Huntington Disease</td>\n",
       "      <td>Basal Ganglia Diseases|Brain Diseases|Central ...</td>\n",
       "      <td>Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...</td>\n",
       "      <td>Cohort 1|Cohort 2</td>\n",
       "      <td>One-time intracerebral bilateral injections of...</td>\n",
       "      <td>Basal Ganglia Diseases</td>\n",
       "      <td>Basal Ganglia Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>569</th>\n",
       "      <td>A Phase I, Open Label, Dual Cohort, Single Cen...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>December 2012</td>\n",
       "      <td>HIV</td>\n",
       "      <td>HIV</td>\n",
       "      <td>Genetic: Autologous CD4+ T cells genetically m...</td>\n",
       "      <td>Cohort 1|Cohort 2</td>\n",
       "      <td>other or NA</td>\n",
       "      <td>HIV</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>A Phase I/II Study of Repeat Intra-articular A...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 2005</td>\n",
       "      <td>Arthritis, Rheumatoid|Arthritis, Psoriatic|Ank...</td>\n",
       "      <td>Joint Diseases|Musculoskeletal Diseases|Bone D...</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>1|1|4|2|2|3|3</td>\n",
       "      <td>Single Dose 1x10^11 DRP/mL|Second dose of 1x10...</td>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>672</th>\n",
       "      <td>A Phase 1 Dose Escalation Study of Intra-Artic...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2004</td>\n",
       "      <td>Rheumatoid Arthritis</td>\n",
       "      <td>Joint Diseases|Musculoskeletal Diseases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>1|2|3</td>\n",
       "      <td>Single Dose 1x10^10 DNase resistant particles ...</td>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>720</th>\n",
       "      <td>Long-term Follow-up Study to Evaluate the Safe...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>December 29, 2022</td>\n",
       "      <td>Diffuse Large B Cell Lymphoma|Large B-cell Lym...</td>\n",
       "      <td>Neoplasms by Histologic Type|Neoplasms|Lymphop...</td>\n",
       "      <td>Genetic: Pell's lentiviral-based gene-edited i...</td>\n",
       "      <td>Group A|Group B</td>\n",
       "      <td>No study drug or other planned treatment will ...</td>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>982</th>\n",
       "      <td>(H-49235) Trivalent Autologous T-Lymphocytes C...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 18, 2023</td>\n",
       "      <td>Leukemia, B-Cell</td>\n",
       "      <td>Neoplasms by Histologic Type|Neoplasms|Hematol...</td>\n",
       "      <td>Genetic: Autologous TRICAR-ALL T-cells and lym...</td>\n",
       "      <td>Autologous TRICAR-ALL T-Cells and lymphodeplet...</td>\n",
       "      <td>Three dose levels will be evaluated with the o...</td>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1014</th>\n",
       "      <td>Immunotherapy With CD19ζ Gene-modified EBV-spe...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 2012</td>\n",
       "      <td>Acute Lymphoblastic Leukemia</td>\n",
       "      <td>Neoplasms by Histologic Type|Neoplasms|Hematol...</td>\n",
       "      <td>Genetic: donor-derived EBV-specific cytotoxic ...</td>\n",
       "      <td>Pre-emptive arm|Prophylaxis arm|Pre-emptive ar...</td>\n",
       "      <td>All patients will be treated at the same total...</td>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1258</th>\n",
       "      <td>Exploratory Study on Gene Profiling of Circula...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>Genetic: ct-DNA guided therapy</td>\n",
       "      <td>ct-DNA test in MPC</td>\n",
       "      <td>treatment according to ct-DNA results:For Pati...</td>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1313</th>\n",
       "      <td>Long-Term Follow-up Protocol for Subjects Trea...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>June 19, 2018</td>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>Genetic: Gene-modified (GM) T cell therapy</td>\n",
       "      <td>Participants exposed to Gene-modified (GM) T c...</td>\n",
       "      <td>No investigational product will be administered</td>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1668</th>\n",
       "      <td>Stem Cells And The Origins Of Barrett's Esopha...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>January 2012</td>\n",
       "      <td>Barrett's Esophagus</td>\n",
       "      <td>Precancerous Conditions|Neoplasms|Esophageal D...</td>\n",
       "      <td>Genetic: response to therapy</td>\n",
       "      <td>Radiofrequency ablation</td>\n",
       "      <td>evaluate specific markers for response to ther...</td>\n",
       "      <td>Precancerous Conditions</td>\n",
       "      <td>others</td>\n",
       "      <td>31 cases</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          OfficialTitle       StudyType  \\\n",
       "0     Phase I/IIa, First-in-human, Open-label, Singl...  Interventional   \n",
       "1     Growth and Development, Health-related Quality...   Observational   \n",
       "5     A Phase I Study to Assess the Safety, Tolerabi...  Interventional   \n",
       "7     A Phase I/II Clinical Trial of Hematopoietic S...  Interventional   \n",
       "8     Phase I/II Clinical Trial of Autologous Hemato...  Interventional   \n",
       "12    A Phase I/II Gene Therapy Trial for X-CGD With...  Interventional   \n",
       "13    PILOT STUDY OF GENE THERAPY FOR LOCALLY ADVANC...  Interventional   \n",
       "21    A Phase 1/2a Open-label Study to Evaluate Safe...  Interventional   \n",
       "24    Lentiviral Gene Therapy for X-linked Adrenoleu...  Interventional   \n",
       "29    ADA Gene Transfer Into Hematopoietic Stem/Prog...  Interventional   \n",
       "39    Gene Therapy for SCID-X1 Using a Self-inactiva...  Interventional   \n",
       "52    Phase I/II Gene Therapy Protocol for X-Linked ...  Interventional   \n",
       "62    AAV8-mediated Low Density Lipoprotein Receptor...  Interventional   \n",
       "64    Phase I, Multicentre, Open Label, Single Dose,...  Interventional   \n",
       "84    Phase I/II Clinical Trial of Haematopoietic St...  Interventional   \n",
       "105   A Phase I/II, Non Randomized, Multicenter, Ope...  Interventional   \n",
       "106   A Phase I/II, Non Randomized, Monocentric Open...  Interventional   \n",
       "177   An Open Label Clinical Trial of Retinal Gene T...  Interventional   \n",
       "330   Phase I/II Study Evaluating Safety and Efficac...  Interventional   \n",
       "342   Preclinical & Phase I/II Trials of AAV-AAT Vec...  Interventional   \n",
       "379   A Phase I/II Study Evaluating Safety and Effic...  Interventional   \n",
       "494   An Open-Label Phase I/II Dose Finding Study to...  Interventional   \n",
       "569   A Phase I, Open Label, Dual Cohort, Single Cen...  Interventional   \n",
       "637   A Phase I/II Study of Repeat Intra-articular A...  Interventional   \n",
       "672   A Phase 1 Dose Escalation Study of Intra-Artic...  Interventional   \n",
       "720   Long-term Follow-up Study to Evaluate the Safe...   Observational   \n",
       "982   (H-49235) Trivalent Autologous T-Lymphocytes C...  Interventional   \n",
       "1014  Immunotherapy With CD19ζ Gene-modified EBV-spe...  Interventional   \n",
       "1258  Exploratory Study on Gene Profiling of Circula...  Interventional   \n",
       "1313  Long-Term Follow-up Protocol for Subjects Trea...  Interventional   \n",
       "1668  Stem Cells And The Origins Of Barrett's Esopha...   Observational   \n",
       "\n",
       "              StartDate                                          Condition  \\\n",
       "0        September 2024                            Drug Resistant Epilepsy   \n",
       "1          June 5, 2023  Transfusion-dependent Beta-Thalassemia|Gene Th...   \n",
       "5      February 7, 2022      Alzheimer's Disease|Mild Cognitive Impairment   \n",
       "7         April 9, 2010  Lysosomal Storage Disease|Metachromatic Leukod...   \n",
       "8         July 23, 2021  Severe Combined Immunodeficiency Due to RAG1 D...   \n",
       "12            July 2013             X-linked Chronic Granulomatous Disease   \n",
       "13        December 2010                          Pancreatic Adenocarcinoma   \n",
       "21    September 8, 2023                   Age-Related Macular Degeneration   \n",
       "24     October 30, 2018                      X-linked Adrenoleukodystrophy   \n",
       "29      October 2, 2002                   Immunologic Deficiency Syndromes   \n",
       "39           April 2011          X-linked Severe Combined Immunodeficiency   \n",
       "52        November 2011  Granulomatous Disease, Chronic, X-linked, Variant   \n",
       "62           March 2016    Homozygous Familial Hypercholesterolemia (HoFH)   \n",
       "64        November 2012                       Acute Intermittent Porphyria   \n",
       "84           March 2011                           Wiskott-Aldrich Syndrome   \n",
       "105       June 24, 2013             X-Linked Chronic Granulomatous Disease   \n",
       "106          March 2016             X-Linked Chronic Granulomatous Disease   \n",
       "177          April 2015                                      Choroideremia   \n",
       "330        May 11, 2018                           Mucopolysaccharidosis IH   \n",
       "342          March 2004                     Alpha 1-Antitrypsin Deficiency   \n",
       "379            May 2015                                   Beta-Thalassemia   \n",
       "494    October 12, 2022                                 Huntington Disease   \n",
       "569       December 2012                                                HIV   \n",
       "637         August 2005  Arthritis, Rheumatoid|Arthritis, Psoriatic|Ank...   \n",
       "672       February 2004                               Rheumatoid Arthritis   \n",
       "720   December 29, 2022  Diffuse Large B Cell Lymphoma|Large B-cell Lym...   \n",
       "982       July 18, 2023                                   Leukemia, B-Cell   \n",
       "1014           May 2012                       Acute Lymphoblastic Leukemia   \n",
       "1258      December 2021                           Multiple Primary Cancers   \n",
       "1313      June 19, 2018                                          Neoplasms   \n",
       "1668       January 2012                                Barrett's Esophagus   \n",
       "\n",
       "                                  ConditionAncestorTerm  \\\n",
       "0     Brain Diseases|Central Nervous System Diseases...   \n",
       "1     Anemia, Hemolytic, Congenital|Anemia, Hemolyti...   \n",
       "5     Dementia|Brain Diseases|Central Nervous System...   \n",
       "7     Metabolism, Inborn Errors|Genetic Diseases, In...   \n",
       "8     Immune System Diseases|Primary Immunodeficienc...   \n",
       "12    Pathologic Processes|Phagocyte Bactericidal Dy...   \n",
       "13    Carcinoma|Neoplasms, Glandular and Epithelial|...   \n",
       "21    Retinal Degeneration|Retinal Diseases|Eye Dise...   \n",
       "24    Brain Diseases, Metabolic, Inborn|Brain Diseas...   \n",
       "29                               Immune System Diseases   \n",
       "39    Immune System Diseases|Primary Immunodeficienc...   \n",
       "52    Chronic Disease|Disease Attributes|Pathologic ...   \n",
       "62    Hyperlipidemias|Dyslipidemias|Lipid Metabolism...   \n",
       "64    Metabolic Diseases|Skin Diseases, Genetic|Gene...   \n",
       "84    Disease|Pathologic Processes|Blood Coagulation...   \n",
       "105   Lymphoproliferative Disorders|Lymphatic Diseas...   \n",
       "106   Lymphoproliferative Disorders|Lymphatic Diseas...   \n",
       "177   Eye Diseases, Hereditary|Eye Diseases|Choroid ...   \n",
       "330   Carbohydrate Metabolism, Inborn Errors|Metabol...   \n",
       "342   Liver Diseases|Digestive System Diseases|Lung ...   \n",
       "379   Anemia, Hemolytic, Congenital|Anemia, Hemolyti...   \n",
       "494   Basal Ganglia Diseases|Brain Diseases|Central ...   \n",
       "569                                                 HIV   \n",
       "637   Joint Diseases|Musculoskeletal Diseases|Bone D...   \n",
       "672             Joint Diseases|Musculoskeletal Diseases   \n",
       "720   Neoplasms by Histologic Type|Neoplasms|Lymphop...   \n",
       "982   Neoplasms by Histologic Type|Neoplasms|Hematol...   \n",
       "1014  Neoplasms by Histologic Type|Neoplasms|Hematol...   \n",
       "1258                           Multiple Primary Cancers   \n",
       "1313                                          Neoplasms   \n",
       "1668  Precancerous Conditions|Neoplasms|Esophageal D...   \n",
       "\n",
       "                               ArmGroupInterventionName  \\\n",
       "0                      Genetic: lentiviral gene therapy   \n",
       "1                                 Genetic: Gene therapy   \n",
       "5     Genetic: AAV2-BDNF Gene Therapy|Biological: AA...   \n",
       "7                         Genetic: OTL-200 Gene Therapy   \n",
       "8                                 Genetic: Gene therapy   \n",
       "12                        Genetic: ex-vivo gene-therapy   \n",
       "13    Genetic: Gene Therapy product CYL-02 = plasmid...   \n",
       "21    Genetic: NG101 AAV gene therapy|Genetic: NG101...   \n",
       "24               Genetic: Intracerebral LV gene therapy   \n",
       "29                 Genetic: Gene Therapy|Drug: Busulfan   \n",
       "39    Genetic: Single infusion of autologous CD34+ c...   \n",
       "52    Genetic: pCCLchimGp91s lentiviral vector trans...   \n",
       "62    Genetic: AAV directed hLDLR gene therapy|Genet...   \n",
       "64    Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...   \n",
       "84    Genetic: Autologous CD34 positive cells transd...   \n",
       "105                        Genetic: X vivo gene therapy   \n",
       "106                        Genetic: X vivo gene therapy   \n",
       "177                          Genetic: rAAV2.REP1 vector   \n",
       "330   Genetic: Frozen autologous CD34+ hematopoietic...   \n",
       "342                  Genetic: rAAV2-CB-hAAT Gene Vector   \n",
       "379   Genetic: Autologous hematopoietic stem cells g...   \n",
       "494   Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...   \n",
       "569   Genetic: Autologous CD4+ T cells genetically m...   \n",
       "637   Genetic: tgAAC94 gene therapy vector|Genetic: ...   \n",
       "672   Genetic: tgAAC94 gene therapy vector|Genetic: ...   \n",
       "720   Genetic: Pell's lentiviral-based gene-edited i...   \n",
       "982   Genetic: Autologous TRICAR-ALL T-cells and lym...   \n",
       "1014  Genetic: donor-derived EBV-specific cytotoxic ...   \n",
       "1258                     Genetic: ct-DNA guided therapy   \n",
       "1313         Genetic: Gene-modified (GM) T cell therapy   \n",
       "1668                       Genetic: response to therapy   \n",
       "\n",
       "                              InterventionArmGroupLabel  \\\n",
       "0     lentiviral gene therapy treatment (Interventio...   \n",
       "1                                    Gene therapy group   \n",
       "5     Gene transfer of AAV2-BDNF|Gene transfer of AA...   \n",
       "7                                  OTL-200 Gene Therapy   \n",
       "8                                          Gene therapy   \n",
       "12                                 ex-vivo gene-therapy   \n",
       "13                                              Therapy   \n",
       "21    NG101 Gene Therapy Group 1|NG101 Gene Therapy ...   \n",
       "24    Lentivirus-mediated delivery of ABCD1 to the CNS.   \n",
       "29                            Gene Therapy|Gene Therapy   \n",
       "39            Single infusion of autologous CD34+ cells   \n",
       "52    pCCLchimGp91s lentiviral vector transduced CD3...   \n",
       "62                 Cohort 1|Cohort 2|Cohort 2 Expansion   \n",
       "64                  Cohort A|Cohort B|Cohort C|Cohort D   \n",
       "84                                      study treatment   \n",
       "105                                          Open label   \n",
       "106                                          open label   \n",
       "177                                          Open Label   \n",
       "330                                           Treatment   \n",
       "342                                                   1   \n",
       "379            Adults|Elderly children|Younger children   \n",
       "494                                   Cohort 1|Cohort 2   \n",
       "569                                   Cohort 1|Cohort 2   \n",
       "637                                       1|1|4|2|2|3|3   \n",
       "672                                               1|2|3   \n",
       "720                                     Group A|Group B   \n",
       "982   Autologous TRICAR-ALL T-Cells and lymphodeplet...   \n",
       "1014  Pre-emptive arm|Prophylaxis arm|Pre-emptive ar...   \n",
       "1258                                 ct-DNA test in MPC   \n",
       "1313  Participants exposed to Gene-modified (GM) T c...   \n",
       "1668                            Radiofrequency ablation   \n",
       "\n",
       "                                InterventionDescription  \\\n",
       "0     lentiviral gene therapy to treat drug resistan...   \n",
       "1     Autologous edited hematopoietic stem cell tran...   \n",
       "5     AAV2-BDNF is a genetically engineered adeno-as...   \n",
       "7     Autologous hematopoietic stem/progenitor cells...   \n",
       "8     Patients will be infused with autologous CD34+...   \n",
       "12    transplantation autologous CD34+ cells, transd...   \n",
       "13    Intratumoral injection of the gene therapy pro...   \n",
       "21    Sub retinal injection of NG101 (a non-replicat...   \n",
       "24    Intracerebral LV gene therapy to deliver high ...   \n",
       "29    Infusion of autologous CD34+ cells transduced ...   \n",
       "39    Single infusion of autologous CD34+ cells tran...   \n",
       "52    pCCLchimGp91s lentiviral vector transduced CD3...   \n",
       "62    AAV directed hLDLR gene therapy is a novel ade...   \n",
       "64    Intravenous injection of rAAV2/5-PBGD vector, ...   \n",
       "84    transplantation of patient's autologous CD34+ ...   \n",
       "105   Transplantation of patient's autologous CD34+ ...   \n",
       "106   Transplantation of patient's autologous CD34+ ...   \n",
       "177                       No additional details needed.   \n",
       "330   The drug product target dose is more or equal ...   \n",
       "342   Participants will attend a 5-day inpatient vis...   \n",
       "379   Autologous CD34+ cell enriched fraction contai...   \n",
       "494   One-time intracerebral bilateral injections of...   \n",
       "569                                         other or NA   \n",
       "637   Single Dose 1x10^11 DRP/mL|Second dose of 1x10...   \n",
       "672   Single Dose 1x10^10 DNase resistant particles ...   \n",
       "720   No study drug or other planned treatment will ...   \n",
       "982   Three dose levels will be evaluated with the o...   \n",
       "1014  All patients will be treated at the same total...   \n",
       "1258  treatment according to ct-DNA results:For Pati...   \n",
       "1313    No investigational product will be administered   \n",
       "1668  evaluate specific markers for response to ther...   \n",
       "\n",
       "                   mod_ConditionAncestorTerm selected_conditionterms  \\\n",
       "0                             Brain Diseases          Brain Diseases   \n",
       "1              Anemia, Hemolytic, Congenital                  others   \n",
       "5                                   Dementia                  others   \n",
       "7                  Metabolism, Inborn Errors                  others   \n",
       "8                     Immune System Diseases  Immune System Diseases   \n",
       "12                      Pathologic Processes                  others   \n",
       "13                                 Carcinoma                  others   \n",
       "21                      Retinal Degeneration                  others   \n",
       "24         Brain Diseases, Metabolic, Inborn                  others   \n",
       "29                    Immune System Diseases  Immune System Diseases   \n",
       "39                    Immune System Diseases  Immune System Diseases   \n",
       "52                           Chronic Disease                  others   \n",
       "62                           Hyperlipidemias                  others   \n",
       "64                        Metabolic Diseases      Metabolic Diseases   \n",
       "84                                   Disease                  others   \n",
       "105            Lymphoproliferative Disorders                  others   \n",
       "106            Lymphoproliferative Disorders                  others   \n",
       "177                 Eye Diseases, Hereditary                  others   \n",
       "330   Carbohydrate Metabolism, Inborn Errors                  others   \n",
       "342                           Liver Diseases          Liver Diseases   \n",
       "379            Anemia, Hemolytic, Congenital                  others   \n",
       "494                   Basal Ganglia Diseases  Basal Ganglia Diseases   \n",
       "569                                      HIV                  others   \n",
       "637                           Joint Diseases          Joint Diseases   \n",
       "672                           Joint Diseases          Joint Diseases   \n",
       "720             Neoplasms by Histologic Type                  others   \n",
       "982             Neoplasms by Histologic Type                  others   \n",
       "1014            Neoplasms by Histologic Type                  others   \n",
       "1258                Multiple Primary Cancers                  others   \n",
       "1313                               Neoplasms                  others   \n",
       "1668                 Precancerous Conditions                  others   \n",
       "\n",
       "     no_of_cases  \n",
       "0       31 cases  \n",
       "1       31 cases  \n",
       "5       31 cases  \n",
       "7       31 cases  \n",
       "8       31 cases  \n",
       "12      31 cases  \n",
       "13      31 cases  \n",
       "21      31 cases  \n",
       "24      31 cases  \n",
       "29      31 cases  \n",
       "39      31 cases  \n",
       "52      31 cases  \n",
       "62      31 cases  \n",
       "64      31 cases  \n",
       "84      31 cases  \n",
       "105     31 cases  \n",
       "106     31 cases  \n",
       "177     31 cases  \n",
       "330     31 cases  \n",
       "342     31 cases  \n",
       "379     31 cases  \n",
       "494     31 cases  \n",
       "569     31 cases  \n",
       "637     31 cases  \n",
       "672     31 cases  \n",
       "720     31 cases  \n",
       "982     31 cases  \n",
       "1014    31 cases  \n",
       "1258    31 cases  \n",
       "1313    31 cases  \n",
       "1668    31 cases  "
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sankey_data = text_data[text_data['ArmGroupInterventionName'].isin(select_gene_therapy_cases)].copy()\n",
    "sankey_data['no_of_cases'] = np.repeat(f'{sankey_data.shape[0]} cases',sankey_data.shape[0])\n",
    "sankey_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [],
   "source": [
    "sankey_diagram = sankey_data[['mod_ConditionAncestorTerm','no_of_cases','ArmGroupInterventionName']].reset_index(drop=True).copy()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>mod_ConditionAncestorTerm</th>\n",
       "      <th>no_of_cases</th>\n",
       "      <th>ArmGroupInterventionName</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: lentiviral gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Dementia</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV2-BDNF Gene Therapy|Biological: AA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: OTL-200 Gene Therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Pathologic Processes</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ex-vivo gene-therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy product CYL-02 = plasmid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Retinal Degeneration</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: NG101 AAV gene therapy|Genetic: NG101...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Brain Diseases, Metabolic, Inborn</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Intracerebral LV gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy|Drug: Busulfan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Single infusion of autologous CD34+ c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Chronic Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: pCCLchimGp91s lentiviral vector trans...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Hyperlipidemias</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV directed hLDLR gene therapy|Genet...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Metabolic Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD34 positive cells transd...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Eye Diseases, Hereditary</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2.REP1 vector</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Carbohydrate Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Frozen autologous CD34+ hematopoietic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2-CB-hAAT Gene Vector</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous hematopoietic stem cells g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Basal Ganglia Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>HIV</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD4+ T cells genetically m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Pell's lentiviral-based gene-edited i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous TRICAR-ALL T-cells and lym...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: donor-derived EBV-specific cytotoxic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ct-DNA guided therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene-modified (GM) T cell therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Precancerous Conditions</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: response to therapy</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 mod_ConditionAncestorTerm no_of_cases  \\\n",
       "0                           Brain Diseases    31 cases   \n",
       "1            Anemia, Hemolytic, Congenital    31 cases   \n",
       "2                                 Dementia    31 cases   \n",
       "3                Metabolism, Inborn Errors    31 cases   \n",
       "4                   Immune System Diseases    31 cases   \n",
       "5                     Pathologic Processes    31 cases   \n",
       "6                                Carcinoma    31 cases   \n",
       "7                     Retinal Degeneration    31 cases   \n",
       "8        Brain Diseases, Metabolic, Inborn    31 cases   \n",
       "9                   Immune System Diseases    31 cases   \n",
       "10                  Immune System Diseases    31 cases   \n",
       "11                         Chronic Disease    31 cases   \n",
       "12                         Hyperlipidemias    31 cases   \n",
       "13                      Metabolic Diseases    31 cases   \n",
       "14                                 Disease    31 cases   \n",
       "15           Lymphoproliferative Disorders    31 cases   \n",
       "16           Lymphoproliferative Disorders    31 cases   \n",
       "17                Eye Diseases, Hereditary    31 cases   \n",
       "18  Carbohydrate Metabolism, Inborn Errors    31 cases   \n",
       "19                          Liver Diseases    31 cases   \n",
       "20           Anemia, Hemolytic, Congenital    31 cases   \n",
       "21                  Basal Ganglia Diseases    31 cases   \n",
       "22                                     HIV    31 cases   \n",
       "23                          Joint Diseases    31 cases   \n",
       "24                          Joint Diseases    31 cases   \n",
       "25            Neoplasms by Histologic Type    31 cases   \n",
       "26            Neoplasms by Histologic Type    31 cases   \n",
       "27            Neoplasms by Histologic Type    31 cases   \n",
       "28                Multiple Primary Cancers    31 cases   \n",
       "29                               Neoplasms    31 cases   \n",
       "30                 Precancerous Conditions    31 cases   \n",
       "\n",
       "                             ArmGroupInterventionName  \n",
       "0                    Genetic: lentiviral gene therapy  \n",
       "1                               Genetic: Gene therapy  \n",
       "2   Genetic: AAV2-BDNF Gene Therapy|Biological: AA...  \n",
       "3                       Genetic: OTL-200 Gene Therapy  \n",
       "4                               Genetic: Gene therapy  \n",
       "5                       Genetic: ex-vivo gene-therapy  \n",
       "6   Genetic: Gene Therapy product CYL-02 = plasmid...  \n",
       "7   Genetic: NG101 AAV gene therapy|Genetic: NG101...  \n",
       "8              Genetic: Intracerebral LV gene therapy  \n",
       "9                Genetic: Gene Therapy|Drug: Busulfan  \n",
       "10  Genetic: Single infusion of autologous CD34+ c...  \n",
       "11  Genetic: pCCLchimGp91s lentiviral vector trans...  \n",
       "12  Genetic: AAV directed hLDLR gene therapy|Genet...  \n",
       "13  Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...  \n",
       "14  Genetic: Autologous CD34 positive cells transd...  \n",
       "15                       Genetic: X vivo gene therapy  \n",
       "16                       Genetic: X vivo gene therapy  \n",
       "17                         Genetic: rAAV2.REP1 vector  \n",
       "18  Genetic: Frozen autologous CD34+ hematopoietic...  \n",
       "19                 Genetic: rAAV2-CB-hAAT Gene Vector  \n",
       "20  Genetic: Autologous hematopoietic stem cells g...  \n",
       "21  Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...  \n",
       "22  Genetic: Autologous CD4+ T cells genetically m...  \n",
       "23  Genetic: tgAAC94 gene therapy vector|Genetic: ...  \n",
       "24  Genetic: tgAAC94 gene therapy vector|Genetic: ...  \n",
       "25  Genetic: Pell's lentiviral-based gene-edited i...  \n",
       "26  Genetic: Autologous TRICAR-ALL T-cells and lym...  \n",
       "27  Genetic: donor-derived EBV-specific cytotoxic ...  \n",
       "28                     Genetic: ct-DNA guided therapy  \n",
       "29         Genetic: Gene-modified (GM) T cell therapy  \n",
       "30                       Genetic: response to therapy  "
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sankey_diagram"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>Target</th>\n",
       "      <th>Value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Dementia</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Pathologic Processes</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Retinal Degeneration</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Brain Diseases, Metabolic, Inborn</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Chronic Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Hyperlipidemias</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Metabolic Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Eye Diseases, Hereditary</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Carbohydrate Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Basal Ganglia Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>HIV</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Precancerous Conditions</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    Source    Target  Value\n",
       "0                           Brain Diseases  31 cases      1\n",
       "1            Anemia, Hemolytic, Congenital  31 cases      2\n",
       "2                                 Dementia  31 cases      1\n",
       "3                Metabolism, Inborn Errors  31 cases      1\n",
       "4                   Immune System Diseases  31 cases      3\n",
       "5                     Pathologic Processes  31 cases      1\n",
       "6                                Carcinoma  31 cases      1\n",
       "7                     Retinal Degeneration  31 cases      1\n",
       "8        Brain Diseases, Metabolic, Inborn  31 cases      1\n",
       "11                         Chronic Disease  31 cases      1\n",
       "12                         Hyperlipidemias  31 cases      1\n",
       "13                      Metabolic Diseases  31 cases      1\n",
       "14                                 Disease  31 cases      1\n",
       "15           Lymphoproliferative Disorders  31 cases      2\n",
       "17                Eye Diseases, Hereditary  31 cases      1\n",
       "18  Carbohydrate Metabolism, Inborn Errors  31 cases      1\n",
       "19                          Liver Diseases  31 cases      1\n",
       "21                  Basal Ganglia Diseases  31 cases      1\n",
       "22                                     HIV  31 cases      1\n",
       "23                          Joint Diseases  31 cases      2\n",
       "25            Neoplasms by Histologic Type  31 cases      3\n",
       "28                Multiple Primary Cancers  31 cases      1\n",
       "29                               Neoplasms  31 cases      1\n",
       "30                 Precancerous Conditions  31 cases      1"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = sankey_diagram[['mod_ConditionAncestorTerm','no_of_cases']].copy()\n",
    "test.columns = ['Source','Target']\n",
    "test['Value'] = [test['Source'].value_counts()[disease_type] for disease_type in test['Source']]\n",
    "test = test.drop_duplicates(subset='Source').copy()\n",
    "test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>Target</th>\n",
       "      <th>Value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: lentiviral gene therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV2-BDNF Gene Therapy|Biological: AA...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: OTL-200 Gene Therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ex-vivo gene-therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy product CYL-02 = plasmid...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: NG101 AAV gene therapy|Genetic: NG101...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Intracerebral LV gene therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy|Drug: Busulfan</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Single infusion of autologous CD34+ c...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: pCCLchimGp91s lentiviral vector trans...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV directed hLDLR gene therapy|Genet...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD34 positive cells transd...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2.REP1 vector</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Frozen autologous CD34+ hematopoietic...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2-CB-hAAT Gene Vector</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous hematopoietic stem cells g...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD4+ T cells genetically m...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Pell's lentiviral-based gene-edited i...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous TRICAR-ALL T-cells and lym...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: donor-derived EBV-specific cytotoxic ...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ct-DNA guided therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene-modified (GM) T cell therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: response to therapy</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Source                                             Target  Value\n",
       "0   31 cases                   Genetic: lentiviral gene therapy      1\n",
       "1   31 cases                              Genetic: Gene therapy      2\n",
       "2   31 cases  Genetic: AAV2-BDNF Gene Therapy|Biological: AA...      1\n",
       "3   31 cases                      Genetic: OTL-200 Gene Therapy      1\n",
       "5   31 cases                      Genetic: ex-vivo gene-therapy      1\n",
       "6   31 cases  Genetic: Gene Therapy product CYL-02 = plasmid...      1\n",
       "7   31 cases  Genetic: NG101 AAV gene therapy|Genetic: NG101...      1\n",
       "8   31 cases             Genetic: Intracerebral LV gene therapy      1\n",
       "9   31 cases               Genetic: Gene Therapy|Drug: Busulfan      1\n",
       "10  31 cases  Genetic: Single infusion of autologous CD34+ c...      1\n",
       "11  31 cases  Genetic: pCCLchimGp91s lentiviral vector trans...      1\n",
       "12  31 cases  Genetic: AAV directed hLDLR gene therapy|Genet...      1\n",
       "13  31 cases  Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...      1\n",
       "14  31 cases  Genetic: Autologous CD34 positive cells transd...      1\n",
       "15  31 cases                       Genetic: X vivo gene therapy      2\n",
       "17  31 cases                         Genetic: rAAV2.REP1 vector      1\n",
       "18  31 cases  Genetic: Frozen autologous CD34+ hematopoietic...      1\n",
       "19  31 cases                 Genetic: rAAV2-CB-hAAT Gene Vector      1\n",
       "20  31 cases  Genetic: Autologous hematopoietic stem cells g...      1\n",
       "21  31 cases  Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...      1\n",
       "22  31 cases  Genetic: Autologous CD4+ T cells genetically m...      1\n",
       "23  31 cases  Genetic: tgAAC94 gene therapy vector|Genetic: ...      1\n",
       "24  31 cases  Genetic: tgAAC94 gene therapy vector|Genetic: ...      1\n",
       "25  31 cases  Genetic: Pell's lentiviral-based gene-edited i...      1\n",
       "26  31 cases  Genetic: Autologous TRICAR-ALL T-cells and lym...      1\n",
       "27  31 cases  Genetic: donor-derived EBV-specific cytotoxic ...      1\n",
       "28  31 cases                     Genetic: ct-DNA guided therapy      1\n",
       "29  31 cases         Genetic: Gene-modified (GM) T cell therapy      1\n",
       "30  31 cases                       Genetic: response to therapy      1"
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test2 = sankey_diagram[['no_of_cases','ArmGroupInterventionName']].copy()\n",
    "test2.columns = ['Source','Target']\n",
    "test2['Value'] = [test2['Target'].value_counts()[gene_the] for gene_the in test2['Target']]\n",
    "test2 = test2.drop_duplicates(subset='Target').copy()\n",
    "test2\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>Target</th>\n",
       "      <th>Value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anemia, Hemolytic, Congenital</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Dementia</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Immune System Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Pathologic Processes</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Retinal Degeneration</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Brain Diseases, Metabolic, Inborn</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Chronic Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Hyperlipidemias</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Metabolic Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Disease</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Eye Diseases, Hereditary</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Carbohydrate Metabolism, Inborn Errors</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Basal Ganglia Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>HIV</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Joint Diseases</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Neoplasms by Histologic Type</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Multiple Primary Cancers</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Precancerous Conditions</td>\n",
       "      <td>31 cases</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: lentiviral gene therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene therapy</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV2-BDNF Gene Therapy|Biological: AA...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: OTL-200 Gene Therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ex-vivo gene-therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy product CYL-02 = plasmid...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: NG101 AAV gene therapy|Genetic: NG101...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Intracerebral LV gene therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene Therapy|Drug: Busulfan</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Single infusion of autologous CD34+ c...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: pCCLchimGp91s lentiviral vector trans...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AAV directed hLDLR gene therapy|Genet...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD34 positive cells transd...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: X vivo gene therapy</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2.REP1 vector</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Frozen autologous CD34+ hematopoietic...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: rAAV2-CB-hAAT Gene Vector</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous hematopoietic stem cells g...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous CD4+ T cells genetically m...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: tgAAC94 gene therapy vector|Genetic: ...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Pell's lentiviral-based gene-edited i...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Autologous TRICAR-ALL T-cells and lym...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: donor-derived EBV-specific cytotoxic ...</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: ct-DNA guided therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: Gene-modified (GM) T cell therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>31 cases</td>\n",
       "      <td>Genetic: response to therapy</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    Source  \\\n",
       "0                           Brain Diseases   \n",
       "1            Anemia, Hemolytic, Congenital   \n",
       "2                                 Dementia   \n",
       "3                Metabolism, Inborn Errors   \n",
       "4                   Immune System Diseases   \n",
       "5                     Pathologic Processes   \n",
       "6                                Carcinoma   \n",
       "7                     Retinal Degeneration   \n",
       "8        Brain Diseases, Metabolic, Inborn   \n",
       "11                         Chronic Disease   \n",
       "12                         Hyperlipidemias   \n",
       "13                      Metabolic Diseases   \n",
       "14                                 Disease   \n",
       "15           Lymphoproliferative Disorders   \n",
       "17                Eye Diseases, Hereditary   \n",
       "18  Carbohydrate Metabolism, Inborn Errors   \n",
       "19                          Liver Diseases   \n",
       "21                  Basal Ganglia Diseases   \n",
       "22                                     HIV   \n",
       "23                          Joint Diseases   \n",
       "25            Neoplasms by Histologic Type   \n",
       "28                Multiple Primary Cancers   \n",
       "29                               Neoplasms   \n",
       "30                 Precancerous Conditions   \n",
       "0                                 31 cases   \n",
       "1                                 31 cases   \n",
       "2                                 31 cases   \n",
       "3                                 31 cases   \n",
       "5                                 31 cases   \n",
       "6                                 31 cases   \n",
       "7                                 31 cases   \n",
       "8                                 31 cases   \n",
       "9                                 31 cases   \n",
       "10                                31 cases   \n",
       "11                                31 cases   \n",
       "12                                31 cases   \n",
       "13                                31 cases   \n",
       "14                                31 cases   \n",
       "15                                31 cases   \n",
       "17                                31 cases   \n",
       "18                                31 cases   \n",
       "19                                31 cases   \n",
       "20                                31 cases   \n",
       "21                                31 cases   \n",
       "22                                31 cases   \n",
       "23                                31 cases   \n",
       "24                                31 cases   \n",
       "25                                31 cases   \n",
       "26                                31 cases   \n",
       "27                                31 cases   \n",
       "28                                31 cases   \n",
       "29                                31 cases   \n",
       "30                                31 cases   \n",
       "\n",
       "                                               Target  Value  \n",
       "0                                            31 cases      6  \n",
       "1                                            31 cases      7  \n",
       "2                                            31 cases      6  \n",
       "3                                            31 cases      6  \n",
       "4                                            31 cases      8  \n",
       "5                                            31 cases      6  \n",
       "6                                            31 cases      6  \n",
       "7                                            31 cases      6  \n",
       "8                                            31 cases      6  \n",
       "11                                           31 cases      6  \n",
       "12                                           31 cases      6  \n",
       "13                                           31 cases      6  \n",
       "14                                           31 cases      6  \n",
       "15                                           31 cases      7  \n",
       "17                                           31 cases      6  \n",
       "18                                           31 cases      6  \n",
       "19                                           31 cases      6  \n",
       "21                                           31 cases      6  \n",
       "22                                           31 cases      6  \n",
       "23                                           31 cases      7  \n",
       "25                                           31 cases      8  \n",
       "28                                           31 cases      6  \n",
       "29                                           31 cases      6  \n",
       "30                                           31 cases      6  \n",
       "0                    Genetic: lentiviral gene therapy      6  \n",
       "1                               Genetic: Gene therapy      7  \n",
       "2   Genetic: AAV2-BDNF Gene Therapy|Biological: AA...      6  \n",
       "3                       Genetic: OTL-200 Gene Therapy      6  \n",
       "5                       Genetic: ex-vivo gene-therapy      6  \n",
       "6   Genetic: Gene Therapy product CYL-02 = plasmid...      6  \n",
       "7   Genetic: NG101 AAV gene therapy|Genetic: NG101...      6  \n",
       "8              Genetic: Intracerebral LV gene therapy      6  \n",
       "9                Genetic: Gene Therapy|Drug: Busulfan      6  \n",
       "10  Genetic: Single infusion of autologous CD34+ c...      6  \n",
       "11  Genetic: pCCLchimGp91s lentiviral vector trans...      6  \n",
       "12  Genetic: AAV directed hLDLR gene therapy|Genet...      6  \n",
       "13  Genetic: rAAV2/5-PBGD vector dosage 1|Genetic:...      6  \n",
       "14  Genetic: Autologous CD34 positive cells transd...      6  \n",
       "15                       Genetic: X vivo gene therapy      7  \n",
       "17                         Genetic: rAAV2.REP1 vector      6  \n",
       "18  Genetic: Frozen autologous CD34+ hematopoietic...      6  \n",
       "19                 Genetic: rAAV2-CB-hAAT Gene Vector      6  \n",
       "20  Genetic: Autologous hematopoietic stem cells g...      6  \n",
       "21  Genetic: AB-1001 Gene Therapy|Genetic: AB-1001...      6  \n",
       "22  Genetic: Autologous CD4+ T cells genetically m...      6  \n",
       "23  Genetic: tgAAC94 gene therapy vector|Genetic: ...      6  \n",
       "24  Genetic: tgAAC94 gene therapy vector|Genetic: ...      6  \n",
       "25  Genetic: Pell's lentiviral-based gene-edited i...      6  \n",
       "26  Genetic: Autologous TRICAR-ALL T-cells and lym...      6  \n",
       "27  Genetic: donor-derived EBV-specific cytotoxic ...      6  \n",
       "28                     Genetic: ct-DNA guided therapy      6  \n",
       "29         Genetic: Gene-modified (GM) T cell therapy      6  \n",
       "30                       Genetic: response to therapy      6  "
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_combined = pd.concat([test,test2]).copy()\n",
    "test_combined['Value'] = test_combined['Value'].values+5\n",
    "test_combined"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [
    {
     "data": {},
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.holoviews_exec.v0+json": "",
      "text/html": [
       "<div id='p2220'>\n",
       "  <div id=\"b2a54f13-9842-4a77-8bd4-dfc57d90afdc\" data-root-id=\"p2220\" style=\"display: contents;\"></div>\n",
       "</div>\n",
       "<script type=\"application/javascript\">(function(root) {\n",
       "  var docs_json = {\"4bfb94de-c075-42a2-b4b0-25d4e157acd9\":{\"version\":\"3.4.1\",\"title\":\"Bokeh Application\",\"roots\":[{\"type\":\"object\",\"name\":\"Row\",\"id\":\"p2220\",\"attributes\":{\"name\":\"Row07074\",\"tags\":[\"embedded\"],\"stylesheets\":[\"\\n:host(.pn-loading):before, .pn-loading:before {\\n  background-color: #c3c3c3;\\n  mask-size: auto calc(min(50%, 400px));\\n  -webkit-mask-size: auto calc(min(50%, 400px));\\n}\",{\"type\":\"object\",\"name\":\"ImportedStyleSheet\",\"id\":\"p2223\",\"attributes\":{\"url\":\"https://cdn.holoviz.org/panel/1.4.2/dist/css/loading.css\"}},{\"type\":\"object\",\"name\":\"ImportedStyleSheet\",\"id\":\"p2341\",\"attributes\":{\"url\":\"https://cdn.holoviz.org/panel/1.4.2/dist/css/listpanel.css\"}},{\"type\":\"object\",\"name\":\"ImportedStyleSheet\",\"id\":\"p2221\",\"attributes\":{\"url\":\"https://cdn.holoviz.org/panel/1.4.2/dist/bundled/theme/default.css\"}},{\"type\":\"object\",\"name\":\"ImportedStyleSheet\",\"id\":\"p2222\",\"attributes\":{\"url\":\"https://cdn.holoviz.org/panel/1.4.2/dist/bundled/theme/native.css\"}}],\"min_width\":900,\"margin\":0,\"sizing_mode\":\"stretch_width\",\"align\":\"start\",\"children\":[{\"type\":\"object\",\"name\":\"Spacer\",\"id\":\"p2224\",\"attributes\":{\"name\":\"HSpacer07081\",\"stylesheets\":[\"\\n:host(.pn-loading):before, .pn-loading:before {\\n  background-color: #c3c3c3;\\n  mask-size: auto calc(min(50%, 400px));\\n  -webkit-mask-size: auto calc(min(50%, 400px));\\n}\",{\"id\":\"p2223\"},{\"id\":\"p2221\"},{\"id\":\"p2222\"}],\"margin\":0,\"sizing_mode\":\"stretch_width\",\"align\":\"start\"}},{\"type\":\"object\",\"name\":\"Figure\",\"id\":\"p2232\",\"attributes\":{\"width\":900,\"height\":500,\"margin\":[5,10],\"sizing_mode\":\"fixed\",\"align\":\"start\",\"x_range\":{\"type\":\"object\",\"name\":\"Range1d\",\"id\":\"p2225\",\"attributes\":{\"tags\":[[[\"x\",\"x\",null]],[]],\"start\":-41.75,\"end\":1238.75,\"reset_start\":-41.75,\"reset_end\":1238.75}},\"y_range\":{\"type\":\"object\",\"name\":\"Range1d\",\"id\":\"p2226\",\"attributes\":{\"tags\":[[[\"y\",\"y\",null]],{\"type\":\"map\",\"entries\":[[\"invert_yaxis\",false],[\"autorange\",false]]}],\"start\":-24.999999999999996,\"end\":524.9999999999999,\"reset_start\":-24.999999999999996,\"reset_end\":524.9999999999999}},\"x_scale\":{\"type\":\"object\",\"name\":\"LinearScale\",\"id\":\"p2242\"},\"y_scale\":{\"type\":\"object\",\"name\":\"LinearScale\",\"id\":\"p2243\"},\"title\":{\"type\":\"object\",\"name\":\"Title\",\"id\":\"p2235\",\"attributes\":{\"text_color\":\"black\",\"text_font_size\":\"12pt\"}},\"outline_line_alpha\":0,\"renderers\":[{\"type\":\"object\",\"name\":\"GraphRenderer\",\"id\":\"p2287\",\"attributes\":{\"layout_provider\":{\"type\":\"object\",\"name\":\"StaticLayoutProvider\",\"id\":\"p2271\",\"attributes\":{\"graph_layout\":{\"type\":\"map\",\"entries\":[[0,[7.5,17.518349208772122]],[1,[7.5,35.37549213734356]],[2,[7.5,53.232635065914984]],[3,[7.5,71.08977799448641]],[4,[7.5,88.94692092305785]],[5,[7.5,106.80406385162928]],[6,[7.5,124.6612067802007]],[7,[7.5,142.51834920877212]],[8,[7.5,160.37549213734357]],[9,[7.5,178.232635065915]],[10,[7.5,196.08977799448644]],[11,[7.5,213.94692092305786]],[12,[7.5,231.80406385162928]],[13,[7.5,249.6612067802007]],[14,[7.5,267.5183492087722]],[15,[7.5,285.3754921373436]],[16,[7.5,303.232635065915]],[17,[7.5,321.08977799448644]],[18,[7.5,338.9469209230578]],[19,[7.5,356.8040638516292]],[20,[7.5,374.66120678020064]],[21,[7.5,392.51834920877207]],[22,[7.5,410.3754921373435]],[23,[7.5,428.2326350659149]],[24,[500.0,224.02113279044715]],[25,[992.5,0.0]],[26,[992.5,17.857142928571427]],[27,[992.5,35.714285857142855]],[28,[992.5,53.57142878571429]],[29,[992.5,71.42857121428571]],[30,[992.5,89.28571414285715]],[31,[992.5,107.14285707142858]],[32,[992.5,125.0]],[33,[992.5,142.85714292857142]],[34,[992.5,160.71428585714284]],[35,[992.5,178.5714287857143]],[36,[992.5,196.42857121428574]],[37,[992.5,214.28571414285716]],[38,[992.5,232.14285707142858]],[39,[992.5,250.0]],[40,[992.5,267.8571429285714]],[41,[992.5,285.71428585714284]],[42,[992.5,303.57142878571426]],[43,[992.5,321.4285712142857]],[44,[992.5,339.2857141428571]],[45,[992.5,357.1428570714285]],[46,[992.5,374.99999999999994]],[47,[992.5,392.85714292857136]],[48,[992.5,410.7142858571428]],[49,[992.5,428.5714287857142]],[50,[992.5,446.4285712142856]],[51,[992.5,464.28571414285705]],[52,[992.5,482.14285707142847]],[53,[992.5,499.9999999999999]]]}}},\"node_renderer\":{\"type\":\"object\",\"name\":\"GlyphRenderer\",\"id\":\"p2277\",\"attributes\":{\"data_source\":{\"type\":\"object\",\"name\":\"ColumnDataSource\",\"id\":\"p2265\",\"attributes\":{\"selected\":{\"type\":\"object\",\"name\":\"Selection\",\"id\":\"p2266\",\"attributes\":{\"indices\":[],\"line_indices\":[]}},\"selection_policy\":{\"type\":\"object\",\"name\":\"UnionRenderers\",\"id\":\"p2267\"},\"data\":{\"type\":\"map\",\"entries\":[[\"index\",[\"Brain Diseases\",\"Anemia, Hemolytic, Congenital\",\"Dementia\",\"Metabolism, Inborn Errors\",\"Immune System Diseases\",\"Pathologic Processes\",\"Carcinoma\",\"Retinal Degeneration\",\"Brain Diseases, Metabolic, Inborn\",\"Chronic Disease\",\"Hyperlipidemias\",\"Metabolic Diseases\",\"Disease\",\"Lymphoproliferative Disorders\",\"Eye Diseases, Hereditary\",\"Carbohydrate Metabolism, Inborn Errors\",\"Liver Diseases\",\"Basal Ganglia Diseases\",\"HIV\",\"Joint Diseases\",\"Neoplasms by Histologic Type\",\"Multiple Primary Cancers\",\"Neoplasms\",\"Precancerous Conditions\",\"31 cases\",\"Genetic: lentiviral gene therapy\",\"Genetic: Gene therapy\",\"Genetic: AAV2-BDNF Gene Therapy|Biological: AAV2-BDNF Gene Therapy\",\"Genetic: OTL-200 Gene Therapy\",\"Genetic: ex-vivo gene-therapy\",\"Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes\",\"Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy\",\"Genetic: Intracerebral LV gene therapy\",\"Genetic: Gene Therapy|Drug: Busulfan\",\"Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre\",\"Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion\",\"Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy\",\"Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4\",\"Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene\",\"Genetic: X vivo gene therapy\",\"Genetic: rAAV2.REP1 vector\",\"Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the \\u03b1-L-iduronidase cDNA, in their final formulation medium.\",\"Genetic: rAAV2-CB-hAAT Gene Vector\",\"Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene\",\"Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy\",\"Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy\",\"Genetic: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy\",\"Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line\",\"Genetic: ct-DNA guided therapy\",\"Genetic: Gene-modified (GM) T cell therapy\",\"Genetic: response to therapy\"]],[\"x0\",[0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,492.5,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0,985.0]],[\"x1\",[15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,507.5,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0]],[\"y0\",[17.518349417544247,35.375492274687105,53.232635131829966,71.08977798897283,88.94692084611569,106.80406370325855,124.66120656040141,142.51834941754427,160.37549227468713,178.23263513183,196.08977798897286,213.94692084611572,231.80406370325858,249.66120656040144,267.5183494175443,285.37549227468713,303.23263513182997,321.0897779889728,338.94692084611563,356.80406370325846,374.6612065604013,392.51834941754413,410.37549227468696,428.2326351318298,224.02113258089435,0.0,17.857142857142858,35.714285714285715,53.57142857142857,71.42857142857143,89.28571428571429,107.14285714285715,125.00000000000001,142.85714285714286,160.71428571428572,178.57142857142858,196.42857142857144,214.2857142857143,232.14285714285717,250.00000000000003,267.8571428571429,285.7142857142857,303.57142857142856,321.4285714285714,339.2857142857142,357.14285714285705,374.9999999999999,392.8571428571427,410.71428571428555,428.5714285714284,446.4285714285712,464.28571428571405,482.1428571428569,499.9999999999997]],[\"y1\",[17.518349,35.375492,53.232635,71.089778,88.946921,106.804064,124.661207,142.518349,160.375492,178.232635,196.089778,213.946921,231.804064,249.661207,267.518349,285.375492,303.232635,321.089778,338.946921,356.804064,374.661207,392.518349,410.375492,428.232635,224.021133,0.0,17.857143,35.714286,53.571429,71.428571,89.285714,107.142857,125.0,142.857143,160.714286,178.571429,196.428571,214.285714,232.142857,250.0,267.857143,285.714286,303.571429,321.428571,339.285714,357.142857,375.0,392.857143,410.714286,428.571429,446.428571,464.285714,482.142857,500.0]]]}}},\"view\":{\"type\":\"object\",\"name\":\"CDSView\",\"id\":\"p2278\",\"attributes\":{\"filter\":{\"type\":\"object\",\"name\":\"AllIndices\",\"id\":\"p2279\"}}},\"glyph\":{\"type\":\"object\",\"name\":\"Scatter\",\"id\":\"p2272\",\"attributes\":{\"size\":{\"type\":\"value\",\"value\":10},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"type\":\"object\",\"name\":\"CategoricalColorMapper\",\"id\":\"p2264\",\"attributes\":{\"palette\":[\"#1f77b4\",\"#aec7e8\",\"#ff7f0e\",\"#ffbb78\",\"#2ca02c\",\"#98df8a\",\"#d62728\",\"#ff9896\",\"#9467bd\",\"#c5b0d5\",\"#8c564b\",\"#c49c94\",\"#e377c2\",\"#f7b6d2\",\"#7f7f7f\",\"#c7c7c7\",\"#bcbd22\",\"#dbdb8d\",\"#17becf\",\"#9edae5\",\"#1f77b4\",\"#aec7e8\",\"#ff7f0e\",\"#ffbb78\",\"#2ca02c\",\"#98df8a\",\"#d62728\",\"#ff9896\",\"#9467bd\",\"#c5b0d5\",\"#8c564b\",\"#c49c94\",\"#e377c2\",\"#f7b6d2\",\"#7f7f7f\",\"#c7c7c7\",\"#bcbd22\",\"#dbdb8d\",\"#17becf\",\"#9edae5\",\"#1f77b4\",\"#aec7e8\",\"#ff7f0e\",\"#ffbb78\",\"#2ca02c\",\"#98df8a\",\"#d62728\",\"#ff9896\",\"#9467bd\",\"#c5b0d5\",\"#8c564b\",\"#c49c94\",\"#e377c2\",\"#f7b6d2\"],\"factors\":[\"Brain Diseases\",\"Anemia, Hemolytic, Congenital\",\"Dementia\",\"Metabolism, Inborn Errors\",\"Immune System Diseases\",\"Pathologic Processes\",\"Carcinoma\",\"Retinal Degeneration\",\"Brain Diseases, Metabolic, Inborn\",\"Chronic Disease\",\"Hyperlipidemias\",\"Metabolic Diseases\",\"Disease\",\"Lymphoproliferative Disorders\",\"Eye Diseases, Hereditary\",\"Carbohydrate Metabolism, Inborn Errors\",\"Liver Diseases\",\"Basal Ganglia Diseases\",\"HIV\",\"Joint Diseases\",\"Neoplasms by Histologic Type\",\"Multiple Primary Cancers\",\"Neoplasms\",\"Precancerous Conditions\",\"31 cases\",\"Genetic: lentiviral gene therapy\",\"Genetic: Gene therapy\",\"Genetic: AAV2-BDNF Gene Therapy|Biological: AAV2-BDNF Gene Therapy\",\"Genetic: OTL-200 Gene Therapy\",\"Genetic: ex-vivo gene-therapy\",\"Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes\",\"Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy\",\"Genetic: Intracerebral LV gene therapy\",\"Genetic: Gene Therapy|Drug: Busulfan\",\"Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre\",\"Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion\",\"Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy\",\"Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4\",\"Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene\",\"Genetic: X vivo gene therapy\",\"Genetic: rAAV2.REP1 vector\",\"Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the \\u03b1-L-iduronidase cDNA, in their final formulation medium.\",\"Genetic: rAAV2-CB-hAAT Gene Vector\",\"Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene\",\"Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy\",\"Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy\",\"Genetic: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy\",\"Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line\",\"Genetic: ct-DNA guided therapy\",\"Genetic: Gene-modified (GM) T cell therapy\",\"Genetic: response to therapy\"]}}}}},\"selection_glyph\":{\"type\":\"object\",\"name\":\"Scatter\",\"id\":\"p2274\",\"attributes\":{\"size\":{\"type\":\"value\",\"value\":10},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}}}},\"nonselection_glyph\":{\"type\":\"object\",\"name\":\"Scatter\",\"id\":\"p2273\",\"attributes\":{\"size\":{\"type\":\"value\",\"value\":10},\"line_alpha\":{\"type\":\"value\",\"value\":0.2},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}},\"fill_alpha\":{\"type\":\"value\",\"value\":0.2},\"hatch_alpha\":{\"type\":\"value\",\"value\":0.2}}},\"hover_glyph\":{\"type\":\"object\",\"name\":\"Scatter\",\"id\":\"p2275\",\"attributes\":{\"size\":{\"type\":\"value\",\"value\":10},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}}}},\"muted_glyph\":{\"type\":\"object\",\"name\":\"Scatter\",\"id\":\"p2276\",\"attributes\":{\"size\":{\"type\":\"value\",\"value\":10},\"line_alpha\":{\"type\":\"value\",\"value\":0.2},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}},\"fill_alpha\":{\"type\":\"value\",\"value\":0.2},\"hatch_alpha\":{\"type\":\"value\",\"value\":0.2}}}}},\"edge_renderer\":{\"type\":\"object\",\"name\":\"GlyphRenderer\",\"id\":\"p2284\",\"attributes\":{\"data_source\":{\"type\":\"object\",\"name\":\"ColumnDataSource\",\"id\":\"p2268\",\"attributes\":{\"selected\":{\"type\":\"object\",\"name\":\"Selection\",\"id\":\"p2269\",\"attributes\":{\"indices\":[],\"line_indices\":[]}},\"selection_policy\":{\"type\":\"object\",\"name\":\"UnionRenderers\",\"id\":\"p2270\"},\"data\":{\"type\":\"map\",\"entries\":[[\"start\",{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AAAAAAEAAAACAAAAAwAAAAQAAAAFAAAABgAAAAcAAAAIAAAACQAAAAoAAAALAAAADAAAAA0AAAAOAAAADwAAABAAAAARAAAAEgAAABMAAAAUAAAAFQAAABYAAAAXAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAA=\"},\"shape\":[53],\"dtype\":\"int32\",\"order\":\"little\"}],[\"end\",{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"GAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGAAAABgAAAAYAAAAGQAAABoAAAAbAAAAHAAAAB0AAAAeAAAAHwAAACAAAAAhAAAAIgAAACMAAAAkAAAAJQAAACYAAAAnAAAAKAAAACkAAAAqAAAAKwAAACwAAAAtAAAALgAAAC8AAAAwAAAAMQAAADIAAAAzAAAANAAAADUAAAA=\"},\"shape\":[53],\"dtype\":\"int32\",\"order\":\"little\"}],[\"xs\",[{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AAAAAAAALkAAAAAAAAAuQAAAAAAAAC5AYhVNL7ZSPUDcnHfmdYlFQA3fp2RuI0xA4vw1RTE9UUDKSvwnuEhUQH8twdbaNVdASvmeTSgGWkBnArCIL7tcQCGdDoR/Vl9A247qndPsYEA57A7WGiNiQMyQgejcTmNAsqZPU+FwZEASWIaU74llQAzPMirPmmZAwDVikkekZ0BUtiFLIKdoQOd6ftIgpGlAna2FphCcakCWeERFt49rQPgFyCzcf2xA4n8d20ZtbUB1EFLOvlhuQNjhcoQLQ29AFI/GPXoWcEDE99aYoItwQA9AcZJcAXFABP2b6RF4cUC0w11dJPBxQDEpvaz3aXJAjMLAlu/lckDWJG/ab2RzQCDlzjbc5XNAepjmaphqdED207w1CPN0QKYsWFaPf3VAmje/i5EQdkDiifiUcqZ2QJG4CjGWQXdAt1j8HmDid0Bm/9MdNIl4QK5BmOx1NnlAoLRPSonqeUBM7QD20aV6QMaAsq6zaHtAHgRrM5IzfEBkDDFD0QZ9QKouC53U4n1AAAAAAADIfkAAAAAAAMh+QAAAAAAAyH5AAAAAAADIfkCpLgud1OJ9QGQMMUPRBn1AHgRrM5IzfEDHgLKus2h7QE7tAPbRpXpAoLRPSonqeUCvQZjsdTZ5QGj/0x00iXhAuVj8HmDid0CRuAoxlkF3QOKJ+JRypnZAmTe/i5EQdkCnLFhWj391QPfTvDUI83RAe5jmaphqdEAh5c423OVzQNgkb9pvZHNAjMLAlu/lckAyKb2s92lyQLPDXV0k8HFABP2b6RF4cUAQQHGSXAFxQMX31pigi3BAFI/GPXoWcEDX4XKEC0NvQHcQUs6+WG5A438d20ZtbUD7Bcgs3H9sQJh4REW3j2tAnq2FphCcakDoen7SIKRpQFO2IUsgp2hAwDVikkekZ0ALzzIqz5pmQBNYhpTviWVAtKZPU+FwZEDNkIHo3E5jQDrsDtYaI2JA3o7qndPsYEAjnQ6Ef1ZfQGkCsIgvu1xASvmeTSgGWkCBLcHW2jVXQNBK/Ce4SFRA5/w1RTE9UUAS36dkbiNMQOGcd+Z1iUVAZhVNL7ZSPUAAAAAAAAAuQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AAAAAAAALkAAAAAAAAAuQAAAAAAAAC5AYhVNL7ZSPUDcnHfmdYlFQA3fp2RuI0xA4vw1RTE9UUDKSvwnuEhUQH8twdbaNVdASvmeTSgGWkBnArCIL7tcQCGdDoR/Vl9A247qndPsYEA57A7WGiNiQMyQgejcTmNAsqZPU+FwZEASWIaU74llQAzPMirPmmZAwDVikkekZ0BUtiFLIKdoQOd6ftIgpGlAna2FphCcakCWeERFt49rQPgFyCzcf2xA4n8d20ZtbUB1EFLOvlhuQNjhcoQLQ29AFI/GPXoWcEDE99aYoItwQA9AcZJcAXFABP2b6RF4cUC0w11dJPBxQDEpvaz3aXJAjMLAlu/lckDWJG/ab2RzQCDlzjbc5XNAepjmaphqdED207w1CPN0QKYsWFaPf3VAmje/i5EQdkDiifiUcqZ2QJG4CjGWQXdAt1j8HmDid0Bm/9MdNIl4QK5BmOx1NnlAoLRPSonqeUBM7QD20aV6QMaAsq6zaHtAHgRrM5IzfEBkDDFD0QZ9QKouC53U4n1AAAAAAADIfkAAAAAAAMh+QAAAAAAAyH5AAAAAAADIfkCpLgud1OJ9QGQMMUPRBn1AHgRrM5IzfEDHgLKus2h7QE7tAPbRpXpAoLRPSonqeUCvQZjsdTZ5QGj/0x00iXhAuVj8HmDid0CRuAoxlkF3QOKJ+JRypnZAmTe/i5EQdkCnLFhWj391QPfTvDUI83RAe5jmaphqdEAh5c423OVzQNgkb9pvZHNAjMLAlu/lckAyKb2s92lyQLPDXV0k8HFABP2b6RF4cUAQQHGSXAFxQMX31pigi3BAFI/GPXoWcEDX4XKEC0NvQHcQUs6+WG5A438d20ZtbUD7Bcgs3H9sQJh4REW3j2tAnq2FphCcakDoen7SIKRpQFO2IUsgp2hAwDVikkekZ0ALzzIqz5pmQBNYhpTviWVAtKZPU+FwZEDNkIHo3E5jQDrsDtYaI2JA3o7qndPsYEAjnQ6Ef1ZfQGkCsIgvu1xASvmeTSgGWkCBLcHW2jVXQNBK/Ce4SFRA5/w1RTE9UUAS36dkbiNMQOGcd+Z1iUVAZhVNL7ZSPUAAAAAAAAAuQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AAAAAAAALkAAAAAAAAAuQAAAAAAAAC5AYhVNL7ZSPUDcnHfmdYlFQA3fp2RuI0xA4vw1RTE9UUDKSvwnuEhUQH8twdbaNVdASvmeTSgGWkBnArCIL7tcQCGdDoR/Vl9A247qndPsYEA57A7WGiNiQMyQgejcTmNAsqZPU+FwZEASWIaU74llQAzPMirPmmZAwDVikkekZ0BUtiFLIKdoQOd6ftIgpGlAna2FphCcakCWeERFt49rQPgFyCzcf2xA4n8d20ZtbUB1EFLOvlhuQNjhcoQLQ29AFI/GPXoWcEDE99aYoItwQA9AcZJcAXFABP2b6RF4cUC0w11dJPBxQDEpvaz3aXJAjMLAlu/lckDWJG/ab2RzQCDlzjbc5XNAepjmaphqdED207w1CPN0QKYsWFaPf3VAmje/i5EQdkDiifiUcqZ2QJG4CjGWQXdAt1j8HmDid0Bm/9MdNIl4QK5BmOx1NnlAoLRPSonqeUBM7QD20aV6QMaAsq6zaHtAHgRrM5IzfEBkDDFD0QZ9QKouC53U4n1AAAAAAADIfkAAAAAAAMh+QAAAAAAAyH5AAAAAAADIfkCpLgud1OJ9QGQMMUPRBn1AHgRrM5IzfEDHgLKus2h7QE7tAPbRpXpAoLRPSonqeUCvQZjsdTZ5QGj/0x00iXhAuVj8HmDid0CRuAoxlkF3QOKJ+JRypnZAmTe/i5EQdkCnLFhWj391QPfTvDUI83RAe5jmaphqdEAh5c423OVzQNgkb9pvZHNAjMLAlu/lckAyKb2s92lyQLPDXV0k8HFABP2b6RF4cUAQQHGSXAFxQMX31pigi3BAFI/GPXoWcEDX4XKEC0NvQHcQUs6+WG5A438d20ZtbUD7Bcgs3H9sQJh4REW3j2tAnq2FphCcakDoen7SIKRpQFO2IUsgp2hAwDVikkekZ0ALzzIqz5pmQBNYhpTviWVAtKZPU+FwZEDNkIHo3E5jQDrsDtYaI2JA3o7qndPsYEAjnQ6Ef1ZfQGkCsIgvu1xASvmeTSgGWkCBLcHW2jVXQNBK/Ce4SFRA5/w1RTE9UUAS36dkbiNMQOGcd+Z1iUVAZhVNL7ZSPUAAAAAAAAAuQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AAAAAAC4f0AAAAAAALh/QAAAAAAAuH9Aqmh6sZVOgEDOeWdel7yAQPF9SuY2JoFAnL+mKKaLgUBaif8EF+2BQLAl2Fq7SoJAK9+zCcWkgkBOABbxZfuCQKXTgfDPToNAtaN65zSfg0ANu4O1xuyDQDJkIDq3N4RArOnTVDiAhEAFliHle8aEQMOzjMqzCoVAcY2Y5BFNhUCWbcgSyI2FQLmenzQIzYVAZ2uhKQQLhkAlHlHR7UeGQH0BMgv3g4ZA+V/HtlG/hkAehJSzL/qGQHa4HOHCNIdAikfjHj1vh0Dhe2tM0KmHQAegOEmu5IdAgv7N9AggiEDa4a4uElyIQJiUXtb7mIhAR2Fgy/fWiEBrkjftNxaJQJByZxvuVolAPUxzNUyZiUD8ad4ahN2JQFMWLKvHI4pAzZvfxUhsikDxRHxKObeKQEhchRjLBItAXCx+DzBVi0Cz/+kOmqiLQNcgTPY6/4tAUNonpURZjECmdgD76LaMQGNAWddZGI1AEIK1Gcl9jUAyhpihaOeNQFWXhU5qVY5AAAAAAADIjkAAAAAAAMiOQAAAAAAAyI5AAAAAAADIjkBTl4VOalWOQDKGmKFo541AD4K1Gcl9jUBkQFnXWRiNQKd2APvotoxAUNonpURZjEDZIEz2Ov+LQLT/6Q6aqItAXSx+DzBVi0BHXIUYywSLQPBEfEo5t4pAzJvfxUhsikBUFiyrxyOKQP1p3hqE3YlAP0xzNUyZiUCQcmcb7laJQGySN+03FolARmFgy/fWiECZlF7W+5iIQNnhri4SXIhAgf7N9AggiEAIoDhJruSHQOJ7a0zQqYdAi0fjHj1vh0B2uBzhwjSHQB2ElLMv+oZA+V/HtlG/hkB/ATIL94OGQCYeUdHtR4ZAZ2uhKQQLhkC7np80CM2FQJVtyBLIjYVAb42Y5BFNhUDCs4zKswqFQAWWIeV7xoRArenTVDiAhEAzZCA6tzeEQA67g7XG7INAt6N65zSfg0Ck04Hwz06DQE0AFvFl+4JAKt+zCcWkgkCwJdhau0qCQFqJ/wQX7YFAnb+mKKaLgUDyfUrmNiaBQM55Z16XvIBAq2h6sZVOgEAAAAAAALh/QA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"}]],[\"ys\",[{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"fqIt7L7FUUB+oi3svsVRQH6iLey+xVFAbfqpDs/RUUDZauEUVfVRQKuQ92xRL1JAywgQhcR+UkAocE7LruJSQKhj1q0QWlNAPIDLmurjU0DGYlEAPX9UQDaoi0wIK1VAcu2d7UzmVUBpz6tRC7BWQATr2OZDh1dALd1IG/dqWEDOQh9dJVpZQNS4fxrPU1pAJNyNwfRWW0CuSW3AlmJcQFieQYW1dV1AD3cuflGPXkC8cFcZa65fQCYUcGIBaWBAUx12d4z8YEBbos8CV5FhQLVxjjvhJmJA0lnEWKu8YkAqKYORNVJjQDOu3BwA52NAYLfiMYt6ZEAoE6cHVwxlQP6PO9Xjm2VAW/yx0bEoZkCwJhw0QbJmQHTdizMSOGdAHu8SB6W5Z0AeKsPleTZoQPBcrgYRrmhABFbmoOofaUDS43zrhotpQM3Ugx1m8GlAbPcMbghOakAkGioU7qNqQGoL7UaX8WpAsplnPYQ2a0Byk6suNXJrQCHHylEqpGtAMgPX3ePLa0AbFuIJ4uhrQFDO/Qyl+mtASPo7Hq0AbEBI+jserQBsQEj6Ox6tAGxASPo7Hq0AbEBQzv0MpfprQBoW4gni6GtAMgPX3ePLa0Aix8pRKqRrQHSTqy41cmtAsplnPYQ2a0BsC+1Gl/FqQCYaKhTuo2pAbvcMbghOakDM1IMdZvBpQNLjfOuGi2lAA1bmoOofaUDvXK4GEa5oQB8qw+V5NmhAIO8SB6W5Z0B13YszEjhnQLEmHDRBsmZAXPyx0bEoZkAAkDvV45tlQCgTpwdXDGVAYbfiMYt6ZEA0rtwcAOdjQCspg5E1UmNA01nEWKu8YkC1cY474SZiQFyizwJXkWFAVB12d4z8YEAnFHBiAWlgQL5wVxlrrl9AEXcuflGPXkBankGFtXVdQK5JbcCWYlxAJNyNwfRWW0DTuH8az1NaQNFCH10lWllAL91IG/dqWEAG69jmQ4dXQGrPq1ELsFZAdO2d7UzmVUA2qItMCCtVQMZiUQA9f1RAO4DLmurjU0CqY9atEFpTQChwTsuu4lJAzAgQhcR+UkCqkPdsUS9SQNlq4RRV9VFAbfqpDs/RUUB+oi3svsVRQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"SPo7Hq0AbEBI+jserQBsQEj6Ox6tAGxA4t3lpXn9a0DHbzJzDPRrQJoKmFep5GtA9giNJJTPa0B+xYerELVrQNGa/r1ilWtAk+NnLc5wa0Bf+jnLlkdrQNc562gAGmtAmvzx107oakBNncTpxbJqQIt22W+peWpA+eKmOz09akAzPaMexf1pQN3fROqEu2lAkSUCcMB2aUD2aFGBuy9pQKgEqe+55mhASVN/jP+baEB5r0op0E9oQNdzgZdvAmhAB/uZqCG0Z0CjnwouKmVnQFK8SfnMFWdArqvN203GZkBcyAyn8HZmQPpsfSz5J2ZAKPSVPavZZUCGuMyrSoxlQLcUmEgbQGVAWGNu5WD1ZEAK/8VTX6xkQG5CFWVaZWRAI4jS6pUgZEDMKnS2Vd5jQAaFcJndnmNAc/E9ZXFiY0CyylLrVCljQGRrJf3L82JAKi4sbBrCYkCibd0JhJRiQG6Er6dMa2JALc0YF7hGYkCCoo8pCidiQApfirCGDGJAZl1/fXH3YUA3+ORhDuhhQByKMS+h3mFAt23btm3bYUC3bdu2bdthQLdt27Zt22FAt23btm3bYUAcijEvod5hQDb45GEO6GFAZ11/fXH3YUAKX4qwhgxiQIGijykKJ2JALM0YF7hGYkBvhK+nTGtiQKJt3QmElGJAKS4sbBrCYkBjayX9y/NiQLDKUutUKWNAcfE9ZXFiY0AFhXCZ3Z5jQMwqdLZV3mNAJIjS6pUgZEBuQhVlWmVkQAv/xVNfrGRAV2Nu5WD1ZEC2FJhIG0BlQIW4zKtKjGVAJ/SVPavZZUD5bH0s+SdmQFvIDKfwdmZArqvN203GZkBRvEn5zBVnQKSfCi4qZWdABvuZqCG0Z0DYc4GXbwJoQHqvSinQT2hASFN/jP+baECoBKnvueZoQPVoUYG7L2lAkiUCcMB2aUDc30TqhLtpQDM9ox7F/WlA+eKmOz09akCNdtlvqXlqQE2dxOnFsmpAm/zx107oakDWOetoABprQF36OcuWR2tAkuNnLc5wa0DRmv69YpVrQH3Fh6sQtWtA9giNJJTPa0CaCphXqeRrQMlvMnMM9GtA4t3lpXn9a0BI+jserQBsQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"SPo7Hq0AbEBI+jserQBsQEj6Ox6tAGxAaj4g00oAbEBTQRxeKf9rQMXUpuFQ/WtAfso2gMn6a0BA9EJcm/drQMwjQpjO82tA6CqrVmvva0BM2/S5eeprQMEGluQB5WtAAX8F+Qvfa0DVFboZoNhrQPicKmnG0WtAL+bNCYfKa0A6wxoe6sJrQNkFiMj3umtAzH+MK7iya0DYAp9pM6prQLlgNqVxoWtANGvJAHuYa0AJ9M6eV49rQPvMvaEPhmtAyMcMLKt8a0AxtjJgMnNrQPlppmCtaWtA4bTeTyRga0CpaFJQn1ZrQBRXeIQmTWtA4FHHDsJDa0DRKrYRejprQKezu69WMWtAIr5OC2Aoa0AEHOZGnh9rQA6f+IQZF2tAAhn959kOa0CiW2qS5wZrQKs4t6ZK/2pA4oFaRwv4akAGCcuWMfFqQNiff7fF6mpAHBjvy8/kakCQQ5D2V99qQPbz2Vlm2mpADvtCGAPWakCbKkJUNtJqQF5UTjAIz2pAFkrezoDMakCH3WhSqMpqQHDgZN2GyWpAkyRJkiTJakCTJEmSJMlqQJMkSZIkyWpAkyRJkiTJakBv4GTdhslqQIbdaFKoympAGErezoDMakBeVE4wCM9qQJoqQlQ20mpADftCGAPWakD289lZZtpqQJBDkPZX32pAHRjvy8/kakDYn3+3xepqQAUJy5Yx8WpA4IFaRwv4akCrOLemSv9qQKFbapLnBmtABBn959kOa0APn/iEGRdrQAUc5kaeH2tAIb5OC2Aoa0Cms7uvVjFrQM8qthF6OmtA4FHHDsJDa0AUV3iEJk1rQKloUlCfVmtA4rTeTyRga0D6aaZgrWlrQDK2MmAyc2tAyMcMLKt8a0D8zL2hD4ZrQAr0zp5Xj2tANGvJAHuYa0C6YDalcaFrQNcCn2kzqmtAzH+MK7iya0DYBYjI97prQDrDGh7qwmtAMObNCYfKa0D6nCppxtFrQNUVuhmg2GtAAn8F+Qvfa0DABpbkAeVrQEvb9Ll56mtA5iqrVmvva0DNI0KYzvNrQED0Qlyb92tAfco2gMn6a0DF1KbhUP1rQFRBHF4p/2tAaj4g00oAbEBI+jserQBsQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"SPo7Hq0AbEBI+jserQBsQEj6Ox6tAGxArm69abMBbEAZKpHTtwRsQNo5rqakCWxAQasLLmQQbECii6C04BhsQEvoY4UEI2xAks5M67kubEDES1Ix6ztsQDVta6KCSmxANUCPiWpabEAZ0rQxjWtsQC4w0+XUfWxAymfh8CuRbEA9htadfKVsQNiYqTexumxA6qxRCbTQbEDJz8Vdb+dsQMIO/X/N/mxAK3fuurgWbUBSFpFZGy9tQIz526bfR21AKC7G7e9gbUB4wUZ5NnptQM7AVJSdk21AejnniQ+tbUDPOPWkdsZtQCHMdTC9321AvABgd834bUD246rEkRFuQB6DTWP0KW5AiOs+nt9BbkCAKnbAPVluQGBN6hT5b25AcmGS5vuFbkAMdGWAMJtuQH6SWi2Br25AGspoONjCbkAwKIfsH9VuQBO6rJRC5m5AFY3Qeyr2bkCGrunswQRvQLkr7zLzEW9A/hHYmKgdb0CobptpzCdvQAhPMPBIMG9Ab8CNdwg3b0Av0KpK9TtvQJqLfrT5Pm9AAQAAAABAb0ABAAAAAEBvQAEAAAAAQG9AAQAAAABAb0CZi360+T5vQC7Qqkr1O29AcMCNdwg3b0AITzDwSDBvQKdum2nMJ29A/RHYmKgdb0C7K+8y8xFvQIeu6ezBBG9AFo3Qeyr2bkASuqyUQuZuQC8oh+wf1W5AGMpoONjCbkB9klotga9uQA10ZYAwm25AdGGS5vuFbkBgTeoU+W9uQIIqdsA9WW5Ah+s+nt9BbkAeg01j9CluQPTjqsSREW5AvABgd834bUAhzHUwvd9tQNE49aR2xm1AfDnniQ+tbUDOwFSUnZNtQHjBRnk2em1AKC7G7e9gbUCM+dum30dtQFQWkVkbL21AKnfuurgWbUDDDv1/zf5sQMfPxV1v52xA6qxRCbTQbEDWmKk3sbpsQD2G1p18pWxAy2fh8CuRbEAxMNPl1H1sQBnStDGNa2xANkCPiWpabEA0bWuigkpsQMJLUjHrO2xAkc5M67kubEBK6GOFBCNsQKCLoLTgGGxAQasLLmQQbEDaOa6mpAlsQBoqkdO3BGxArm69abMBbEBI+jserQBsQA==\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"},{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[104],\"dtype\":\"float64\",\"order\":\"little\"}]],[\"Source\",[\"Brain Diseases\",\"Anemia, Hemolytic, Congenital\",\"Dementia\",\"Metabolism, Inborn Errors\",\"Immune System Diseases\",\"Pathologic Processes\",\"Carcinoma\",\"Retinal Degeneration\",\"Brain Diseases, Metabolic, Inborn\",\"Chronic Disease\",\"Hyperlipidemias\",\"Metabolic Diseases\",\"Disease\",\"Lymphoproliferative Disorders\",\"Eye Diseases, Hereditary\",\"Carbohydrate Metabolism, Inborn Errors\",\"Liver Diseases\",\"Basal Ganglia Diseases\",\"HIV\",\"Joint Diseases\",\"Neoplasms by Histologic Type\",\"Multiple Primary Cancers\",\"Neoplasms\",\"Precancerous Conditions\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\"]],[\"Target\",[\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"31 cases\",\"Genetic: lentiviral gene therapy\",\"Genetic: Gene therapy\",\"Genetic: AAV2-BDNF Gene Therapy|Biological: AAV2-BDNF Gene Therapy\",\"Genetic: OTL-200 Gene Therapy\",\"Genetic: ex-vivo gene-therapy\",\"Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes\",\"Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy\",\"Genetic: Intracerebral LV gene therapy\",\"Genetic: Gene Therapy|Drug: Busulfan\",\"Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre\",\"Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion\",\"Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy\",\"Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4\",\"Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene\",\"Genetic: X vivo gene therapy\",\"Genetic: rAAV2.REP1 vector\",\"Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the \\u03b1-L-iduronidase cDNA, in their final formulation medium.\",\"Genetic: rAAV2-CB-hAAT Gene Vector\",\"Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene\",\"Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy\",\"Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo\",\"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy\",\"Genetic: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy\",\"Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line\",\"Genetic: ct-DNA guided therapy\",\"Genetic: Gene-modified (GM) T cell therapy\",\"Genetic: response to therapy\"]],[\"Value\",{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"AQAAAAIAAAABAAAAAQAAAAMAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAIAAAABAAAAAQAAAAEAAAABAAAAAQAAAAIAAAADAAAAAQAAAAEAAAABAAAAAQAAAAIAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAACAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAABAAAAAQAAAAEAAAA=\"},\"shape\":[53],\"dtype\":\"int32\",\"order\":\"little\"}]]}}},\"view\":{\"type\":\"object\",\"name\":\"CDSView\",\"id\":\"p2285\",\"attributes\":{\"filter\":{\"type\":\"object\",\"name\":\"AllIndices\",\"id\":\"p2286\"}}},\"glyph\":{\"type\":\"object\",\"name\":\"Patches\",\"id\":\"p2304\",\"attributes\":{\"xs\":{\"type\":\"field\",\"field\":\"xs\"},\"ys\":{\"type\":\"field\",\"field\":\"ys\"},\"fill_alpha\":{\"type\":\"value\",\"value\":0.6}}},\"selection_glyph\":{\"type\":\"object\",\"name\":\"Patches\",\"id\":\"p2305\",\"attributes\":{\"xs\":{\"type\":\"field\",\"field\":\"xs\"},\"ys\":{\"type\":\"field\",\"field\":\"ys\"},\"fill_alpha\":{\"type\":\"value\",\"value\":0.6}}},\"nonselection_glyph\":{\"type\":\"object\",\"name\":\"Patches\",\"id\":\"p2306\",\"attributes\":{\"xs\":{\"type\":\"field\",\"field\":\"xs\"},\"ys\":{\"type\":\"field\",\"field\":\"ys\"},\"line_alpha\":{\"type\":\"value\",\"value\":0.2},\"fill_alpha\":{\"type\":\"value\",\"value\":0.2}}},\"hover_glyph\":{\"type\":\"object\",\"name\":\"Patches\",\"id\":\"p2307\",\"attributes\":{\"xs\":{\"type\":\"field\",\"field\":\"xs\"},\"ys\":{\"type\":\"field\",\"field\":\"ys\"},\"line_alpha\":{\"type\":\"value\",\"value\":0.9},\"fill_alpha\":{\"type\":\"value\",\"value\":0.9}}},\"muted_glyph\":{\"type\":\"object\",\"name\":\"Patches\",\"id\":\"p2308\",\"attributes\":{\"xs\":{\"type\":\"field\",\"field\":\"xs\"},\"ys\":{\"type\":\"field\",\"field\":\"ys\"},\"fill_alpha\":{\"type\":\"value\",\"value\":0.6}}}}},\"selection_policy\":{\"type\":\"object\",\"name\":\"NodesAndLinkedEdges\",\"id\":\"p2309\"},\"inspection_policy\":{\"type\":\"object\",\"name\":\"EdgesAndLinkedNodes\",\"id\":\"p2310\"}}},{\"type\":\"object\",\"name\":\"GlyphRenderer\",\"id\":\"p2322\",\"attributes\":{\"data_source\":{\"id\":\"p2265\"},\"view\":{\"id\":\"p2278\"},\"glyph\":{\"type\":\"object\",\"name\":\"Quad\",\"id\":\"p2317\",\"attributes\":{\"left\":{\"type\":\"field\",\"field\":\"x0\"},\"right\":{\"type\":\"field\",\"field\":\"x1\"},\"bottom\":{\"type\":\"field\",\"field\":\"y0\"},\"top\":{\"type\":\"field\",\"field\":\"y1\"},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}}}},\"selection_glyph\":{\"type\":\"object\",\"name\":\"Quad\",\"id\":\"p2319\",\"attributes\":{\"left\":{\"type\":\"field\",\"field\":\"x0\"},\"right\":{\"type\":\"field\",\"field\":\"x1\"},\"bottom\":{\"type\":\"field\",\"field\":\"y0\"},\"top\":{\"type\":\"field\",\"field\":\"y1\"},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}}}},\"nonselection_glyph\":{\"type\":\"object\",\"name\":\"Quad\",\"id\":\"p2318\",\"attributes\":{\"left\":{\"type\":\"field\",\"field\":\"x0\"},\"right\":{\"type\":\"field\",\"field\":\"x1\"},\"bottom\":{\"type\":\"field\",\"field\":\"y0\"},\"top\":{\"type\":\"field\",\"field\":\"y1\"},\"line_alpha\":{\"type\":\"value\",\"value\":0.2},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}},\"fill_alpha\":{\"type\":\"value\",\"value\":0.2},\"hatch_alpha\":{\"type\":\"value\",\"value\":0.2}}},\"hover_glyph\":{\"type\":\"object\",\"name\":\"Quad\",\"id\":\"p2320\",\"attributes\":{\"left\":{\"type\":\"field\",\"field\":\"x0\"},\"right\":{\"type\":\"field\",\"field\":\"x1\"},\"bottom\":{\"type\":\"field\",\"field\":\"y0\"},\"top\":{\"type\":\"field\",\"field\":\"y1\"},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}}}},\"muted_glyph\":{\"type\":\"object\",\"name\":\"Quad\",\"id\":\"p2321\",\"attributes\":{\"left\":{\"type\":\"field\",\"field\":\"x0\"},\"right\":{\"type\":\"field\",\"field\":\"x1\"},\"bottom\":{\"type\":\"field\",\"field\":\"y0\"},\"top\":{\"type\":\"field\",\"field\":\"y1\"},\"line_alpha\":{\"type\":\"value\",\"value\":0.2},\"fill_color\":{\"type\":\"field\",\"field\":\"index\",\"transform\":{\"id\":\"p2264\"}},\"fill_alpha\":{\"type\":\"value\",\"value\":0.2},\"hatch_alpha\":{\"type\":\"value\",\"value\":0.2}}}}},{\"type\":\"object\",\"name\":\"GlyphRenderer\",\"id\":\"p2334\",\"attributes\":{\"data_source\":{\"type\":\"object\",\"name\":\"ColumnDataSource\",\"id\":\"p2325\",\"attributes\":{\"selected\":{\"type\":\"object\",\"name\":\"Selection\",\"id\":\"p2326\",\"attributes\":{\"indices\":[],\"line_indices\":[]}},\"selection_policy\":{\"type\":\"object\",\"name\":\"UnionRenderers\",\"id\":\"p2327\"},\"data\":{\"type\":\"map\",\"entries\":[[\"x\",{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[54],\"dtype\":\"float64\",\"order\":\"little\"}],[\"y\",{\"type\":\"ndarray\",\"array\":{\"type\":\"bytes\",\"data\":\"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\"},\"shape\":[54],\"dtype\":\"float64\",\"order\":\"little\"}],[\"text\",[\"Brain Diseases - 1\",\"Anemia, Hemolytic, Congenital - 2\",\"Dementia - 1\",\"Metabolism, Inborn Errors - 1\",\"Immune System Diseases - 3\",\"Pathologic Processes - 1\",\"Carcinoma - 1\",\"Retinal Degeneration - 1\",\"Brain Diseases, Metabolic, Inborn - 1\",\"Chronic Disease - 1\",\"Hyperlipidemias - 1\",\"Metabolic Diseases - 1\",\"Disease - 1\",\"Lymphoproliferative Disorders - 2\",\"Eye Diseases, Hereditary - 1\",\"Carbohydrate Metabolism, Inborn Errors - 1\",\"Liver Diseases - 1\",\"Basal Ganglia Diseases - 1\",\"HIV - 1\",\"Joint Diseases - 2\",\"Neoplasms by Histologic Type - 3\",\"Multiple Primary Cancers - 1\",\"Neoplasms - 1\",\"Precancerous Conditions - 1\",\"31 cases - 31\",\"Genetic: lentiviral gene therapy - 1\",\"Genetic: Gene therapy - 2\",\"Genetic: AAV2-BDNF Gene Therapy|Biological: AAV2-BDNF Gene Therapy - 1\",\"Genetic: OTL-200 Gene Therapy - 1\",\"Genetic: ex-vivo gene-therapy - 1\",\"Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes - 1\",\"Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy|Genetic: NG101 AAV gene therapy - 1\",\"Genetic: Intracerebral LV gene therapy - 1\",\"Genetic: Gene Therapy|Drug: Busulfan - 1\",\"Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre - 1\",\"Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion - 1\",\"Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy|Genetic: AAV directed hLDLR gene therapy - 1\",\"Genetic: rAAV2/5-PBGD vector dosage 1|Genetic: rAAV2/5-PBGD vector dosage 2|Genetic: rAAV2/5-PBGD vector dosage 3|Genetic: rAAV2/5-PBGD vector dosage 4 - 1\",\"Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene - 1\",\"Genetic: X vivo gene therapy - 2\",\"Genetic: rAAV2.REP1 vector - 1\",\"Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the \\u03b1-L-iduronidase cDNA, in their final formulation medium. - 1\",\"Genetic: rAAV2-CB-hAAT Gene Vector - 1\",\"Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene|Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene - 1\",\"Genetic: AB-1001 Gene Therapy|Genetic: AB-1001 Gene Therapy - 1\",\"Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion.|Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF-T), given via intravenous infusion. - 1\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo - 1\",\"Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 gene therapy vector|Genetic: tgAAC94 placebo - 1\",\"Genetic: Pell's lentiviral-based gene-edited immune cell therapy|Genetic: Pell's lentiviral-based gene-edited immune cell therapy - 1\",\"Genetic: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy - 1\",\"Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line|Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta|Biological: Irradiated donor-derived Lymphoblastoid Cell Line - 1\",\"Genetic: ct-DNA guided therapy - 1\",\"Genetic: Gene-modified (GM) T cell therapy - 1\",\"Genetic: response to therapy - 1\"]]]}}},\"view\":{\"type\":\"object\",\"name\":\"CDSView\",\"id\":\"p2335\",\"attributes\":{\"filter\":{\"type\":\"object\",\"name\":\"AllIndices\",\"id\":\"p2336\"}}},\"glyph\":{\"type\":\"object\",\"name\":\"Text\",\"id\":\"p2331\",\"attributes\":{\"x\":{\"type\":\"field\",\"field\":\"x\"},\"y\":{\"type\":\"field\",\"field\":\"y\"},\"text\":{\"type\":\"field\",\"field\":\"text\"},\"text_color\":{\"type\":\"value\",\"value\":\"black\"},\"text_font_size\":{\"type\":\"value\",\"value\":\"8pt\"},\"text_baseline\":{\"type\":\"value\",\"value\":\"middle\"}}},\"selection_glyph\":{\"type\":\"object\",\"name\":\"Text\",\"id\":\"p2337\",\"attributes\":{\"x\":{\"type\":\"field\",\"field\":\"x\"},\"y\":{\"type\":\"field\",\"field\":\"y\"},\"text\":{\"type\":\"field\",\"field\":\"text\"},\"angle\":{\"type\":\"value\",\"value\":0},\"x_offset\":{\"type\":\"value\",\"value\":0},\"y_offset\":{\"type\":\"value\",\"value\":0},\"text_color\":{\"type\":\"value\",\"value\":\"black\"},\"text_outline_color\":{\"type\":\"value\",\"value\":null},\"text_alpha\":{\"type\":\"value\",\"value\":1.0},\"text_font_size\":{\"type\":\"value\",\"value\":\"8pt\"},\"text_font_style\":{\"type\":\"value\",\"value\":\"normal\"},\"text_align\":{\"type\":\"value\",\"value\":\"left\"},\"text_baseline\":{\"type\":\"value\",\"value\":\"middle\"},\"text_line_height\":{\"type\":\"value\",\"value\":1.2},\"background_fill_color\":{\"type\":\"value\",\"value\":null},\"background_fill_alpha\":{\"type\":\"value\",\"value\":1.0},\"background_hatch_color\":{\"type\":\"value\",\"value\":null},\"background_hatch_alpha\":{\"type\":\"value\",\"value\":1.0},\"background_hatch_scale\":{\"type\":\"value\",\"value\":12.0},\"background_hatch_pattern\":{\"type\":\"value\",\"value\":null},\"background_hatch_weight\":{\"type\":\"value\",\"value\":1.0},\"border_line_color\":{\"type\":\"value\",\"value\":null},\"border_line_alpha\":{\"type\":\"value\",\"value\":1.0},\"border_line_width\":{\"type\":\"value\",\"value\":1},\"border_line_join\":{\"type\":\"value\",\"value\":\"bevel\"},\"border_line_cap\":{\"type\":\"value\",\"value\":\"butt\"},\"border_line_dash\":{\"type\":\"value\",\"value\":[]},\"border_line_dash_offset\":{\"type\":\"value\",\"value\":0}}},\"nonselection_glyph\":{\"type\":\"object\",\"name\":\"Text\",\"id\":\"p2332\",\"attributes\":{\"x\":{\"type\":\"field\",\"field\":\"x\"},\"y\":{\"type\":\"field\",\"field\":\"y\"},\"text\":{\"type\":\"field\",\"field\":\"text\"},\"text_color\":{\"type\":\"value\",\"value\":\"black\"},\"text_alpha\":{\"type\":\"value\",\"value\":0.1},\"text_font_size\":{\"type\":\"value\",\"value\":\"8pt\"},\"text_baseline\":{\"type\":\"value\",\"value\":\"middle\"}}},\"muted_glyph\":{\"type\":\"object\",\"name\":\"Text\",\"id\":\"p2333\",\"attributes\":{\"x\":{\"type\":\"field\",\"field\":\"x\"},\"y\":{\"type\":\"field\",\"field\":\"y\"},\"text\":{\"type\":\"field\",\"field\":\"text\"},\"text_color\":{\"type\":\"value\",\"value\":\"black\"},\"text_alpha\":{\"type\":\"value\",\"value\":0.2},\"text_font_size\":{\"type\":\"value\",\"value\":\"8pt\"},\"text_baseline\":{\"type\":\"value\",\"value\":\"middle\"}}}}}],\"toolbar\":{\"type\":\"object\",\"name\":\"Toolbar\",\"id\":\"p2241\",\"attributes\":{\"tools\":[{\"type\":\"object\",\"name\":\"WheelZoomTool\",\"id\":\"p2230\",\"attributes\":{\"tags\":[\"hv_created\"],\"renderers\":\"auto\",\"zoom_together\":\"none\"}},{\"type\":\"object\",\"name\":\"HoverTool\",\"id\":\"p2231\",\"attributes\":{\"tags\":[\"hv_created\"],\"renderers\":[{\"id\":\"p2287\"}],\"tooltips\":[[\"Source\",\"@{Source}\"],[\"Target\",\"@{Target}\"],[\"Value\",\"@{Value}\"]]}},{\"type\":\"object\",\"name\":\"SaveTool\",\"id\":\"p2254\"},{\"type\":\"object\",\"name\":\"PanTool\",\"id\":\"p2255\"},{\"type\":\"object\",\"name\":\"BoxZoomTool\",\"id\":\"p2256\",\"attributes\":{\"overlay\":{\"type\":\"object\",\"name\":\"BoxAnnotation\",\"id\":\"p2257\",\"attributes\":{\"syncable\":false,\"level\":\"overlay\",\"visible\":false,\"left\":{\"type\":\"number\",\"value\":\"nan\"},\"right\":{\"type\":\"number\",\"value\":\"nan\"},\"top\":{\"type\":\"number\",\"value\":\"nan\"},\"bottom\":{\"type\":\"number\",\"value\":\"nan\"},\"left_units\":\"canvas\",\"right_units\":\"canvas\",\"top_units\":\"canvas\",\"bottom_units\":\"canvas\",\"line_color\":\"black\",\"line_alpha\":1.0,\"line_width\":2,\"line_dash\":[4,4],\"fill_color\":\"lightgrey\",\"fill_alpha\":0.5}}}},{\"type\":\"object\",\"name\":\"ResetTool\",\"id\":\"p2262\"},{\"type\":\"object\",\"name\":\"TapTool\",\"id\":\"p2263\",\"attributes\":{\"renderers\":\"auto\"}}],\"active_drag\":{\"id\":\"p2255\"},\"active_scroll\":{\"id\":\"p2230\"}}},\"left\":[{\"type\":\"object\",\"name\":\"LinearAxis\",\"id\":\"p2249\",\"attributes\":{\"visible\":false,\"ticker\":{\"type\":\"object\",\"name\":\"BasicTicker\",\"id\":\"p2250\",\"attributes\":{\"mantissas\":[1,2,5]}},\"formatter\":{\"type\":\"object\",\"name\":\"BasicTickFormatter\",\"id\":\"p2251\"},\"axis_label\":\"y\",\"major_label_policy\":{\"type\":\"object\",\"name\":\"AllLabels\",\"id\":\"p2252\"}}}],\"below\":[{\"type\":\"object\",\"name\":\"LinearAxis\",\"id\":\"p2244\",\"attributes\":{\"visible\":false,\"ticker\":{\"type\":\"object\",\"name\":\"BasicTicker\",\"id\":\"p2245\",\"attributes\":{\"mantissas\":[1,2,5]}},\"formatter\":{\"type\":\"object\",\"name\":\"BasicTickFormatter\",\"id\":\"p2246\"},\"axis_label\":\"x\",\"major_label_policy\":{\"type\":\"object\",\"name\":\"AllLabels\",\"id\":\"p2247\"}}}],\"center\":[{\"type\":\"object\",\"name\":\"Grid\",\"id\":\"p2248\",\"attributes\":{\"axis\":{\"id\":\"p2244\"},\"grid_line_color\":null}},{\"type\":\"object\",\"name\":\"Grid\",\"id\":\"p2253\",\"attributes\":{\"dimension\":1,\"axis\":{\"id\":\"p2249\"},\"grid_line_color\":null}}],\"min_border_top\":10,\"min_border_bottom\":10,\"min_border_left\":10,\"min_border_right\":10,\"output_backend\":\"webgl\"}},{\"type\":\"object\",\"name\":\"Spacer\",\"id\":\"p2339\",\"attributes\":{\"name\":\"HSpacer07082\",\"stylesheets\":[\"\\n:host(.pn-loading):before, .pn-loading:before {\\n  background-color: #c3c3c3;\\n  mask-size: auto calc(min(50%, 400px));\\n  -webkit-mask-size: auto calc(min(50%, 400px));\\n}\",{\"id\":\"p2223\"},{\"id\":\"p2221\"},{\"id\":\"p2222\"}],\"margin\":0,\"sizing_mode\":\"stretch_width\",\"align\":\"start\"}}]}}],\"defs\":[{\"type\":\"model\",\"name\":\"ReactiveHTML1\"},{\"type\":\"model\",\"name\":\"FlexBox1\",\"properties\":[{\"name\":\"align_content\",\"kind\":\"Any\",\"default\":\"flex-start\"},{\"name\":\"align_items\",\"kind\":\"Any\",\"default\":\"flex-start\"},{\"name\":\"flex_direction\",\"kind\":\"Any\",\"default\":\"row\"},{\"name\":\"flex_wrap\",\"kind\":\"Any\",\"default\":\"wrap\"},{\"name\":\"gap\",\"kind\":\"Any\",\"default\":\"\"},{\"name\":\"justify_content\",\"kind\":\"Any\",\"default\":\"flex-start\"}]},{\"type\":\"model\",\"name\":\"FloatPanel1\",\"properties\":[{\"name\":\"config\",\"kind\":\"Any\",\"default\":{\"type\":\"map\"}},{\"name\":\"contained\",\"kind\":\"Any\",\"default\":true},{\"name\":\"position\",\"kind\":\"Any\",\"default\":\"right-top\"},{\"name\":\"offsetx\",\"kind\":\"Any\",\"default\":null},{\"name\":\"offsety\",\"kind\":\"Any\",\"default\":null},{\"name\":\"theme\",\"kind\":\"Any\",\"default\":\"primary\"},{\"name\":\"status\",\"kind\":\"Any\",\"default\":\"normalized\"}]},{\"type\":\"model\",\"name\":\"GridStack1\",\"properties\":[{\"name\":\"mode\",\"kind\":\"Any\",\"default\":\"warn\"},{\"name\":\"ncols\",\"kind\":\"Any\",\"default\":null},{\"name\":\"nrows\",\"kind\":\"Any\",\"default\":null},{\"name\":\"allow_resize\",\"kind\":\"Any\",\"default\":true},{\"name\":\"allow_drag\",\"kind\":\"Any\",\"default\":true},{\"name\":\"state\",\"kind\":\"Any\",\"default\":[]}]},{\"type\":\"model\",\"name\":\"drag1\",\"properties\":[{\"name\":\"slider_width\",\"kind\":\"Any\",\"default\":5},{\"name\":\"slider_color\",\"kind\":\"Any\",\"default\":\"black\"},{\"name\":\"value\",\"kind\":\"Any\",\"default\":50}]},{\"type\":\"model\",\"name\":\"click1\",\"properties\":[{\"name\":\"terminal_output\",\"kind\":\"Any\",\"default\":\"\"},{\"name\":\"debug_name\",\"kind\":\"Any\",\"default\":\"\"},{\"name\":\"clears\",\"kind\":\"Any\",\"default\":0}]},{\"type\":\"model\",\"name\":\"FastWrapper1\",\"properties\":[{\"name\":\"object\",\"kind\":\"Any\",\"default\":null},{\"name\":\"style\",\"kind\":\"Any\",\"default\":null}]},{\"type\":\"model\",\"name\":\"NotificationAreaBase1\",\"properties\":[{\"name\":\"js_events\",\"kind\":\"Any\",\"default\":{\"type\":\"map\"}},{\"name\":\"position\",\"kind\":\"Any\",\"default\":\"bottom-right\"},{\"name\":\"_clear\",\"kind\":\"Any\",\"default\":0}]},{\"type\":\"model\",\"name\":\"NotificationArea1\",\"properties\":[{\"name\":\"js_events\",\"kind\":\"Any\",\"default\":{\"type\":\"map\"}},{\"name\":\"notifications\",\"kind\":\"Any\",\"default\":[]},{\"name\":\"position\",\"kind\":\"Any\",\"default\":\"bottom-right\"},{\"name\":\"_clear\",\"kind\":\"Any\",\"default\":0},{\"name\":\"types\",\"kind\":\"Any\",\"default\":[{\"type\":\"map\",\"entries\":[[\"type\",\"warning\"],[\"background\",\"#ffc107\"],[\"icon\",{\"type\":\"map\",\"entries\":[[\"className\",\"fas fa-exclamation-triangle\"],[\"tagName\",\"i\"],[\"color\",\"white\"]]}]]},{\"type\":\"map\",\"entries\":[[\"type\",\"info\"],[\"background\",\"#007bff\"],[\"icon\",{\"type\":\"map\",\"entries\":[[\"className\",\"fas fa-info-circle\"],[\"tagName\",\"i\"],[\"color\",\"white\"]]}]]}]}]},{\"type\":\"model\",\"name\":\"Notification\",\"properties\":[{\"name\":\"background\",\"kind\":\"Any\",\"default\":null},{\"name\":\"duration\",\"kind\":\"Any\",\"default\":3000},{\"name\":\"icon\",\"kind\":\"Any\",\"default\":null},{\"name\":\"message\",\"kind\":\"Any\",\"default\":\"\"},{\"name\":\"notification_type\",\"kind\":\"Any\",\"default\":null},{\"name\":\"_destroyed\",\"kind\":\"Any\",\"default\":false}]},{\"type\":\"model\",\"name\":\"TemplateActions1\",\"properties\":[{\"name\":\"open_modal\",\"kind\":\"Any\",\"default\":0},{\"name\":\"close_modal\",\"kind\":\"Any\",\"default\":0}]},{\"type\":\"model\",\"name\":\"BootstrapTemplateActions1\",\"properties\":[{\"name\":\"open_modal\",\"kind\":\"Any\",\"default\":0},{\"name\":\"close_modal\",\"kind\":\"Any\",\"default\":0}]},{\"type\":\"model\",\"name\":\"TemplateEditor1\",\"properties\":[{\"name\":\"layout\",\"kind\":\"Any\",\"default\":[]}]},{\"type\":\"model\",\"name\":\"MaterialTemplateActions1\",\"properties\":[{\"name\":\"open_modal\",\"kind\":\"Any\",\"default\":0},{\"name\":\"close_modal\",\"kind\":\"Any\",\"default\":0}]},{\"type\":\"model\",\"name\":\"copy_to_clipboard1\",\"properties\":[{\"name\":\"fill\",\"kind\":\"Any\",\"default\":\"none\"},{\"name\":\"value\",\"kind\":\"Any\",\"default\":null}]}]}};\n",
       "  var render_items = [{\"docid\":\"4bfb94de-c075-42a2-b4b0-25d4e157acd9\",\"roots\":{\"p2220\":\"b2a54f13-9842-4a77-8bd4-dfc57d90afdc\"},\"root_ids\":[\"p2220\"]}];\n",
       "  var docs = Object.values(docs_json)\n",
       "  if (!docs) {\n",
       "    return\n",
       "  }\n",
       "  const py_version = docs[0].version.replace('rc', '-rc.').replace('.dev', '-dev.')\n",
       "  function embed_document(root) {\n",
       "    var Bokeh = get_bokeh(root)\n",
       "    Bokeh.embed.embed_items_notebook(docs_json, render_items);\n",
       "    for (const render_item of render_items) {\n",
       "      for (const root_id of render_item.root_ids) {\n",
       "\tconst id_el = document.getElementById(root_id)\n",
       "\tif (id_el.children.length && (id_el.children[0].className === 'bk-root')) {\n",
       "\t  const root_el = id_el.children[0]\n",
       "\t  root_el.id = root_el.id + '-rendered'\n",
       "\t}\n",
       "      }\n",
       "    }\n",
       "  }\n",
       "  function get_bokeh(root) {\n",
       "    if (root.Bokeh === undefined) {\n",
       "      return null\n",
       "    } else if (root.Bokeh.version !== py_version) {\n",
       "      if (root.Bokeh.versions === undefined || !root.Bokeh.versions.has(py_version)) {\n",
       "\treturn null\n",
       "      }\n",
       "      return root.Bokeh.versions.get(py_version);\n",
       "    } else if (root.Bokeh.version === py_version) {\n",
       "      return root.Bokeh\n",
       "    }\n",
       "    return null\n",
       "  }\n",
       "  function is_loaded(root) {\n",
       "    var Bokeh = get_bokeh(root)\n",
       "    return (Bokeh != null && Bokeh.Panel !== undefined)\n",
       "  }\n",
       "  if (is_loaded(root)) {\n",
       "    embed_document(root);\n",
       "  } else {\n",
       "    var attempts = 0;\n",
       "    var timer = setInterval(function(root) {\n",
       "      if (is_loaded(root)) {\n",
       "        clearInterval(timer);\n",
       "        embed_document(root);\n",
       "      } else if (document.readyState == \"complete\") {\n",
       "        attempts++;\n",
       "        if (attempts > 200) {\n",
       "          clearInterval(timer);\n",
       "\t  var Bokeh = get_bokeh(root)\n",
       "\t  if (Bokeh == null || Bokeh.Panel == null) {\n",
       "            console.warn(\"Panel: ERROR: Unable to run Panel code because Bokeh or Panel library is missing\");\n",
       "\t  } else {\n",
       "\t    console.warn(\"Panel: WARNING: Attempting to render but not all required libraries could be resolved.\")\n",
       "\t    embed_document(root)\n",
       "\t  }\n",
       "        }\n",
       "      }\n",
       "    }, 25, root)\n",
       "  }\n",
       "})(window);</script>"
      ],
      "text/plain": [
       ":Sankey   [Source,Target]   (Value)"
      ]
     },
     "execution_count": 117,
     "metadata": {
      "application/vnd.holoviews_exec.v0+json": {
       "id": "p2220"
      }
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sankey = hv.Sankey(pd.concat([test,test2]))\n",
    "\n",
    "sankey.opts(width=900, height=500)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
